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Foreword
The proportion of older people in the
population is increasing in almost every
country. By 2050, around two billion people
globally will be aged 60 years or over.
Dementia is currently the seventh leading
cause of death among all diseases and
one of the major causes of disability and
dependency among older people globally. It
can be overwhelming not only for the person
living with dementia, but also for carers,
families and society as a whole.
The alarming estimates of increasing
numbers of people living with dementia
worldwide, especially in lower income
settings, cannot be ignored. Left
unaddressed, such an increase would
significantly undermine social and economic
development globally.
The COVID-19 pandemic presents health
systems, economies and societies globally
with an unprecedented challenge, particularly
for older populations. Older populations are
most at risk from severe disease and death
from COVID-19, and for people living with
dementia, the profound disruptions of the
pandemic are even more acute.

To achieve the goals of the Global action
plan on the public health response to dementia
2017-2025, we need a concerted effort
by all stakeholders to improve the lives of
people with dementia and their families. We
must work together as a global community,
coordinating research efforts and leveraging
the tools and knowledge at our disposal.
WHO is fully committed to working with
our Member States, civil society, the private
sector and people living with dementia and
their carers, to fulfil the targets in the Global
dementia action plan.
We are all ageing, and many of us will one
day need services for dementia. Building
the services and systems to prevent, delay
and mitigate the effects of dementia and
providing quality care for people with
dementia and their families is essential now,
and for the future in our ageing world.

Dr Tedros Adhanom Ghebreyesus
Director-General
World Health Organization

WHO
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Preface
The increasing global prevalence of dementia
and consequent social and economic impacts on
people living with dementia and their families
pose significant challenges for societies. Ageism,
stigma and social exclusion faced by people living
with dementia, their families and carers cannot
have a place in our society.

Dementia affects every country. A challenge
of this size cannot be tackled by working in
silos. We must combine forces, improve the
capacity of health systems to prevent and treat
dementia, share quality data, reach beyond our
traditional ways of conducting research, and
address dementia as a global community.

In recent years, the international community
has recognized the urgent need for action on
dementia. The Global action plan on the public
health response to dementia 2017-2025
represents this international commitment
to meaningfully improve the lives of people
with dementia, their families and carers. The
Global action plan proposes recommendations
across seven key action areas: dementia policy;
awareness and friendliness; risk reduction;
diagnosis, treatment, care and support; support
for carers; health information systems; and
research and innovation.

It is my hope that this report will shine a
light on ongoing challenges in the field of
dementia and present opportunities for
accelerating action globally. We must all
work together to ensure that people living
with dementia, their families and carers can
continue to live in their communities with
respect and dignity, while receiving the care
and support they need and deserve.

The Global status report on the public health
response to dementia takes stock of progress
made four years into the Global action plan.
Data presented in this report shows that
we must act urgently. We need renewed,
coordinated efforts by all stakeholders across all
action areas if we are to achieve the targets set
by the Global action plan.

Dévora Kestel
Director
Department Mental Health and Substance Use
World Health Organization

WHO
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Executive
summary
Chapter 1 Introduction
Dementia is a leading cause of disability and dependency globally. Lack
of awareness and understanding lead to widespread stigmatization
and discrimination against people with dementia, which may prevent
them from accessing diagnosis and care.
The Global action plan on the public health response to dementia
2017-2025 represents the formal commitment by WHO Member
States to develop comprehensive multisectoral responses to address
dementia worldwide. It contributes to WHO’s Triple Billion Targets
and achieving the United Nations Sustainable Development Goals
(SDGs) by improving timely diagnosis, treatment, (long-term) care and
rehabilitation for people with dementia; promoting population-wide
risk reduction efforts for dementia; and ensuring that the needs of
people with dementia and their carers are met within the context of
humanitarian crises and emergencies, such as the ongoing COVID-19
pandemic which has had a disproportionate impact on older people
and especially people living with dementia.

"People with dementia should be
involved in all stages in order to create
a positive dementia society."

Halfway into the implementation of the Global dementia action plan,
the Global status report on the public health response to dementia aims
to provide essential information to assess the global progress. It takes
stock of actions driven by Member States, WHO and civil society since
the adoption of the Global dementia action plan in 2017, identifies
barriers to its implementation especially in light of the COVID-19
pandemic, and highlights areas where urgent, accelerated action is
required. It is hoped that the report will lead to increased international
and national advocacy efforts and the prioritization of dementia on the
global health agenda.

Berrie Holtzhausen,
Namibia

WHO
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Target audience

Chapter 2 Global burden of dementia

This report is written for national and state policy-makers,
health-sector planners, academics and researchers,
organizations involved in dementia education and service
provision, as well as people living with dementia, their
carers and families.

Improvements in health care in the past century have
contributed to people living longer and healthier lives. As
a result, the world’s population is ageing. However, this
has also led to an increase in the number of people with
noncommunicable diseases (NCDs), including dementia.

Methodology

For this report, dementia prevalence estimates have been
updated on the basis of GBD2019 data, using age-specific
prevalence estimates for all-cause dementia by sex and age
group. Prevalence rates continue to increase progressively
with age, both for males and females.

This report is based on the first wave of
Global Dementia Observatory (GDO) data
collection, conducted between 2017 and
2020 and supplemented by WHO’s Global
health estimates (2019), the Global Burden of
Disease (GBD) study (2019) as well as case
studies and country examples.
The GDO collates country data on 35 key
dementia indicators that can strengthen
countries’ ability to respond to the needs
of people with dementia, their carers and
families. GDO data have been collected in a
phased approach across countries in WHO’s
six regions. To date, 62 Member States have
submitted GDO data, of which 56% are
high-income countries (HICs), while 44% are
low and middle-income countries (LMICs).
Together, countries participating in the GDO
account for 65.5% of the global population and

2
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76% of the population aged 60 years or older.
While a report that is largely based on survey
data from a subset of Member States certainly
bears its limitations, the fact that these
countries represent a large proportion of the
global population, especially for older adults,
lends credibility and confidence in the results
presented here.
The overall completion of GDO indicators
by countries was largely satisfactory but the
response rate was low for indicators that
reflected quantitative availability of services/
personnel/health infrastructure as well as the
number of people providing/receiving such
services. If the preparedness and response to
dementia is to be improved, it is key to support
countries in collecting quality and standardized
data in order to inform the design of sizeable
responses and targeted interventions.

Global status report on the public health response to dementia

It is estimated that in 2019 55.2 million people worldwide
were living with dementia. WHO’s Western Pacific Region has
the highest number of people with dementia (20.1 million),
followed by the European Region (14.1 million), the Region of
the Americas (10.3 million), the South-East Asia Region (6.5
million), the Eastern Mediterranean Region (2.3 million) and
the African Region (1.9 million).
Assuming that there will be no change in the age-specific
prevalence rates over the next decades and applying UN
population forecasts, it is estimated that there will be about
78 million people with dementia worldwide in 2030 and about
139 million in 2050. However, the prevalence of dementia
risk and protective factors has been changing – and continues
to change – in most regions. This can drastically influence
projections of dementia prevalence and incidence estimates.

55.2
million

people worldwide
living with dementia

Dementia is one of the leading causes of care dependency and
disability in old age, both in HICs and LMICs. In people aged 60
years and older, dementia is among the top ten causes of years
of healthy life lost due to disability (YLDs). Considering all
ages, dementia is the twenty-fifth cause of disability-adjusted
life years (DALYs) globally with an alarming trend. Over the
past 20 years, DALYs due to dementia more than doubled,
representing the biggest rate of increase among the Top 30
causes of DALYs. Also of concern is that globally, DALYs are
roughly 60% higher for women than for men.

Executive summary
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Population growth and improved longevity,
combined with increases of certain dementia
risk factors, have led to a dramatic increase
in the number of deaths caused by dementia
in the last 20 years. In 2019, 1.6 million
deaths occurred worldwide due to dementia,
making it the seventh leading cause of death.
Nearly half of these deaths occurred in HICs
and, similarly to what is observed for DALYs,
women represented roughly 65% of the total
number of dementia-related deaths.
While dementia risk may decline as societal
conditions improve with concerted efforts to
reduce risk factors and enhance protective
factors, persistent inequalities need to be

addressed in order to ensure that these
changes are equitable across societies.
Several barriers stand in the way of the
effective collection and sharing of quality
data. Accurate estimation of the impact of
dementia relies on robust and standardized
data with geographical and wide economic
representation. Enhancement in data quality
can be achieved by improving the overall data
infrastructure in countries, and especially
in LMICs, with accurate diagnosis and
reporting, with continuous and standardized
epidemiological data collection and with
relevant disaggregated information.

Chapter 3 Global societal costs of dementia
The overall consequences of dementia are
challenging for any health care system. Aside
from understanding the impacts on people with
dementia and their families, data on resource
use and costs in combination with prevalence
figures are essential for planning care
infrastructure. The availability of such data is
also vital to inform the design of public policies
that aim to mitigate the tremendous direct and
indirect economic impact of dementia on the
society and the implications that the economic
burden has for national health-care systems.
In 2019, the global cost of dementia was
estimated to be US$ 1.3 trillion. Most of
these costs occur in HICs although the
majority of people with dementia live in
LMICs. Based on the expected increase in
people with dementia over the next 10 years,
the global costs of dementia will increase to
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a projected US$ 1.7 trillion by 2030. If these
projections are corrected for increases in
care costs, global dementia costs will even
reach US$2.8 trillion by 2030.
Dementia care costs can be split into direct
medical costs, direct social (non-medical)
costs and informal care costs. Other cost
drivers for society and families include, for
example, the loss of carers’ productivity and
the early retirement of adults with young-onset
dementia, but are generally not included in the
estimates presented in this report.

South-East Asian and Eastern Mediterranean regions, the
proportion of the social care sector cost is low (<15%).
In 2019, informal dementia carers spent over 89 billion hours
providing support with activities of daily living (ADLs) – about
5 hours per day per person with dementia. Informal care
provision – the bulk of it provided by women (about 70%) – is
particularly high in countries with low resources where there
is a scarcity or lack of formal support services for dementia.
Dementia severity is an important driver of cost and the
proportion of mild, moderate, and severe dementia cases
living in a country can influence the cost estimates. The
annual per-patient costs increase steadily with increasing
dementia severity, ranging from US$16000 for mild
dementia, US$27000 for moderate dementia to US$36000
for severe dementia.
The cost of dementia worldwide has a significant impact on
care systems. Worryingly, long-term care systems in LMICs
are not well-prepared, placing a heavy burden on carers and
families and although the current estimates of the impact and
cost of dementia are markedly high, these numbers are likely
underestimating the true cost.

50%
Informal care
accounts for half
the global costs
of dementia

The estimation of global economic costs of dementia is
complex for various reasons. There is a lack of data from many
parts of the world, particularly from LMICs, and a scarcity
of population-based cohort studies that represent their
diverse communities. Available studies are often conducted
in small geographical areas and then extrapolated to whole
countries, and even regions. Moreover, many people with
dementia are not detected by the health-care system or may
not have a formal diagnosis and, as such, their numbers are
not routinely captured by national health information systems,
adding complexity to cost studies and potentially leading to an
underestimation of costs.

Informal care accounts for about half the
global cost of dementia, while social care
costs make up over one third. In LMICs,
the majority of dementia care costs are
attributable to informal care, while in HICs
informal and social care costs each amount to
approximately 40%. Particularly in the African,
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Chapter 4 Dementia policy
and legislation
National dementia plans represent important commitments
by governments to address dementia in partnership with
other relevant stakeholders such as civil society, academia,
health and social care providers, the private sector and people
with dementia. The Global dementia action plan reflects this
by setting the global target of 75% of Member States having
developed or updated a national policy, strategy, plan or
framework for dementia, either stand-alone or integrated into
other policies by 2025.

26%
of WHO Member
States have a
dementia plan
(stand-alone,
integrated or
subnational)
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Using GDO data and other available sources, 50 countries (26%
of Member States) currently meet this target. The majority of
existing national dementia plans are well aligned with the seven
action areas of the Global dementia action plan, although fewer
address the strengthening of health information systems for
dementia or prioritize dementia research and innovation. In
addition, while national dementia plans often put emphasis on
person-centred care, it is less common for them to outline how
care pathways are to be implemented, monitored and integrated
into existing service models across sectors.
Many national dementia plans also reflect the cross-cutting
principles of the Global dementia action plan by recognizing the
importance of human rights, multisectoral collaboration, equity,
empowerment and UHC. However, the needs of minority and
vulnerable populations remain largely unaddressed in national
dementia plans and people with dementia, their carers and
families need to be more comprehensively involved in policy
development and implementation processes.
The distribution of national dementia plans is largely
uneven across WHO regions, with half of the policies (n=26)
originating from the European Region and the remaining
reported from other regions. However, even within the
European Region, many plans are expiring, or have expired, and
require renewed commitment by governments to prioritize
dementia. HICs are more likely to create stand-alone national
dementia plans while LMICs tend to integrate dementia into
existing policies such as those for mental health or ageing.

Global status report on the public health response to dementia

Among countries with a dementia plan, there
is vast heterogeneity in funding allocation
as well as in implementation and monitoring
targets. While many national dementia plans
identify the need for financial investment,
few delineate mechanisms for mobilizing
and allocating funding (e.g. between national
and subnational levels of the health and
social care system). Similarly, while many
GDO countries (90%) include dementia in
their ministry portfolio, fewer (68%) have
appointed a dementia-specific government
unit or representative.
Of all GDO countries, just over two thirds
report having legal provisions that protect
the rights of people with dementia; few have
adopted dementia-specific legislation. The use of
coercive practices continues to exist in countries
with weak legislative and regulatory regimes.

In summary, many countries have insufficient
technical expertise and capacity to implement
national dementia policies, and there is an
ongoing lack of earmarked funding in national
health budgets. WHO resources such as the
Global Dementia Observatory Knowledge
Exchange Platform (www.globaldementia.
org) can help foster mutual learning and
policy exchange between countries, while
WHO’s Towards a dementia plan: a WHO
guide can provide support in developing and
operationalizing national dementia plans.
Technical support provided through national
and regional workshops in partnership with
WHO can also help strengthen national
capacity, facilitate intercountry learning, and
assist in rationalizing available resources to
improve the lives of people with dementia, their
carers and families.

Chapter 5 Dementia awareness
and inclusion
People with dementia, their carers and
families worldwide continue to experience
stigma, discrimination and human rights
violations. Moreover, dementia is frequently
misconceived as a natural and inevitable part
of ageing. The first step to dispelling myths and
stereotypes is to provide accurate information
to improve public understanding of dementia.
The Global dementia action plan recognizes
this by focusing one action area on
increasing public awareness, acceptance and
understanding of dementia and sets global
targets of reaching 100% of countries with at
least one functioning public awareness-raising

campaign on dementia and 50% of countries
with at least one dementia-friendly initiative
(DFI) to foster a dementia-inclusive society.
Across WHO regions, countries have made
good progress in implementing public
awareness campaigns to improve public
understanding of dementia, with strong
leadership by civil society. Of all GDO
countries, approximately two thirds reported
running awareness raising campaigns.
Similarly, two thirds of GDO countries
reported implementing initiatives to improve
the accessibility of the physical and social
environment for people with dementia.
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21%
of WHO Member
States with
awareness raising
campaign

Common dimensions addressed by DFIs include increasing
accessibility of public spaces and buildings, creating
community places where older people can meet, and offering
social opportunities and accessible information on leisure and
social activities. Placing people with dementia, and their carers
and families, at the centre of dementia awareness campaigns
and DFIs represents an important success factor for impact.

sustainability of dementia awareness raising efforts. WHO
resources such as Towards a dementia-inclusive society: WHO
toolkit for dementia-friendly initiatives can also provide support
for training and building the capacity of non-health and social
care professionals on dementia.

The Global dementia action plan further recommends
developing programmes to encourage positive attitudes
towards dementia in the community, informed by experiences
of people with dementia. One way of accomplishing this
is through training and education on dementia for groups
outside the health and social sector. According to GDO data,
two thirds of countries across all six WHO regions provide
training and education on dementia to populations outside the
health and social sector, with volunteers, police, fire services
and first responders/paramedics being the most commonly
trained groups. Further efforts are needed to educate
other population groups such as judges, solicitors, notaries,
community and city workers, and financial and retail staff,
particularly in LMICs.

Chapter 6 Dementia risk reduction

While notable progress is being made in both HICs and LMICs
to raise public awareness and improve the understanding
of dementia, there remains much stigma and discrimination
globally against people with dementia and their carers.
Well-resourced public awareness campaigns implemented
in partnership with civil society, people with dementia and
their carers, and other relevant stakeholders represent an
important actionable step towards achieving the targets
included in the Global dementia action plan. Regional
awareness-raising campaigns such as the joint Let’s Talk
about Dementia campaign of the Pan American Health
Organization (PAHO) and Alzheimer’s Disease International
(ADI) can provide strong impetus to implement national
efforts and a good example that can be replicated in other
regions of the world. Creating strategic links with the UN
Decade of Healthy Ageing 2020–2030 and integrating
dementia into existing initiatives – such as WHO’s Global
network for age-friendly cities and communities can ensure
that dementia is reflected within the context of broader
political agendas and thereby support the scale-up and
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Growing evidence suggests an interrelationship between
dementia on one side and NCDs and behavioural risk factors
– such as physical inactivity, unhealthy diets, tobacco use
and the harmful use of alcohol – on the other. NCDs that
are associated with the risk of cognitive impairment and
dementia include depression, hypertension, diabetes, hearing
impairments, mid-life hypercholesterolemia and obesity.
Additionally, air pollution and traumatic brain injuries are
increasingly being recognized as risk factors. At the same
time, access to formal education, employment and other
opportunities for cognitive stimulation – as well as social
connections – are considered protective.
The Global dementia action plan recognizes the inherent links
between dementia and other NCDs by linking its risk reduction
target directly to the Global action plan for prevention and
control of NCDs. Globally, from 2000 to 2016, the probability of
dying from cardiovascular diseases, cancer, diabetes and chronic
lung diseases has declined from 22% to 18% . Additionally,
there has been a roughly 2% decrease in both tobacco smoking
and heavy episodic drinking among people 15 years of age
or older, and a 1% reduction in the prevalence of high blood
pressure. However, these changes fall short of global NCD
targets. Physical inactivity in adults remains unchanged and the
prevalence of diabetes and obesity in adults have increased.
Importantly, the COVID-19 pandemic has presented major
challenges to NCD prevention and control. WHO’s two Pulse
surveys on continuity of essential health services during the
COVID-19 pandemic showed that many countries experienced
disruptions in services for diagnosis and treatment of NCDs.
Although 2021 showed improvements over 2020,

2%

decrease in tobacco
smoking and heavy
episodic drinking and

1%

reduction in the
prevalence of high
blood pressure
Physical activity
in adults remains
unchanged
Increase in the
prevalence of
diabetes and obesity
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persistent disruptions still continued,
potentially impeding global progress with
respect to NCD targets and thereby also
impacting dementia risk reduction efforts.
GDO data on efforts to reduce dementia
risk show that a large number of countries
(58%) have plans or guidelines for reducing
dementia risk. Of the countries that report
having clinical guidelines for dementia risk
reduction, about 78% are high-income and
most are in the European Region.
Almost half the GDO countries (45%) –
again most of them high-income – have
run dementia risk reduction campaigns
by television, radio, print, billboards and
social media. Most of these campaigns have
aimed either to reduce behaviours known
to be associated with cognitive decline or
to promote behaviours that prevent or slow
such decline. The majority of these campaigns
were organized at the national level by the
government, nongovernmental organizations
(NGOs) or the private sector.
Numerous barriers impede progress in the
area of dementia risk reduction – including
stigma and the lack of public awareness of
its importance, lack of financial resources
available for dementia risk reduction

programmes, inequitable distribution
of services, human resource limitations,
and lack of coordination between sectors
both nationally and locally. More recently,
the disruptions caused by the COVID-19
pandemic have held up dementia risk
reduction programmes.
Addressing the myriad of obstacles to
dementia risk reduction requires action
in multiple disciplines and sectors. First,
dementia risk reduction should be linked with
other programmes, policies, and campaigns
on NCDs. Second, evidence-based risk
reduction interventions should be developed,
delivered and promoted within primary care
settings. Both actions will require widespread
availability of training and education on
dementia risk reduction for the health
workforce. In support of these efforts, WHO
Regional Office for the Western Pacific has
implemented a successful awareness raising
campaign through social media. Finally,
progress can be achieved by developing
national and local dementia risk reduction
guidelines, utilizing WHO’s Guidelines on risk
reduction of cognitive decline and dementia and
devising national risk reduction programmes
using mDementia (prevention).

Chapter 7 Dementia diagnosis,
treatment and care
In line with the principle of universal health coverage, the
Global dementia action plan emphasizes that people with
dementia should have access to health and social services
when and where they need them, without financial hardship.
However, dementia is associated with complex care needs
and high levels of dependency and morbidity in its later
stages. Thus, dementia requires a range of services from both
within and outside the health sector – such as primary health
care, specialist medical care, community-based services,
rehabilitation, long-term care, and palliative care. Diagnosis is
the first step to accessing any dementia care and support. The
critical importance of early diagnosis is reflected in target 4
of the Global dementia action plan (i.e., that in at least 50% of
countries, the diagnostic rate for dementia is at least 50%).
Yet, less than half of GDO countries are currently able to report
on dementia diagnostic rates, falling short of the first condition
of the global target. This is of concern since GDO countries
are likely to be more “dementia-ready”. Therefore, the global
proportion of countries able to report on diagnostic rates is
expected to be far lower. Moreover, limited access to diagnostic
services creates barriers into achieving the second condition of
the global target, diagnosing at least 50% of dementia cases.

Only 29
GDO countries can
report on dementia
diagnostic rate

While most GDO countries (89%) report providing some
community-based services for dementia, provision is overall
19% higher in HICs than in LMICs. Similarly, HICs report up
to 51% more coverage in rural areas for community-based
dementia services compared to LMICs.
Anti-dementia medication, hygiene products, assistive
technologies and household adjustments are also more
available in wealthier countries and their cost is more likely
to be reimbursable than in LMICs, which has implications
for out-of-pocket costs to people living with dementia and
their families.
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Across GDO countries, the availability
of, or access to, dementia specialists –
namely neurologists, geriatricians, or
psychogeriatricians – varies greatly. The median
number of (psycho)geriatricians, for instance,
ranges from 0.02 per 100 000 population in
LMICs to 2.2 per 100 000 in HICs.
With the exception of few LMICs, mainly
HICs provide routine dementia training to
all professionals (e.g. doctors, specialists and
nurses) but not necessarily to all relevant
cadres (e.g. pharmaceutical personnel). The
majority of countries only train some health
professionals. Similarly, although dementiaspecific clinical guidelines, standards and
protocols are essential for strengthening
workforce capacity, fewer than two thirds of
GDO countries report having them available.
Many barriers impede progress in the area
of dementia diagnosis, treatment, care and
support. These include limited financial
resources, urban-versus-rural inequities, lack
of coordination between sectors, lack of public
awareness of dementia and pervasive stigma.

These barriers were further exacerbated during
the COVID-19 pandemic with disruption
of essential services for all NCDs, as well as
services for people with dementia. Urgent
investment in the scale-up and coordination
of evidence-based, culturally appropriate
services and interventions for dementia
across sectors and in all parts of world is
crucial for achieving not only the Global
dementia action plan’s vision but also
universal health coverage.
WHO has developed guidelines, tools and
packages which can be used to accelerate
action – such as WHO’s Mental Health
Gap Action Programme (mhGAP) and its
derivative products. Additionally, WHO’s
Package on Integrated Care for Older People
(ICOPE) give guidance on community-level
interventions to prevent, slow or reverse
declines in the physical and mental capacities
of older people. WHO’s Compendium of
interventions for UHC contains 22 actions
related to dementia risk reduction, diagnosis
and management.

Chapter 8 Support for carers of people living
with dementia
Most people with dementia are cared for
by family members or other unpaid carers,
especially in LMICs. Carers often face financial,
social and psychological stressors which have
an impact on their physical and mental health.
To prevent this from happening, dementia
carers need access to information, training,
and services, as well as social and financial
support. Reflective of this, the Global
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dementia action plan set the target of 75%
of countries providing support and training
programmes for carers and families of people
with dementia by 2025.
While three out of four GDO countries offer
services, supports or programmes for carers
of people with dementia, most of these are
provided in HICs. Yet, the bulk of informal care
is provided in LMICs. The most common
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types of carer services include training and education on
dementia management across the course of the disease,
psychosocial support for carers, respite services and
information or advice on legal rights. Fewer countries provide
comprehensive financial and social security benefits to
protect carers from financial risk. Moreover, caregiving
disproportionately affects women who are responsible for
roughly 70% of informal care hours globally, with the highest
proportion in LMICs.
In many LMICs, existing services and supports are concentrated
in the capital and main cities and tend to be underutilized due
to lack of knowledge about these programmes and associated
stigma. Carer services and supports are supplied by a mix of
non-profit, public and private providers, with NGOs providing
the majority of services in LMICs. While monitoring carer
service availability and effectiveness is important, including
ensuring that under-represented carer groups receive
appropriate support, much needs to be done to strengthen
health and social information systems in this area.

70%

of informal care is
provided by women

Up to
80%

higher access to
carer services in
rural areas in HICs

Across GDO countries, efforts to train the health and
social care workforce in dementia core competencies,
including assessment and treatment of carer distress,
remain insufficient. Moreover, few countries have standards,
guidelines or protocols for carer treatment and support.
In summary, carer policies, programmes and services remain
underfunded and underdeveloped due to an overreliance on
informal caregiving, which may in turn affect carers’ likelihood to
seek support. As a result, the availability of – and access to – carer
services remains particularly limited in LMICs. There continues
to be a global lack of legislation for ending discrimination and
ensuring carer protection in the form of social, financial and
disability benefits.
Health and social care workers in particular need to be
appropriately trained to manage carer stress and guide carers
through accessing services and resources. This has proven
particularly important within the context of COVID-19
which for many carers resulted in increased social isolation,
greater carer burden, and deterioration of physical and mental
health. In times of lockdowns and physical distancing, digital
interventions have gained momentum in facilitating
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carer access to training and support. WHO’s iSupport,
mDementia and e-mhGAP represent opportunities to
overcome barriers related to access and cost as well as service
discontinuation due to COVID-19, if adapted to the cultural,
accessibility and socioeconomic needs of carers.

Chapter 9 Dementia health
information systems and
monitoring

32%
of WHO Member
States reporting on a
core set of dementia
indicators through
the GDO
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Effective and routine data collection on key dementia
indicators is crucial to support the formulation and
implementation of policy, service planning and delivery and to
track progress. Similarly, regular monitoring helps to identify
trends in the prevalence of dementia risk factors, disease
impact and mortality. The Global dementia action plan set the
global target of 50% of countries routinely collecting a core set
of dementia indicators every two years by 2025.
As of 2020, 62 Member States (32%) participated in the GDO,
thus contributing to the global target. However, fewer than
20% of GDO countries report that they collect dementia data
at national level and report on it in a specific dementia report.
Similarly, routine collection of health information on people with
dementia is very limited. Less than one third of GDO countries
report routine monitoring of people with dementia. Those that
do use sources such as clinical records, administrative data,
and facility and household surveys. At the policy level, however,
of the countries that indicated having a dementia plan, the
majority include the promotion of monitoring and information
systems. Though, fewer than half routinely monitor the number
of people with dementia, revealing a gap between policy and
implementation. Many countries also lack routine monitoring of
medicine prescriptions, outpatient care and hospital admissions
for dementia.
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Several barriers stand in the way of
strengthening health information systems
for dementia. Resources are scarce to collect
data across different sectors, and adequate
digital infrastructure such as electronic medical
records using unique patient identifiers are
often lacking, hampering the integration of
data across sectors and providers into national
surveillance systems or patient registries,
especially in low-income settings. Moreover,
there is a pressing need to monitor health
inequality, using health data disaggregated by
relevant inequality dimensions to identify who
is being “left behind”.

WHO initiatives such as the GDO can help
countries to collect key dementia data to
strengthen their response to the needs
of people with dementia. Though overall,
more Member States need to participate
by contributing their data. WHO’s SCORE
technical package supports the development
and strengthening of health data and
information systems, while the WHO Health
Equity Monitor makes tools and resources
available for monitoring health inequalities.

Chapter 10 Dementia research and innovation
Developing new prioritization strategies and
implementing innovative health technologies
is paramount to advancing capabilities for
prevention, risk reduction, early diagnosis,
therapies and care for people with dementia.
Social and medical priorities must be
identified for dementia research to increase
the likelihood of effectiveness and real
progress. To stimulate dementia research
overall, the Global dementia action plan set a
target for doubling dementia-related research
output between 2017 and 2025.
Indexed peer-reviewed publications in
biomedical and life sciences databases serve
as a proxy for the amount of research being
conducted globally and can also be used to track
research output on different disease areas.
These data show that the research output on
other NCDs such as cancer, heart conditions,
kidney disease, diabetes and depression is up
to 14 times higher compared to research on

dementia. If the trend over the last 10 years is
sustained until 2025, we will not meet the 2025
target. Instead, we need more research, steeper
curves to meet the target and achieve similar
research outputs as other NCDs.
Whether or not a country has a research
plan appears to be linked to the country’s
income, as no low-income or lower-middleincome countries in the GDO reported having
such a plan. This contrasts with countries
of higher wealth, where almost one third of
upper-middle-income countries and half of
HICs report having national or subnational
dementia research plans.
The implementation of research plans needs
to be accompanied by appropriate funding and
infrastructure. Although funding allocation for
Alzheimer’s disease and other dementias has
increased in recent years, it is chiefly found in
HICs such as Canada, the United Kingdom and
the United States of America.
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Another important issue in dementia research is the
meaningful inclusion of people with dementia, their carers
and families in the entire research process, including
conceptualization and priority setting, decision in funding
allocation as well as evaluation of research outcomes. GDO
data show that, although some countries involve people with
dementia in the research process “frequently”, two thirds of
countries involve people with dementia either “rarely” or not
at all. If progress is to be realized, people with dementia – from
a diversity of backgrounds and areas – must be seen as key
stakeholders in research.

Other NCDs
have up to

14x
higher
research output
compared to
dementia

Global coordination is needed to address these challenges and
cultivate an equitable and collaborative environment in which
the output of dementia research can yield innovative results.
WHO strongly supports the inclusion of LMICs in dementia
research, while acknowledging country-specific needs.
The lack of dementia awareness, insufficient funding and a
fragmented research landscape represent major barriers to
effective research development and implementation. The
under-representation of LMICs due to scarce funding and
insufficient research capacity, together with the exclusion of
people with dementia and their carers from the development
of research, hinders inclusiveness which is an essential
approach in dementia research. Given the complexity of the
disease, dementia cannot be solved by working in silos.
In order to support worldwide innovation in our approach
to dementia, address the gaps and barriers that stand in the
way of effective actions, and increase research collaboration,
WHO is developing the Dementia Research Blueprint,
a global coordination mechanism to facilitate policy in
dementia research.
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Conclusion
The report clearly shows that renewed and
concerted efforts across all stakeholders are
needed to realize the vision of the Global
dementia action plan “to prevent dementia
and ensure that people with dementia and their
carers live well and receive the care and support
they need to fulfil their potential with dignity,
respect, autonomy and equality”. While important
progress has been made in achieving global
targets, there is much work left to be done.
Too few countries have prioritized dementia
in national policies, too many people with
dementia continue to lack access to diagnostic
and post-diagnostic services, and too high a
number of carers remain socially isolated due
to a lack of support.
There is a global need to place dementia on
national health agendas through policy forums
(including the G7 and G20) in order to achieve
the targets outlined in the Global dementia action
plan as well as create strategic links with existing
global commitments such as the 2030 Agenda
for Sustainable Development and its Sustainable
Development Goals (SDGs), UHC and the UN
Decade of Healthy Ageing 2021–2030. The
forthcoming Intersectoral global action plan
on epilepsy and other neurological disorders
also represents a unique opportunity to renew
concerted action for dementia within the broader
context of addressing neurological disorders.

Building back better in light of the COVID-19
pandemic necessitates working together as a
global community – with people with dementia,
their carers, governments, civil society, the
private sector, academia and international
organizations – to better coordinate their
efforts and leverage the tools and knowledge
that are available.
Urgent action is needed to ensure that all
countries have dementia policies and plans
(either stand-alone or integrated), including
components of dementia awareness, stigma
reduction, inclusiveness and risk reduction.
Strengthened health and social care systems
are required to ensure universal access to
dementia diagnosis, treatment and care, and
especially to reduce income and urban–rural
inequities. Carer programmes and services
must be developed and funded to reduce the
burden of informal caregiving and support
carers. Everywhere in the world, countries’
capacity needs to be increased to maintain
health information systems for dementia and
monitor core indicators to guide evidencebased actions and monitor progress. Finally,
global investment and the meaningful
participation of people with lived experience
are imperative for dementia research
programmes, especially in LMICs.
WHO stands ready to work hand-in-hand
with Member States, civil society and other
partners to increase efforts to accelerate
dementia actions worldwide, bringing us
closer to the 2025 targets and making sure
we leave no one behind.
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1. Introduction
A global public
health matter
80%
of the older
population will
be living in
LMICs by 2050

World demographic changes will challenge societies in many
ways. For instance, increasing life-expectancy and population
ageing lead to increases in certain noncommunicable diseases
(NCDs) such as dementia. However, although dementia mainly
affects older people and age is the most important risk factor
for dementia, dementia is not an inevitable part of ageing.
Dementia is one of the major causes of disability and care
dependence among older people worldwide (1). It can be
overwhelming not only for the individuals who have dementia
but also for their carers and families. There is often a lack
of awareness and understanding of dementia, resulting in
stigmatization and barriers to diagnosis and care. In many
countries, health and social care systems are not prepared
for the current – let alone future – numbers of people with
dementia. The World Health Organization (WHO) has been
working in collaboration with Member States to make dementia
a public health priority through the implementation of the
Global action plan on the public health response to dementia
2017-2025 (2). See Annex 1 of this report for more information.

“I was Helen before the diagnosis,
and I’m still the same Helen after
the diagnosis.”
Helen Rochford-Brennan,
Ireland

WHO
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BOX 1

What is dementia?
Dementia is a syndrome, usually of a chronic or progressive nature, that leads
to deterioration in cognitive function (i.e. the ability to process thought) beyond
what might be expected from the usual consequences of biological ageing.
Dementia affects memory, thinking, orientation, comprehension, calculation,
learning capacity, language and judgement. Consciousness is not affected. The
impairment in cognitive function is commonly accompanied, and occasionally
preceded, by changes in mood, emotional control, behaviour or motivation.
Dementia results from a variety of diseases and injuries that primarily or
secondarily affect the brain, such as Alzheimer’s disease or stroke.

Moreover, in addition to a high proportion
of deaths related to COVID-19 in long-term
care facilities, there were reports in some
countries of unexplained increased numbers
of deaths among people with dementia, with
83% more deaths than expected among
people with dementia reported in England
and Wales in April 2020 (6). These increased
deaths reported in 2020 may be due to factors
such as interruptions in routine care, breaks
in medication supply chains and resultant
medication stock-outs, decreased access to
emergency services, and the psychosocial
impacts of public health measures designed to
control the pandemic (7, 8).

In addition to the direct impacts of COVID-19,
the societal impacts of the pandemic (namely
persistent stress, economic scarcity and social
isolation) can affect brain health. Studies
around the world are beginning to show
the impacts of the pandemic on outcomes
in people living with dementia – including
brain health, quality of life, mental well-being
and overall health (9). It is therefore more
important than ever to review progress and
develop plans to build back better in order to
strengthen health and social care systems for
people with dementia.

WHO’s response to the COVID-19 pandemic

COVID-19 and dementia
The world was transformed in 2020 by the
COVID-19 pandemic which continues to
present health systems, economies and
societies globally with one of the biggest
challenges of the past 100 years. The burden
and losses in terms of mortality and morbidity
have been particularly high among older
people, and especially people with dementia,
for multiple reasons. First, people with preexisting neurological conditions, including
dementia, are more vulnerable to SARSCoV-2 infection, including having higher
risks of severe outcomes and mortality (3).
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A WHO-commissioned rapid review on
pre-existing neurological conditions and
COVID-19 showed that cerebrovascular
disease and dementia/neurodegenerative
diseases were most frequently associated
with severe COVID-19 disease (4). These
conditions were also independently
associated with longer hospital stays and
greater mortality, with a high proportion
of deaths due to COVID-19 in residents of
long-term care facilities, many of whom have
underlying neurological conditions (5).
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From the earliest days of the pandemic, WHO took the lead in
providing important information about the virus to the global
community, including for people with neurological conditions,
older adults, and people living with dementia and their carers.

"The burden and losses
of the COVID-19 pandemic
have been particularly
high among older people,
and especially people with
dementia and their carers."

Dementia - a public health matter

WHO
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BOX 2

WHO COVID-19 guidance and tools relevant to dementia
and other neurological conditions
WHO has highlighted the direct and indirect impacts of the pandemic on older adults, including
people living with dementia and their carers, with the following guidance, tools and reports:
WHO Clinical management of COVID-19:
interim guidance, 27 May 2020
WHO COVID-10 Clinical management:
living guidance, 25 January 2021
Coronavirus disease (COVID-19): Risks
and safety for older people, 8 May 2020
UN policy brief: The Impact of
COVID-19 on older persons
IASC older adults toolkit: Living with the
Times, a toolkit specifically to help older
adults maintain good mental health and
well-being during the pandemic
iSupport Lite
WHO infection prevention and control
guidance for long-term care facilities
in the context of COVID-19, update 8
January 2021
Disability considerations during the
COVID-19 outbreak, 26 March 2020.
Maintaining essential health services:
operational guidance for the COVID-19
context (interim guidance), 1 June 2020

Second round of the national pulse
survey on continuity of essential health
services during the COVID-19 pandemic,
23 April 2021
The impact of COVID-19 on mental,
neurological and substance use
services: results of a rapid assessment,
5 October 2020
Preventing and managing COVID-19
across long-term care services: policy
brief, 24 July 2020
Rehabilitation considerations during the
COVID-19 outbreak, 26 April 2020
Support for rehabilitation: selfmanagement after COVID-19 related
illness, 25 June 2020
WHO Neurology & COVID-19 Global
Forum, established by WHO’s Brain
Health Unit in June 2020 in order to
address the myriad challenges raised
by the pandemic related to neurology.
A working group was set up to examine
the Provision of Essential services and
disruptions to care. A rapid review
was undertaken to identify effective
mitigation strategies for disruptions (10).

Pulse survey on continuity of essential
health services during the COVID-19
pandemic: interim report, 27 August 2020
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Aims and objectives
of this report
2020 marked five years since the first WHO Ministerial
Conference on Global Action Against Dementia (11) and
coincided with the first progress report on the Global
dementia action plan to the Seventy-third World Health
Assembly. It was therefore an opportune time to take stock
of the actions carried out by Member States, WHO and civil
society since the adoption of the action plan and to identify
existing gaps. Most importantly, this was an opportunity to
outline ways in which progress can be accelerated during the
remaining five years of the Global dementia action plan with
the aim of achieving the SDGs by 2030.
The Global status report on the public health response to
dementia aims to provide essential information to gauge
global progress in implementation of the Global dementia
action plan. The report highlights the progress made to date
and identifies areas where accelerated action is required. It is
hoped that the report will lead to continued (and intensified)
high-level commitment and investment in dementia,
increased international and national advocacy efforts and the
prioritization of dementia on the global health agenda.

20172025

Global dementia
action plan

Target audience
The target audiences for the report include not only national
and state ministries of health, policy-makers and health sector
planners, but also academics and researchers, organizations
involved in education and in health and social service provision
for older people and people living with dementia, and people
living with dementia and their carers and families.
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Methodology
Global monitoring of dementia

Visit the GDO data portal
www.globaldementia.org

The Global status report on the public health response to
dementia uses information collected from countries through
the Global Dementia Observatory (GDO), which is WHO’s
monitoring mechanism for the Global dementia action plan.
GDO data collection started in 2017 with 21 countries and
has since been expanded. The information outlined in this
report represents a subset of the data collected and serves as
both an accountability mechanism and a tool for countries to
monitor dementia policy and service delivery across the seven
action areas of the Global dementia action plan. Member
States are encouraged to submit up-to-date data to the GDO
approximately every two years to allow for accurate and
relevant progress monitoring.
The information provided in this report highlights the
persistent need for strengthened health information systems
for dementia in order to collect and use reliable data that will
ultimately inform the development of evidence-based policies.
The COVID-19 pandemic has reinforced the need to develop
robust health information systems in all countries to enable
accurate monitoring of health information, resources and
service provision. Especially in the case of dementia, given
the predicted rise in prevalence, the existence of efficient and
reliable health information systems will play a vital role.
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The Global Dementia
Observatory (GDO)
As the monitoring and accountability mechanism for the
Global dementia action plan, the GDO collates data from
WHO Member States on 35 key dementia indicators.
Together, the 35 GDO indicators and sub-indicators from
a comprehensive logic model of input, output and outcome
measures to monitor progress and impact across the Global
dementia action plan's seven strategic areas at national and
global level.
Monitoring this information over time will strengthen countries'
ability to respond to the needs of people with dementia, their
carers and families and enable us collectively to achieve the
vision of the Global dementia action plan (Figure 1, page 26).

FIGURE 1

The Global Dementia Observatory (GDO) framework
ACTION AREA

INPUTS

OUTPUTS

OUTCOMES

IMPACT

VISION OF GLOBAL ACTION PLAN

Indicators:
POLICY AND
LEGISLATION

1 governance
2 policy/plan
3 legislation for dementia
5 care coordination mechanism

Dementia is a public health
priority for countries

AWARENESS/
FRIENDLINESS

2 policy/plan
13 awareness raising campaigns
14 dementia-friendly environments
15 training and education of population groups

Society is aware of dementia
and inclusive of people with
dementia and their carers

RISK
REDUCTION

2 policy/plan
4 standards & guidelines
13 risk reduction campaigns
28-35 prevalence of dementia risk factors

Dementia risk factors are
reduced at population-level

DIAGNOSIS,
TREATMENT
AND CARE

2 policy/plan
4 standards & guidelines
5 care coordination mechanism
6 workforce
7 diagnostic rate
8 community-based services
9 dementia care facilities
10 anti-dementia medicines/care products
11 dementia NGO

People with dementia are
diagnosed in a timely manner
and receive the services that
they need

CARER
SUPPORT

2 policy/plan
4 standards & guidelines
12 carer support services

Dementia carers receive the
support that they need

INFORMATION
SYSTEMS

16 dementia monitoring
21-22 prevalence and incidence
23-24 mortality/deaths
25-26 disability associated with dementia
27 economic costs

Disaggregated key dementia
data are available at
country-level

RESEARCH AND
INNOVATION

17 research agenda
18 research investment
19 involvement of people with dementia in research
20 research output

Dementia research is
strengthened and streamlined

A world in which dementia
is prevented and people
with dementia and their
carers live well and receive
the care and support they
need to fulfil their potential
with dignity, respect,
autonomy and equality

Dark green indicators are used to monitor global targets
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Data collection process

65.5%

GDO data have been collected in a phased approach across
countries in WHO’s six regions. WHO worked closely across its
three organizational levels (headquarters, regional and country
level) to identify high-income countries (HICs) and low- and
middle-income countries (LMICs) interested in participating in
the GDO. Each country identified a national GDO focal point
responsible for coordinating data collection across government
agencies and national and subnational stakeholders. WHO
supported national GDO focal points through onboarding/
orientation meetings with relevant stakeholders and ongoing
technical assistance. Onboarding meetings provided national
GDO focal points with an overview of the GDO framework and
indicators, how the GDO was developed, the data collection
process and the supporting resources available, including the
GDO Reference Guide1. The GDO e-tool, a smart online survey,
facilitated the data collection process. A unique password
was shared with each country’s GDO focal point to access the
e-tool, which included questions corresponding to each of the
GDO’s 35 indicators. The GDO e-tool could be shared by the
GDO focal point with relevant stakeholders for data-collection
purposes before data were submitted.

of world's population
covered by the GDO

1 The Global Dementia Observatory (GDO) Reference Guide, available here https://www.who.int/publications/i/item/whomsd-mer-18.1

28

INTRODUCTION

Global status report on the public health response to dementia

Countries participating in the Global Dementia Observatory by WHO region

African Region

Region of the Americas

Eswatini

Belize

Grenada

Bangladesh

Mauritius

Brazil

Guyana

India

South Africa

Canada

Saint Lucia

Maldives

Togo

Chile

Trinidad and Tobago

Myanmar

Costa Rica

United States of
America

Thailand

Dominican Republic

Western Pacific
Region
Australia

Italy

Iran
(Islamic Republic of)

Cyprus

Lithuania

Jordan

China

Czechia

Malta

Lebanon

Cook Islands

Denmark

Netherlands

Morocco

Fiji

Estonia

Norway

Oman

Japan

Finland

Poland

Pakistan

Malaysia

France

Slovenia

Qatar

Republic of Korea

Germany

Sweden

Tunisia

Singapore

Greece

Switzerland

Hungary

Turkey

Ireland

United Kingdom

Austria

Israel

Belgium
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GDO data analyses in this report are
complemented by a selection of country
spotlights. These relate to one of the seven
action areas and/or cross-cutting principles
included in the Global dementia action
plan. Case studies focusing on advances
or changes in legislation, policy, or reforms
with an impact on dementia were also
accepted. The country spotlights included in

this report were selected on the basis of: 1)
their potential to illustrate good practice in
one of the seven action areas of the Global
dementia action plan; 2) their relevance to key
messages identified in each of the chapters;
and 3) representation across income levels
and geography. All case studies submitted by
countries to WHO can be accessed on the
GDO Knowledge Exchange Platform.

Limitations
Eastern
Mediterranean
Region

European Region

30

South-East Asia
Region

Country spotlights/case studies

Global status report on the public health response to dementia

Brunei Darussalam

Viet Nam

A number of limitations should be taken
into consideration when reading this report.
The information presented here represents
the first wave of GDO data collection. Over
a period of three years (2018–2020), 62
countries formally submitted their GDO data
to WHO. While these countries account for
almost two thirds of the world’s population,
this represents a response rate of only 31.9%
(62 of 194 WHO Member States) globally,
with large regional variation. Although
GDO data coverage in the WHO European
and South-East Asia regions reaches
45%, response rates in other regions are
substantially lower, especially in the African
Region (8.5%, or 4 out of 47 countries). While
a report that is largely based on survey data
from a subset of Member States certainly
bears its limitations, the fact that these
countries represent a large proportion of the
global population, especially for older adults,
lends certain credibility and confidence in the
results presented here.

Another limitation is the fact that the data
included in the report are self-reported by the
appointed representatives in WHO Member
States. Moreover, the long time lag between
the first and last country submissions of
GDO data necessitates timely repetitions
of the data-collection effort to ensure data
currency and recency. An additional limitation
is observed in the small number of GDO
indicators pertaining to social care services.
Furthermore, most available GDO data come
from high-income or upper-middle-income
countries, where the availability of services is
higher when compared to LMICs.
Throughout the report, data displayed in tables
and graphs may not sum up to the total number
of GDO countries because not all countries
were able to provide data for all indicators or
sub-indicators. Additionally, one GDO country,
Cook Islands, does not have a World Bank
classification for the reference year, and for
this reason their responses were not included
in analyses disaggregated by income-levels.
Dementia - a public health matter

WHO
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Thus, monitoring of the Global dementia
action plan and dementia activities globally
continues. As countries participate in
future rounds of GDO data collection, more
comprehensive analyses concerning dementia

trends will be the subject of future reports.
A particular effort will be made to support
the submission of data from LMICs, thus
improving the accuracy of data on dementia at
global and regional levels.

Contents of this report
The Global dementia status report dedicates
one chapter each to the global burden and
economic costs of dementia, as well as one
chapter each to the seven strategic action
areas of the Global dementia action plan.
Throughout the report, reference is made to
the ongoing COVID-19 pandemic and how it
has affected, and continues to affect, progress
in each area.

It should be noted that the chapters do not
represent comprehensive literature reviews.
Rather, the goal is to provide a global overview
of the current status relative to each of the
action areas and associated targets included in
the Global dementia action plan based on GDO
data, complemented by illustrative examples
and information from peer-reviewed and grey
literature. The chapters are as follows:

Chapter 2: Global burden of dementia – This chapter provides an overview
of the epidemiology of dementia, with updated estimates for dementia
prevalence derived from GBD 2019 data and latest disability and mortality
figures based on WHO’s Global health estimates of 2019. Estimates are
reported globally, by WHO region as well as World Bank income classification
from 2019 and are disaggregated by age and sex where feasible.
Chapter 3: Global societal costs of dementia – This chapter discusses
the global societal costs of dementia, showing costs associated with
direct medical care, direct social care and indirect/informal care. Data
are presented globally, by WHO region, World Bank income level, and for
different types of dementia severity. This chapter also puts a focus on the
disproportionate cost of dementia on women (since the majority of care
providers, both formal or informal, are women).
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Chapter 4: Dementia policy and legislation – This chapter provides an
overview of global progress to date in the area of dementia as a public health
priority, including as it relates to dementia policy and legislation. It begins by
assessing country-driven progress based on GDO data and other sources and
provides a complementary analysis of national dementia policies, including
continuing gaps and opportunities as well as country case studies. The
chapter closes with activities of WHO’s secretariat to support countries in
developing and implementing national dementia plans, and recommendations
to accelerate future action.
Chapter 5: Dementia awareness and inclusion – This chapter highlights
global progress made to date in dementia awareness and friendliness. The
chapter begins by assessing country-driven progress based on available GDO
data. It also identifies success factors associated with dementia awareness
campaigns and dementia initiatives that have had positive impacts, ongoing
gaps and opportunities to improve the social and built environments, good
practices in including people with dementia and their carers in decisionmaking, and the impact of COVID-19 on efforts related to dementia
awareness and friendliness. The chapter outlines spotlight activities carried
out by WHO’s secretariat and regional offices to support countries in raising
public awareness of dementia and fostering dementia-inclusive environments.
Chapter 6: Dementia risk reduction – This chapter showcases the best
available evidence for reducing dementia risk, including WHO’s normative work
in this area and progress reported by countries in addressing dementia risk
factors – including high-level commitments agreed on for the prevention and
control of NCDs. Data are presented by WHO region and World Bank income
classification. The chapter additionally outlines spotlight activities, country case
studies and opportunities to accelerate action for dementia risk reduction.
Chapter 7: Dementia diagnosis, treatment and care – This chapter
summarizes the global progress made in improving dementia diagnosis
and care pathways, beginning with diagnosis and continuing through postdiagnostic support, treatment and rehabilitation to palliative and end-of-life
care. The chapter makes linkages to WHO’s normative work in this area,
including mhGAP, Guidelines on Integrated Care for Older People (ICOPE),
the Package of Interventions for Rehabilitation (PIR) for dementia and
quality services for Mental Health. The chapter additionally outlines spotlight
activities, country case studies and opportunities to accelerate action in the
area of dementia care pathways.
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WHO

33

Chapter 8: Dementia carer support – This chapter details global progress in
the area of dementia carer support based on GDO data and complementary
evidence-based examples and information. The chapter addresses the impact
of COVID-19 on carers’ mental health and outlines spotlight activities carried
out by WHO’s secretariat to assist countries in supporting carers of people
with dementia. Country case studies are also included.
Chapter 9: Health information systems for dementia – This chapter focuses
on demonstrating the importance of health information systems and their
capacity to monitor population-level core dementia indicators systematically
and routinely. It discusses how data collection is vital to guide evidence-based
actions to improve services and to measure progress in the implementation of
national dementia policies. It also identifies gaps and opportunities associated
with monitoring dementia data across countries.
Chapter 10: Dementia research and innovation – This chapter provides an
overview of country-driven progress in implementing and funding dementia
research programmes, as well as the current status of dementia research
output. Data are reported globally, as well as being disaggregated by WHO
regions and World Bank income levels. The chapter analyses the current
status of dementia research worldwide, draws attention to the participation
of people with dementia and their carers in research processes, and identifies
existing gaps and opportunities for improvement.

"It is hoped that the report will
lead to increased international
and national advocacy efforts and
the prioritization of dementia on
the global health agenda."
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2. Global burden
of dementia
Context

55 million
people with dementia

The world’s population is ageing. Improvements in health
care in the past century have contributed to people living
longer and healthier lives. However, this has also resulted in
an increase in the number of people with NCDs, including
dementia (12). Today, dementia is one of the commonest
neurological disorders and, according to the latest Global
health estimates 2019, released in December 2020, it is the
seventh leading cause of death (1). Although dementia mainly
affects older people and its incidence increases with age, it is
not an inevitable part of ageing.
Based on WHO’s Global health estimates 2019 (1), the
Global Burden of Disease (GBD) 2019 estimates (13) and
UN population data (14), this chapter provides updated
global, regional estimates of dementia prevalence, disability
and mortality.

“There is not enough focus or
not enough information available
about dementia”
Sheshadri K. S.
India

WHO
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Dementia prevalence
In 2017, the number of people living
with dementia worldwide was estimated
at approximately 50 million and was
anticipated to triple by 2050 because of the
expected changes in the world population’s
demographic structure (15).
These estimates have been updated using a
new approach based on the latest GBD data.

There is a marked variation in prevalence
among adults aged 65 years and over across
regions, ranging from 4% in the South-East

The updated prevalence estimates for allcause dementia by sex and age group are
presented in Figure 2 and Table 1. The
progressively increasing risk of dementia
associated with age is reflected in higher
prevalence rates in older age groups for both
males and females.

Global dementia prevalence rates by sex and age

0.2%

0.2%

0.2%

60–64

1.0%

1.1%

1.1%

65–69

1.9%

2.2%

2.1%

3.5%

4.3%

3.9%

75–79

80–84

85–89

90+

6.4%
11.7%
18.4%
28.9%

Dementia prevalence estimates (%), by sex (male, female, all),
age group (5-year age bands) and WHO regions
Age group (years)

WHO
region

Region
of the
Americas

40–59

70–74

TA B L E 1

African
Region

FIGURE 2

8.2%

South-East
Asia Region

7.4%

15.0%

Europe
Region

13.6%

23.9%

21.9%

39.0%

35.9%

Eastern
Mediterranean Region

Western
Pacific
Region
Global Male

Global Female

Global All

Asia Region to 8.5% in the European Region.
However, most of the estimated prevalence
figures lie in a band between 5% and 8%.

60-64 65-69 70-74 75-79

80-84

85-89

90+

M

0.14% 0.81% 1.49% 2.73% 5.00%

9.10%

15.47%

27.84%

2.53%

3.57%

F

0.15% 0.94% 1.89% 3.75% 7.05% 12.43% 19.90%

32.81%

3.65%

5.13%

All

0.15% 0.88% 1.71% 3.30% 6.17% 11.07% 18.15%

30.86%

3.14%

4.44%

M

0.23% 1.07% 2.12% 4.19% 7.43% 12.88% 19.89%

32.70%

5.05%

6.83%

F

0.24% 1.03% 2.10% 4.35% 8.13% 14.64% 23.40%

40.54%

6.67%

8.88%

All

0.23% 1.05% 2.11% 4.27% 7.82% 13.89% 22.05%

37.95%

5.94%

7.97%

M

0.13% 0.75% 1.37% 2.50% 4.55%

8.10%

12.79%

19.32%

2.49%

3.50%

F

0.16% 0.99% 1.84% 3.17% 5.36%

9.10%

14.01%

22.22%

3.31%

4.52%

All

0.15% 0.87% 1.61% 2.85% 4.99%

8.67%

13.49%

21.04%

2.92%

4.04%

M

0.19% 0.86% 1.65% 3.27% 6.55% 12.20% 19.07%

29.07%

4.76%

6.34%

F

0.22% 0.99% 2.02% 4.19% 8.45% 15.64% 24.98%

39.05%

7.73%

9.95%

All

0.21% 0.93% 1.85% 3.79% 7.67% 14.35% 22.96%

36.32%

6.47%

8.46%

M

0.16% 1.03% 2.00% 3.70% 6.85% 12.54% 20.80%

32.98%

3.81%

5.44%

F

0.18% 1.12% 2.24% 4.29% 7.84% 13.83% 22.19%

36.94%

4.51%

6.33%

All

0.17% 1.07% 2.12% 4.01% 7.37% 13.22% 21.54%

35.25%

4.17%

5.89%

M

0.22% 1.23% 2.24% 3.90% 7.09% 12.63% 19.49%

29.46%

4.26%

5.68%

F

0.25% 1.35% 2.62% 5.08% 9.90% 17.84% 27.44%

42.87%

6.96%

9.21%

All

0.23% 1.29% 2.43% 4.52% 8.63% 15.66% 24.53%

39.01%

5.68%

7.59%

Sex

40-59

Dementia Dementia
prevalence prevalence
60+
65+

Note: Data are derived from IHME age-specific prevalence and UN population statistics.
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Having applied the age-specific, or age- and
sex-specific, prevalence estimates to UN
population projections (14), it was estimated
that, in 2019, 55.2 million people worldwide
were living with dementia (Table 2). WHO’s
Western Pacific Region has the highest number
of people with dementia (20.1 million), followed
by the European Region with 14.1 million and
the Region the Americas with 10.3 million.
These differences are only in part explained by
the different demographic structures across

regions and may represent other geographical
variations that are worth exploring.
On the assumption that there will be no
change in the age-specific prevalence rates
over the coming decades and applying UN
population forecasts, it is estimated that there
will be some 78 million people with dementia
in 2030 and about 139 million with dementia
in 2050 (Figure 3).

of epidemiological data between neighbouring
countries within regions relies on assumptions
that may not hold as the epidemiological
transition unfolds, and the prevalence of
dementia risk factors varies markedly over
time and between countries.
Importantly, the prevalence of dementia is
higher for women than men over the age of
65 years in all WHO regions and also globally
(5.4% versus 8.1%, respectively). Many

reasons have been posited for this trend,
including potential biological differences
between women and men (including
epigenetic and hormonal differences),
differential exposure to risk and protective
factors across the life course (including
opportunities for education and cognitive
stimulation), and longer life expectancy for
women in many parts of the world, among
other factors (16).

TA B L E 2

FIGURE 3

Estimated number of people living with dementia (millions) by WHO region

Number of people living with dementia in 2019, 2030 and 2050
(in million) by country income group
139 M

Region
GLOBAL

78 M

Crude estimated
Number of people
Number of people
prevalence (%) with dementia (millions)
with dementia
over 65 years
over 65 years
(millions)

697.3

6.9

48.4

55.2

African Region

34.1

4.4

1.5

1.9

Region of the Americas

115.8

7.9

9.2

10.3

South-East Asia Region

130.7

4.0

5.3

6.5

European Region

154.3

8.5

13.1

14.1

Eastern Mediterranean
Region

32.6

5.9

1.9

2.3

Western Pacific Region

229.8

7.6

17.5

20.1

Low-income

22.0

5.0

1.1

1.4

Lower-middle-income

164.6

4.4

7.2

8.8

Upper-middle-income

291.7

6.9

20.1

23.6

High-income

219.7

9.1

20.0

21.4

WHO region

55 M

2019

Population
over 65 years
(millions)

2030

2050

High-income countries

Lower-middle-income countries

Upper-middle-income countries

Low-income countries

Income level

These estimates are slightly lower than
previously calculated (15). The primary data
and the modelling approaches used for the
previous and new estimates calculations both
differed as they are based on slightly different
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assumptions. Moreover, these discrepancies
should be interpreted with caution because
direct estimates of dementia occurrence and
impact are still lacking or are out-of-date for
most countries worldwide. The extrapolation
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Since population ageing is occurring at
an unprecedentedly fast rate in low- and,
particularly, middle-income countries, the
bulk of the increase in numbers through
to 2050 will occur in those regions (17).
The prevalence of dementia risk and
protective factors is also changing in most
of these regions. While average educational
attainment increases and other modifiable
risk factors are better addressed and
treated, inequalities may become more

marked and create barriers to preventative
measures. Moreover, other factors such
as air pollution, unhealthy diets, reduced
physical activity and social isolation may
contribute to worsen risk profiles in
populations. As such, addressing modifiable
risk factors by finding synergies with other
risk reduction campaigns, implementing
existing evidence into policies and tackling
social inequalities can drastically influence
future dementia prevalence and impact.

Disability associated
with dementia
Dementia is one of the leading causes of
care dependence and disability in old age,
both in HICs and LMICs (11). While older
people can often cope well and can remain
relatively independent even with marked
physical disability, the onset of cognitive
impairment may compromise their ability to
carry out complex but essential tasks in daily
life. In addition, people living with dementia
will increasingly have difficulty in meeting
their basic personal care needs (11). It should
be noted that this is highly dependent on
a person’s social and familial context, with
potential for maintenance of independence in
many settings for considerable periods.
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One of the parameters used to estimate
disease burden is the number of years of
life lived in states of less than full health, or
years of healthy life lost due to disability
(YLDs). Based on age-disaggregated data for
people aged 60 years and older, dementia is
among the top ten causes of YLDs. Disease
burden can be assessed by using the
disability-adjusted life year (DALY), a timebased measure that combines years of life
lost due to premature mortality (YLLs) and
the aforementioned YLDs (18). One DALY
represents the loss of the equivalent of one
year of full health.

TA B L E 3

Top 30 causes of DALYs in 2019
Rank

Cause

DALYs (000s)

Rank

Cause

DALYs (000s)

1

Neonatal conditions

201 820

16

HIV/AIDS

40 146

2

Ischaemic heart disease

180 846

17

Other hearing loss

39 476

3

Stroke

139 428

18

Falls

38 215

4

Lower respiratory
infections

105 652

19

Malaria

33 398

5

Diarrhoeal diseases

79 311

20

Uncorrected refractive
errors

31 981

6

Road injury

79 115

21

Self-harm

31 864

7

Chronic obstructive
pulmonary disease

73 980

22

Interpersonal violence

30 254

8

Diabetes mellitus

70 410

23

Gynecological diseases

28 448

9

Tuberculosis

66 024

24

Anxiety disorders

28 415

10

Congenital anomalies

51 796

25

Alzheimer’s disease and
other dementias

28 352

11

Back and neck pain

46 531

26

Iron-deficiency anaemia

28 287

12

Depressive disorders

46 358

27

Migraine

26 832

13

Cirrhosis of the liver

42 798

28

Other circulatory diseases

25 470

14

Trachea, bronchus,
lung cancers

41 377

29

Other endocrine, blood
and immune disorders

23 739

15

Kidney diseases

40 570

30

Asthma

21 706

Based on recent data from the WHO Global
health estimates and considering all ages,
dementia is the twenty-fifth leading cause of
DALYs (Table 3).

Global status report on the public health response to dementia

Global burden of dementia

WHO

43

It is concerning that, when compared to the top 30 causes
of DALYs between 2000 and 2019, dementia yields the
highest rate of increase, with DALYs due to dementia more
than doubling in this 20-year period (Figure 4).

The disease burden expressed as DALYs
disaggregated by sex allows us to further
understand the different impact on women
and men. The Global health estimates data
show the disproportional impact of dementia
on women, with DALYs being roughly 66%
higher for women considering the 60 year and
over population. Although large variations

FIGURE 4

DALYs variation among the top 30 causes (2000–2019)
122%

Alzheimer's disease and other dementias

83%

Diabetes mellitus

49%
46%
44%
42%
36%
36%
32%
31%
30%
29%
28%
26%
22%
11%
11%
9%
6%
5%

Oral conditions
Other hearing loss
Kidney diseases
Hypertensive heart disease
Trachea, bronchus, lung cancers
Back and neck pain
Uncorrected refractive errors
Migraine
Falls
Depressive disorders
Anxiety disorders
Ischaemic heart disease
Gynecological diseases
Stroke
Cirrhosis of the liver
Chronic obstructive pulmonary disease
Road injury
Iron-deﬁciency anaemia
Asthma
Interpersonal violence
Congenital anomalies
Self-harm
Tuberculosis
Neonatal conditions
Lower respiratory infections
Malaria
Diarrhoeal diseases
HIV/AIDS
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-1%
-2%
-16%
-17%
-29%
-32%
-42%
-46%
-51%
-52%
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can be found regionally, the burden of disease
is higher on women across all regions, being
62.5% higher in the African Region, 68.5% in
the Region of the Americas, 38% in the SouthEast Asia Region, 95.5% in the European
Region, 16% in Eastern Mediterranean
Region, and 76% higher in the Western Pacific
Region (Figure 5).

FIGURE 5

DALYs by sex in the six WHO regions (population over 60)

African Region

379.4
616.5
2109.3

Region
of the Americas

South-East
Asia Region

3553.6
1470.9
2031.0
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4901.8
488.7
569.8
2992.8

Western Pacific
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5266.5
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Mortality

TA B L E 4

Top 20 causes of death in 2000 and 2019

In 2019, a total of 1.6 million deaths occurred
worldwide due to dementias, including
Alzheimer’s disease. As many as 50% of these
deaths occurred in HICs and, similarly to what

is observed for DALYs, women represented
roughly 65% of the total number of dementiarelated deaths. (Figure 6).

FIGURE 6

Deaths caused by Alzheimer’s disease and other dementias worldwide, 2019

Low-income

Lower middle-income

Upper middle-income

14 235
24 104
108 697
156 173
178 302
343 695
277 357

High-income

536 521
Male

7th

leading cause
of death
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Female

Population growth and improved longevity, probably combined
with an increase in the prevalence of risk factors, has led to a
dramatic increase in the number of deaths caused by dementia
over the past 20 years. Dementia and its clinical subtypes,
including Alzheimer’s disease, have become the seventh
leading cause of death among all diseases (Table 4).
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2019

Cause

Deaths (000s)

% of total
deaths

% change in deaths

Rank
0

All Causes

55 416

100.0

8%

1

Ischaemic heart disease

8 885

16.0

32%

2

Stroke

6 194

11.2

13%

3

Chronic obstructive pulmonary disease

3 228

5.8

8%

4

Lower respiratory infections

2 593

4.7

-15%

5

Neonatal conditions

2 038

3.7

-36%

6

Trachea, bronchus, lung cancers

1 784

3.2

48%

7

Alzheimer’s disease and other dementias

1 639

3.0

181%

8

Diarrhoeal diseases

1 519

2.7

-43%

9

Diabetes mellitus

1 496

2.7

71%

10

Kidney diseases

1 334

2.4

64%

11

Cirrhosis of the liver

1 315

2.4

20%

12

Road injury

1 282

2.3

10%

13

Tuberculosis

1 208

2.2

-30%

14

Hypertensive heart disease

1 149

2.1

58%

15

Colon and rectum cancers

916

1.7

53%

16

Stomach cancer

831

1.5

5%

17

Self-harm

703

1.3

-11%

18

Falls

684

1.2

53%

19

HIV/AIDS

675

1.2

-51%

20

Breast cancer

640

1.2

44%

from 2000 to 2019
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Concluding
remarks
As populations age, the number of people with dementia
is expected to rise substantially. With the only approved
disease-modifying treatment yet to show clinical benefit, it is
essential to focus on the development of public health policies
for implementing risk reduction and prevention strategies
aimed at averting brain damage and/or buffering its effect
on the expression of clinical symptoms. The postponement
of dementia onset by an average of five years would greatly
contribute to mitigating the impact of dementia on society and
on health systems (see Chapter 6 for more details). It should
be noted that, while dementia risk may decline as societal
conditions improve with concerted efforts to reduce risk
factors and enhance protective factors, persistent inequalities
must be addressed in order to ensure that these changes are
equitable across society.

"It is imperative to support
the wide-spread collection of
epidemiological data, especially
from low-resource settings, to
reduce data gaps and improve
estimation methods."
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3. Global societal
costs of dementia
Context

Informal care
accounts for nearly

50%

of the global cost
of dementia

“Do you want our healthcare
system and our economy to prosper?
Address dementia. The return on
investment will be ten-fold.”

The tremendous societal cost of dementia can be attributed
to several direct and indirect factors. Worldwide, there is
a hidden but enormous cost associated with informal care
provided by families and carers. Current care models and
pharmacological treatments are not highly cost-effective,
despite improving the quality of life of people with dementia
and their carers. The adoption of risk reduction strategies
targeting modifiable risk factors can substantially help to
mitigate the economic impact of dementia, although the
fact that longer follow-up periods are needed to observe
outcomes hinders implementation. Additionally, potential
new disease-modifying therapies can play a huge role in
meaningfully improving the lives of people with dementia
and alleviating the consequent economic burden caused
by the disease, but problems of affordability may create
barriers in accessing such treatments.
The overall consequences of dementia are challenging for any
care system. Aside from understanding the impacts on people
with dementia and their families, data on resource use and
costs in combination with prevalence figures are essential for
planning care infrastructure.

Roger Marple,
Canada

WHO
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Methodology
The estimation of the global economic costs
of dementia is complex as a result of several
factors. First, there is a lack of data from many
parts of the world, particularly from LMICs.
Second, even for countries with data, there
is a lack of population-based cohort studies
that represent diverse communities with data
on resource use and costs. Consequently,
most costing studies are based on clinical or
convenience samples without being anchored
to known populations. Many of the studies
providing data are conducted only in limited
geographical areas where research capacity
is sufficient and are extrapolated to whole
countries, and even regions. Third, many people
with dementia are not detected by the healthcare system or may not have a formal diagnosis.
As a result, their numbers are not routinely
captured by national health information
systems. Additionally, nationwide dementia
case registries are largely missing (19, 20),
leading overall to an underestimation of costs.
Fourth, while the quantification and costing
of informal care have a great impact on global
cost estimates, the nature of support will vary
according to the sociocultural environment,
with an assumption of generalizability of
findings across the world from limited research
bases; this lack of transparency complicates
comparisons of informal care costs. Sixth,
certain indirect drivers of overall dementia
costs such as the loss of carers’ productivity
and the early retirement of adults with youngonset dementia are difficult to determine
and were not included in the indirect cost
aggregate reported here. Additional challenges
include insufficient demographic data on
older adults, data aggregated over different
years, lack of country-specific prevalence
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data and national data on care systems, and
resource use of persons with dementia. Finally,
delineating expenditure reporting in the
literature for health (i.e. direct medical care)
versus social care (e.g. support with activities
of daily living) in the sense of WHO’s System
of Health Accounts (SHA)(21), is extremely
difficult, especially in the context of long-term
care where the boundaries of what constitutes
medical care and assistance are blurry. For
the purpose of this report, costs for long-term
care are included under direct social care,
not without acknowledging though that a
proportion of these costs are attributable to
medical care.
All costs reported in this chapter are expressed
as US dollars by exchange rates and inflated
to 2019 by the use of inflation and average
consumer prices derived from the International
Monetary Fund, World Economic Outlook
Database, October 2020 (22).
Acknowledging these limitations, this chapter
provides an overview of the economic costs
associated with dementia based on the
age-specific prevalence data for all-cause
dementia presented in Chapter 2 of this
report. These prevalence estimates were
derived from the Global Burden of Disease
Study (GBD 2019). World population
prospects from the UN were used as the
source for the country- and age-specific
population data (14).
The model underlying these cost
estimates uses available GDO data as
well as information collected through
systemic reviews and the work of other
institutions such as the the World Bank,

Global status report on the public health response to dementia

the International Monetary Fund, the
Organisation for Economic Co-operation
and Development (OECD), the International
Labour Organization (ILO), the Institute
of Health Metrics and Evaluation (IHME),
ADI, the 10/66 Dementia Research Group
(23), and the United Kingdom’s initiative
Strengthening responses to dementia

in developing countries (STRIDE) (24).
Throughout this chapter, the term “estimate”
is used to acknowledge that exact calculations
pertaining to the economic costs of dementia
are not possible. For a detailed description of
the methodology, refer to the Web annex.

Global dementia costs
In 2019, the global cost of dementia was estimated to be 1.3
trillion US$ (Table 5), with 74% of costs occurring in HICs
while the majority of people with dementia live in LMICs
(61%). On the basis of the expected increase in people
with dementia, as outlined in Chapter 2, the global costs
of dementia will increase to about 1.7 trillion US$ in 2030.
In addition, if projections are corrected for the expected
increases in costs for providing care, global dementia costs
will increase to almost 2.8 trillion US$ in 2030.

1.3 trillion
US$ estimated cost of
dementia in 2019

" Delineating expenditure reporting
for health (i.e. direct medical care)
versus social care (e.g. support with
activities of daily living) is extremely
difficult, especially in the context of
long-term care where the boundaries
of what constitutes medical care and
assistance are blurry."
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TA B L E 5

Estimated worldwide costs of dementia in 2019 (billion US$), by WHO region
and World Bank country classification, 2019
Number of
people with
dementia
(millions)

African Region

Costs

%

Costs
(billion US$)

95% CI

%

1.9

3.4

15.6

10.3-20.9

1.2%

8202

47

Region of the
Americas

10.3

18.6

364.6

279.6-449.7

27.8%

35501

35

South-East Asia
Region

6.5

11.8

23.9

16.3-31.4

1.8%

3651

11

European Region

14.1

25.5

438.8

375.0-502.5

33.4%

31144

53

Eastern
Mediterranean Region

2.3

4.2

31.2

19.1-43.3

2.4%

13428

21

Western Pacific
Region

20.1

36.4

439.3

313.0-565.5

33.4%

21890

27

All

55.2

100

1 313.4

1157.8-1468.9

100.0%

23796

194

Low-income

1.4

2.5

3.5

2.6-4.4

0.3

2575

29

Lower-middle-income

8.8

16.0

44.3

31.4-57.2

3.4

5010

49

Upper-middle-income

23.6

42.8

293.2

259.9-326.5

22.3

12414

56

33.8

61.3

341.0

304.7-377.4

26.0

10083

134

High-income

21.4

38.7

972.3

895.2-1049.5

74.0

45500

60

All

55.2

100.0

1313.4

1157.8-1468.9

100.0%

23796

194

WHO region

Costs per
Number of
person (US$) countries

Income level

Low- and
middle-income
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Dementia costs by
type of care
This section gives an overview of costs associated with
different types of dementia care (i.e. direct medical care, direct
social care and informal care).

Direct medical costs refer to direct health expenditures or costs incurred by
the medical care system, such as hospital care, medicines, diagnostic tests and
visits to clinics.
Direct social (nonmedical) costs (sometimes referred to as “direct
nonmedical costs”) arise from services provided outside the medical care
system – such as community-based services to assist with activities of daily
living, but also including costs for providing long-term institutional care.
Informal care costs are more difficult to measure directly and are usually
approximated on the basis of the time required by family members or informal
carers to provide support and assistance with basic and instrumental activities
of daily living (ADL). Supervision time, which makes up a substantial proportion
of carer time and the associated burden for family members, is listed separately.

Table 6 presents dementia care costs associated with different
types of care, broken down by WHO region and World Bank
income classification. When direct care costs are expressed as
a proportion of the cumulated Gross Domestic Product (GDP),
a clear income gradient is visible.
Globally, approximately half of the dementia care costs are
attributable to informal care with huge variations by country
income classification. In LMICs, almost two thirds of dementia
care costs are attributable to informal care, while direct medical
and social care together account for a bit over one third of the
costs. In HICs, on the other hand, informal care and social care
costs contribute almost equally to 84% of the overall cost, with
direct medical costs accounting only for 16% (Figure 7).
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FIGURE 7

Percentage of costs associated with different types of dementia care, by
World Bank income level

TA B L E 6

Sub-category costs of dementia in 2019 (billion US$, and % of total costs), by
WHO region and World Bank income level

5%
Low-income

Lower-middle-income

Upper-middle-income

LMICS

10%
11%
19%
17%

Direct medical
costs

85%

13%

Billion
US$

African Region

%

Billion
US$

0.4

2.8

Region of the Americas

74.4

18%

HICS

16%

40%

Total

16%

34%

65%

South-East Asia Region

44%
50%

%

1.0

6.3

14.2

90.9

15.6

0.07

20.4

124.8

34.2

165.4

45.4

364.6

0.70

7.5

31.4

3.0

12.6

13.4

55.9

23.9

0.21

European Region

51.0

11.6

184.9

42.2

202.8

46.2

438.8

1.02

Eastern Mediterranean
Region

0.9

2.9

1.7

5.4

28.6

91.8

31.2

0.08

Western Pacific Region

78.9

18.0

133.3

30.3

227.1

51.7

439.3

0.86

213.2

16.2

448.7

34.2

651.4

49.6

1313.4

0.76

Low-income

0.2

4.6

0.4

10.5

3.0

84.9

3.5

0.11

Lower-middle-income

4.8

10.9

5.8

13.2

33.6

75.9

44.3

0.17

Upper-middle-income

54.4

18.5

54.8

18.7

184.0

62.8

293.2

0.42

59.4

17.4

61.0

17.9

220.6

64.7

341.0

0.37

High-income

153.9

15.8

387.7

39.9

430.8

44.3

972.3

1.00

All

213.2

16.2

448.7

34.2

651.4

49.6

1313.4

0.76

All
Direct medical care

Direct social care

Total costs

%

WHO region

62%

Informal care
costs
Billion
US$

76%
19%

Direct social
sector costs

Billion Direct costs % of
US$
cumulated GDP

Informal care

Income level

The costs per person with dementia are also strongly linked
to World Bank income classifications (Table 7). In low-income
countries, the costs for the social care sector (including longterm institutional care) are very low.
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Low- and
middle-income
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TA B L E 7

Sub-category costs of dementia per person (US$) in 2019 by WHO region and
World Bank income level
Direct medical
costs

Direct social
sector costs

Informal care
costs

Total costs

226

519

7 457

8 202

Region of the Americas

7 247

12 152

16 102

35 501

South-East Asia Region

1 147

462

2 043

3 651

European Region

3 624

13 128

14 393

31 144

384

720

12 323

13 428

Western Pacific Region

3 934

6 640

11 316

21 890

All

3 864

8 130

11 803

23 796

Low-income

118

270

2 187

2 575

Lower-middle income

546

660

3 804

5 010

Upper-middle income

2 302

2 321

7 790

12 413

WHO region
African Region

Eastern Mediterranean Region

Direct medical care costs
As seen in Table 7, with the exception of low-income countries
where direct costs are very low (due to a lack of availability
of diagnostic and care services), direct medical care costs are
relatively stable across different income levels, with some
variations by WHO region.
In HICs, the costs of long-term institutional care represent
a large proportion of both the direct social costs (about
50%) and total social costs (about 25%) of dementia, while
such resources are scarce in LMICs. As such, there is an
inverse relationship between the costs of institutional care
and the costs of informal care in relation to income level.
Urbanization and migration, which results in generation and
nuclear family splits in many countries (25), also makes the
prerequisites for informal care weaker.

" In HICs, the
costs of long-term
institutional care
represent a large
proportion of both
the direct social
costs (about 50%)
and total social
costs (about 25%)
of dementia, while
such resources are
scarce in LMICs."

Income level

Low- and
middle income

1 755

1 805

6 523

10 083

High-income

7 201

18 140

20 159

45 500

All

3 864

8 130

11 803

23 796

Direct social care costs
The social care sector costs constitute some 34% of the total
societal costs of dementia, with a clear gradient in terms of
income level: about 18% in LMICs and 40% in HIC. In the WHO
regions of Africa, South-East Asia and the Eastern Mediterranean,
the proportion of the social care sector is particularly low.
The largest contributor to cost in the social care sector is the
cost of long-term institutional care (LTIC). For the purpose
of this report, LTIC is defined as part of the social care sector,
although it is acknowledged that a proportion of LTIC associated
costs could be attributed to direct health care costs as well.
As of 2019, it was estimated that some 8.5 million people with
dementia were cared for in LTC facilities. This corresponds to
roughly 15% of the global dementia population, ranging from
about 2% in LIC to 25% in HIC. LTIC constitutes about 25% of
the total societal costs and about 50% of direct costs associated
with dementia. In HICs the figures are higher, corresponding to
27% of the societal costs and about 50–60% of direct care costs.
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34%
of total dementia
costs are
attributable to
social care costs
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Informal care provided
by family, friends, and
neighbours

89 billion
hours of informal care

In 2019, informal dementia carers spent over 89 billion hours
providing ADL support, corresponding to approximately 5
hours per day per person with dementia (Table 8). When
accounting for supervision time, this figure increases to some
133 billion hours (about 8 hours per day). Informal care
provision is particularly high in countries with low resources,
generally reflecting the scarcity or lack of available formal
support services for dementia.

TA B L E 8

Hours of informal care by WHO region and World Bank income level, 2019
All ADLs

Supervision

Total hours

Million
hours

Hours
per day

Million
hours

Hours
per day

Million
hours

Hours
per day

African Region

5 799

8.6

2 827

4.2

8 626

12.9

Region of the Americas

12 168

4.2

10 137

3.5

22 305

7.6

South-East Asia Region

12 454

5.4

5 156

2.2

17 610

7.6

European Region

21 038

5.3

8 601

2.2

29 639

7.4

Eastern Mediterranean
Region

5 222

6.4

3 070

3.7

8 292

10.1

Western Pacific Region

32 692

5.2

14 092

2.2

46 783

7.4

Total

89 373

5.2

43 882

2.6

133 255

7.8

Low-income

3 871

8.0

1 807

3.7

5 678

11.7

Lower-middle-income

18 693

6.0

7 229

2.3

25 922

8.3

Upper-middle-income

40 874

5.3

16 864

2.2

57 739

7.5

Low- and middleincome

63 438

5.6

25 901

2.3

89 339

7.9

High-income

25 935

4.5

17 982

3.1

43 916

7.6

Total

89 373

5.2

43 882

2.6

133 255

7.8

WHO region

Income level

Note: The accumulated figures for hours spent per day providing informal care are adjusted to represent the proportion of
people with dementia who live at home.
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If the proportions of caregiving hours are
compared to costs, there is a discrepancy
between LMICs and HIC (Figure 8). Most
hours spent providing informal care are in
LMICs, while most costs across all categories
occur in HICs (Table 8). If it is assumed that
a full-time worker works 2000 hours per
year, the informal care hours correspond
to about 45 million full-time workers (for
support to ADL only) and approximately 67

million full-time workers if supervision time is
also included (Table 9). The greatest number
of full-time workers would be in uppermiddle-income countries. Women provide
a disproportionate amount of informal
care hours (roughly 70%), particularly in
low-income countries (77%). Additional
information on the impact on carers is
discussed on chapter 8 of this report.

FIGURE 8

Comparison of the percentages of number of people with dementia, informal
care hours, informal care costs and total costs in HIC and LMICs.

61%

39%

Number of people
with dementia

TA B L E 9

Corresponding number of full-time workers (millions) to amounts of informal
care by WHO region and World Bank income level, 2019
WHO Region

All ADLs

Supervision

Total hours

African Region

2.9

1.4

4.3

Region of the Americas

6.1

5.1

11.2

South-East Asia Region

6.2

2.6

8.8

European Region

10.5

4.3

14.8

Eastern Mediterranean Region

2.6

1.5

4.1

Western Pacific Region

16.3

7.0

23.4

Total

44.7

21.9

66.6

Low-income

1.9

0.9

2.8

Lower-middle-income

9.3

3.6

13.0

Upper-middle-income

20.4

8.4

28.9

31.7

13.0

44.7

High-income

13.0

9.0

22.0

Total

44.7

21.9

66.6

71%

29%
34%

Hours of
informal care
LMICs

66%

Informal
care costs

26%

74%

Total costs

HICs

"Women provide a
disproportionate amount of
informal care hours (roughly
70%), particularly in low-income
countries (77%)."

Income level

Low- and middle-income
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Costs and
dementia
severity

TA B L E 1 0

Worldwide costs in relation to dementia severity, by WHO region and World
Bank country classification, 2019: cumulated (billion US$) (10a), per person
with dementia (US$) (10b)
10a
Severity
WHO region

cost by severity
per person with
dementia (US$)

15 889
mild dementia

26 859

moderate dementia

36 180

The severity of dementia is an important driver of cost. Based
on the 2019 dementia prevalence figures in Chapter 2 and
estimated dementia severity rates derived from IHME2, there
were approximately 26.9 million people with mild dementia,
14.9 million people with moderate dementia and 13.4 million
with severe dementia. The model for estimating dementia
costs based on severity contains fewer records and thus
produces slightly different overall cost estimates (i.e. US$
23 764 per patient/year versus US$ 23 796 per patient/year
in the base model).
Severity-specific cost estimates (accumulated as well as per
patient) for WHO regions and World Bank income groups are
listed in Table 10. Annual per-patient costs increase steadily
with increasing dementia severity, ranging from US$ 15 899
for a person with mild dementia to US$ 36 180 for a person
with severe dementia (Table 10b). Given the greater number
of people with mild dementia, this gradient gets diluted when
looking at accumulated costs (Table 10a).

severe dementia

Mild

Moderate

Severe

Total costs

Billion US$

%

Billion US$

%

Billion US$

%

Billion US$

%

African Region

6.5

1.5

4.2

1.1

5.5

1.2

16.2

1.2

Region of the
Americas

91.6

21.4

130.6

32.7

147.5

30.5

369.7

28.2

South-East Asia
Region

16.4

3.8

12.0

3.0

12.2

2.5

40.7

3.1

European Region

193.6

45.2

162.6

40.7

186.0

38.5

542.1

41.3

Eastern
Mediterranean
Region

13.6

3.2

8.6

2.2

9.3

1.9

31.6

2.4

Western Pacific
Region

106.8

24.9

81.7

20.4

122.7

25.4

311.3

23.7

All

428.5

100.0

399.7

100.0

483.4

100.0

1311.6

100.0

Low-income

1.5

0.3

1.0

0.3

1.5

0.3

4.0

0.3

Lower-middle-income

24.8

5.8

17.2

4.3

18.9

3.9

60.9

4.6

Upper-middle-income

99.7

23.3

72.4

18.1

103.1

21.3

275.1

21.0

Low- and middleincome

126.0

29.4

90.6

22.7

123.4

25.5

340.0

25.9

High-income

302.5

70.6

309.2

77.3

359.9

74.5

971.6

74.1

All

428.5

100.0

399.7

100.0

483.4

100.0

1 311.6

100.0

Income level

2 Based on personal communications about a forthcoming IHME report
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10b
WHO region

Mild

Moderate

Severe

Average cost

African Region

6 683

8 424

12 781

8 531

Region of the Americas

18 675

46 110

58 168

35 993

South-East Asia Region

4 880

7 053

8 312

6 220

European Region

29 204

42 010

51 817

38 482

Eastern Mediterranean Region

11 343

14 499

17 681

13 591

Western Pacific Region

10 803

15 184

25 575

15 511

All

15 899

26 859

36 180

23 764

Income level
Low-income

2 122

2 836

4 897

2 942

Lower-middle-income

5 486

7 448

9 385

6 884

Upper-middle-income

8 453

11 558

18 518

11 647

7 405

10 150

15 654

10 052

High-income

30 445

51 869

65 749

45 464

All

15 899

26 859

36 180

23 764

Low- and middle-income

"The greatest methodological
challenge is the lack of
research and evidence from
many parts of the world."
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Concluding remarks
The cost of dementia worldwide is very high
and has a significant impact on care systems
across the world. The burden on unpaid
informal carers is substantial, including stress
and role strain as well as deterioration of
mental and physical health (see Chapter 8).
Additionally, there is an important imbalance
between how people with dementia live
and the distribution of costs (and thereby
resources). The majority of people with
dementia live in LMICs but the highest costs
are in HICs. In many LMICs, long-term care
systems are not well-prepared, placing a
heavy burden on carers and families.
The estimation of dementia costs is
hampered by a variety of issues. The greatest
methodological challenge is the lack of
research and evidence from many parts of
the world – even from HICs but particularly
from LMICs. In addition, the few available
studies may not always be representative
of the entire population or reflective of the
variation within populations in terms of
inequalities and specific areas of need. Most
studies included in the costing model are in
fact based on convenience or clinical samples,
which may overestimate dementia direct
costs, particularly the few studies from LMICs
which mostly in these countries are conducted
in urban areas. Since there are no cost studies
from low-income countries, the consequent
imputation method probably over-estimates
direct costs in these countries. On the other
hand, the same problems with representativity
may result in underestimating costs of

informal care in LMICs.
Population-based cohort studies with data
on resource use and costs continue to be
rare, preventing us from developing more
robust and representative dementia costing
models. Moreover, sociocultural factors
which could not be quantified in these cost
estimates also have an impact on the societal
costs of dementia.
Another challenge is the under-reporting of
dementia, both in registries and in clinical
practices (20, 26, 27). Because of lacking
awareness and the presence of stigma and
misconceptions, dementia is often undetected
and undiagnosed. This is a problem not only
for the quality of care but also for studies on
cost. An undiagnosed person with dementia
will nevertheless incur some cost. Therefore,
if cost estimates are based only on a fixed
dementia diagnosis in registry-based studies,
costs will be underestimated.
Finally, the quantification and costing
of informal care greatly impact global
cost estimates. It is obvious that without
transparency it is very difficult to make any
comparisons of the costs of informal care. A
forthcoming WHO report on global dementia
costs, will include a comprehensive review of
all methodological issues linked to the costing
of informal care.
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4. Dementia policy
and legislation
Context
Addressing dementia requires a whole-of-government,
multisectoral and multistakeholder public health response.
Such a response should be developed in close collaboration
with people with dementia, their carers and other relevant
stakeholders such as civil society and the private sector. The
importance of dementia policy and legislation is reflected in
global target 1 of the Global dementia action plan: 75% of
Member States will have developed or updated a national policy,
strategy, plan or framework for dementia, either stand-alone, or
integrated into other policies/plans by 2025.

“There is a stigma around dementia
that compounds the existing ageism
within society, which emphasizes the
need for a groundswell of support from
the worldwide community to push local
governments to address dementia and to
implement better policies and improve the
long-term care system with rights-based,
person-centred care.”

Dementia plans indicate political commitment to address
the challenges and impacts associated with dementia and
to improve health and social system readiness to address
the needs of people living with dementia and their carers.
Dementia plans also serve to raise public awareness, create
mutual understanding of dementia and protect the human
rights of people living with dementia, their carers and families
(28-30). The 2019 Okayama Declaration of the G20 Health
Ministers (31) reiterated political commitment to developing

Jim Mann,
Canada

WHO
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and implementing multisectoral national
action plans through integrated approaches to
improve the quality of care and quality of life of
people with dementia, their families and carers.
The UN Decade of Healthy Ageing 2021–2030
(12) endorsed by the UN General Assembly in
August 2020 also highlights the central role
of policy change in promoting healthy ageing,
including for people with dementia.
This chapter provides an overview of global
progress made to date in achieving the global
target associated with Action area 1 of the

Global dementia action plan. It begins by
assessing country-driven progress based on
GDO data and other sources and provides a
complementary analysis of national dementia
policies – including ongoing gaps and
opportunities as well as country case studies.
The chapter closes with activities carried out
by WHO’s secretariat to support countries
in developing and implementing national
dementia plans and recommendations to
accelerate action for the future.

FIGURE 9

Government branches where dementia is included

Ageing

5%

Mental Health
N/A
Social Services

Progress to date
Inclusion of dementia in ministry portfolios
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18%

10%

19%

Noncommunicable diseases (NCDs)

70

5%

Health

Labour, Social Affairs

The Global dementia action plan identifies
the need for countries to establish a focal
point, unit or functional division that is
responsible for dementia, or a coordinating
mechanism within the entity responsible for
NCDs, mental health or ageing within the
health ministry (or equivalent body). Doing
this helps ensure sustainable funding, clear
lines of responsibility for strategic planning,
implementation, mechanisms for multisectoral
collaboration, service evaluation, monitoring
and reporting on dementia. Data submitted
by 62 GDO countries show that 90% of

2%

1%

these countries include dementia in ministry
portfolios and 68% have appointed a
dementia-specific representative. Figure 9
shows the ministry branches under which
dementia is included, with most countries
including dementia under a ministry branch
focused on health (40%), followed by mental
health (19%) and ageing (18%). Interestingly,
whereas HICs tend to include dementia in the
health and ageing branches, LMICs mainly
include dementia in mental health.
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40%

Social Affairs & Health

Existence of national dementia plans
The Global dementia action plan indicates
(in its Global target 1) the need for countries
to develop, strengthen and implement
national and/or subnational strategies,
policies, plans or frameworks that address
dementia, whether as separate instruments
or integrated into other planned actions for
NCDs, mental health or ageing. The GDO
measures progress towards achieving this
target using three sub-indicators, namely:
1) existence of a stand-alone dementia plan;
2) existence of another relevant policy into
which dementia is integrated; and 3) existence
of subnational dementia plans that cover
more than 50% of the country.

GDO data collected from 62 countries show
that 27 currently have a dementia-specific
(i.e. stand-alone) national dementia plan, 14 of
which have expired in 2020, and 9 countries
are developing one. ADI has been monitoring
dementia policy development around the
world, including for countries that have not
yet submitted data to the GDO. On the basis
of ADI’s 2020 report (32), an additional 7
national stand-alone dementia plans had been
adopted as of May 2021. This brings the total
number of countries with national standalone dementia plans to 34. The distribution
of national dementia plans is largely uneven
across WHO regions. While many countries
in WHO’s European Region have developed
national dementia plans, this is not the case in
other regions.
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The GDO also measures whether a country has integrated
dementia into existing policies, either in addition to or in lieu
of a stand-alone national dementia plan. Of the 62 GDO
countries, 31 have integrated dementia into an existing policy,
and 5 are in the process of doing so (Table 11). Figure 11
shows that the majority of countries have integrated dementia
into a general health/social welfare policy or ageing strategy.

FIGURE 10

Countries with a stand-alone or integrated dementia plan

African Region

Region of the Americas

Mauritius

Belize

Dominican Republic

India

Canada

Mexico

Indonesia

Chile

Trinidad and Tobago

Maldives

Costa Rica

United States of
America

Thailand

TA B L E 1 1

Number of countries with stand-alone, integrated and subnational
dementia plans
Dementia plan integrated
into other plans

Subnational
dementia plan

African Region

0

1

0

Region of the Americas

4

5

3

South-East Asia Region

0

3

1

European Region

17

10

10

European Region

Eastern Mediterranean Region

2

5

0

Austria

Luxembourg

Western Pacific Region

4

8

4

Belgium

Income level

Eastern
Mediterranean
Region

Western Pacific
Region
Australia

Malta

Iran
(Islamic Republic of)

Czechia

Netherlands

Jordan

Denmark

Norway

Morocco

China
(People’s Republic of)

Brunei Darussalam

Low-and-middle income

2

13

2

Finland

Russian Federation

Oman

Cook Islands

High-income

25

18

16

France

Slovenia

Qatar

Japan

Germany

Spain

Malaysia

Greece

Sweden

Republic of Korea

Iceland

Switzerland

Singapore

Ireland

Turkey

Israel

United Kingdom

On the basis of GDO data, a total of 43 countries have a
dementia plan which may be stand-alone, integrated into
another policy or at a subnational level. The additional seven
plans reported by ADI bring the total to 50 countries that meet
the global target, or 26% of countries. Figure 10 identifies the
countries that currently meet the global target.
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Cuba

Stand-alone
dementia plan

WHO region

South-East Asia
Region
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BOX 3

Cuba’s National Strategy for Alzheimer’s disease
and Dementia Syndromes
The policy of the State and Ministry of Public Health of Cuba includes priority
objectives focused on ageing and dementia. In 2014, the National Strategy for
Alzheimer’s disease and dementia syndromes was developed. In 2017, it was
updated with elements related to gender equity, friendly environments, health
information system strengthening and the alignment of indicators with those
proposed by WHO.
Each province in Cuba has health coverage for cognitive deterioration from
primary health care to specialist care through 449 polyclinics and 10 869 family
doctor and nurse consultations, with coordination between levels of care. Work
is ongoing to improve prevalence registration at primary health-care level.

FIGURE 11

Types of policies into which dementia is integrated

Mental Health
Care Services
Ageing

3%
3%
3%

Each year, Cuba organizes activities that contribute to the international
dementia awareness campaign through a call launched by the National
Alzheimer’s Society. Various activities taking place during World Alzheimer’s
Month and Day are covered by the media.
A national protocol for action in nursing homes was developed specifically for
residents with dementia during the COVID-19 pandemic.
Across the country, multiple centres are working on research related to early
diagnosis, risk factors, treatment efficacy and alternative treatments for mild
and major cognitive disorders. Additionally, national courses in the area of
dementia are being developed at diploma and master’s levels. Cuba counts
more than 70 publications, including in high-impact journals.
Multiple programmes focused on non-pharmacological interventions for mild
cognitive disorders and dementia have been created in view of supporting
scientific evidence.
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47%

Demographic changes
Health (Social welfare)
End-of-life care
Other

Ninety-five percent of Cuba’s health areas provide care and support for
carers of people with dementia. A Manual for caregivers of care-dependent adults
was developed and there has been an increased focus on carer training in
coordination with primary health care and related health-care professionals.
As part of the National Strategy, the Centre for Alzheimer and other cognitive
disorders was created on 21 September 2019 as part of the Centre for Research
on Longevity, Ageing and Health. The centre functions as a national reference
platform and includes an interdisciplinary team specialized in early diagnosis and
intervention for Alzheimer’s disease and other neurocognitive disorders.

14%

27%

3%

Dedicated funding and implementation
targets for national dementia plans
Among the countries with a dementia
plan, there is vast heterogeneity in funding
allocation as well as in implementation and
monitoring targets (33). While many national
dementia plans identify the need for financial
investment, few delineate the mechanisms
for mobilizing and allocating funding – e.g.
between national and subnational levels.
The Global dementia action plan
recommends the allocation of sustainable
financial resources commensurate with the
identified service needs and human and
other resources required to implement
national dementia plans and actions. It also
identifies the need to establish mechanisms
to track expenditures on dementia in health,

social and other relevant sectors such as
education and employment.
Of 27 GDO countries for which data
are available for this indicator, 70% have
allocated dedicated funding to implement
their national dementia plan and targets for
monitoring implementation. There is a lot
of variation between WHO regions: while
data reported by countries in the Americas,
European and Western Pacific regions
have allocated dedicated funding and set
implementation targets, few or none have
done so in the African, South-East Asia, and
Eastern Mediterranean regions. Additionally,
only one LMIC has done so, with all other
countries being HICs.
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Strategic action areas and principles of
national dementia plans
Action areas
Thematic analyses reveal that the majority of
dementia plans recognize the need to address
rapidly changing demographics, including
the increase in ageing populations and in
numbers of people living with dementia (33).
Yet there remains great variation among
countries in terms of identifying dementia as
a public health imperative. This has important
implications in terms of widening health
inequities between HICs and LMICs, where
the majority of people with dementia live
(see Chapter 2). In this respect, it is worth
acknowledging the unequivocal impact of the
ongoing COVID-19 pandemic on competing
priorities, thus placing increased pressure
on demands for financing for dementia. The
pandemic has also brought to light underlying
health system weaknesses, such as those
associated with community care coordination
and continuity, and has raised issues related
to care quality, rights-based access to care
and supported decision-making, particularly in
long-term care facilities.

Dementia plans typically cover a number of
common themes, broadly mapping onto the
seven action areas of the Global dementia
action plan. These themes include awarenessraising and stigma reduction; dementia risk
reduction; timely diagnosis through preventive,
quality person-centered approaches to care;
integrated health care models and systems;
investment in research; specialist training
and workforce education; carer support; and
dementia health information.
Table 12 shows the areas covered by
countries’ national dementia plans on the
basis of GDO data, stratified by WHO
regions and income classification. Globally,
most dementia plans (86%) address
timely diagnosis, post-diagnostic support
and care; workforce training and carer
support; followed by dementia awareness,
stigma reduction and friendliness (84%)
and dementia risk reduction (81%). Fewer
countries indicated that their national
dementia plans covered monitoring and
information systems for dementia, or
dementia research and innovation.
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TA B L E 1 2

Action areas covered by countries’ national dementia plans
Dementia awareness,
stigma reduction and
dementia-friendly
communities

Dementia prevention
and risk reduction

Timely diagnosis,
post-diagnostic
support and care

Support for dementia
carers and families

Improved monitoring
or information
systems for dementia

Workforce training
on dementia

Dementia research
and innovation

36

35

37

37

37

33

33

African Region (n = 1)

1

1

1

1

1

1

1

Region of the Americas
(n = 6)

4

4

5

5

5

5

4

South-East Asia Region
(n = 2)

2

2

2

2

2

2

2

European Region (n = 19)

19

16

19

19

19

17

18

Eastern Mediterranean
Region (n = 5)

4

5

3

3

3

2

2

Western Pacific Region
(n = 7)

6

7

7

7

7

6

6

Low-and-middle income
(n = 12)

9

10

9

9

9

9

8

High-income (n = 28)

27

25

28

28

28

24

25

Global (n = 43)

WHO region

Income level

Note: Numbers reported by region and/or World Bank income classification do not necessarily add up to 100%, as
some information was missing.
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GDO data indicate that national dementia
plans generally cover most of the seven action
areas of the Global dementia action plan.
However, a more detailed analysis of national
policies reveals that many documents do not
explicitly identify how person-centered care
pathways are to be implemented, monitored
and integrated into existing service models
across sectors. This is despite the identified
need for integrated health and social care (30,
33). Similarly, dementia plans scarcely identify
what the key components of such pathways
ought to be (see Chapter 7). Moreover, while
the burden of caregiving is well recognized
in national dementia plans, there continues
to be a significant over-reliance on informal
carers, a disproportionate amount of whom
are women, with the majority living in LMICs
(6) (see Chapters 3 and 8).

Finally, the role of technology (e.g. assistive
technologies, artificial intelligence-based
technologies, remote diagnosis and postdiagnostic support) in enhancing the quality
of life of people living with dementia and
improving service delivery remains underaddressed in national dementia plans (5).
Additional research is needed to enable
evidence-based decision-making related to
the role and impact of technology in service
delivery and daily living. These gaps are
particularly salient within the context of the
COVID-19 pandemic and its impact on the
discontinuation of services. Technology could
help ensure that people with dementia can
continue to live at home in the community
for longer by preventing delays in accessing
diagnostic and post-diagnostic services,
providing needed supports to carers and
reducing social isolation. Additional researchspecific data is discussed in Chapter 8.

Multisectoral coordination, human rights
and equity
Existing dementia plans can be assessed
as to whether they address cross-cutting
principles such as multisectoral coordination
as well as issues relating to human rights,
equity and UHC that are embedded in
the Global dementia action plan. These
principles also include a focus on empowering
and engaging people with dementia and
their carers in decision-making and policy
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development. For the 43 GDO countries with
national dementia plans (either stand-alone,
subnational or integrated), over 90% stated
that their dementia policy document takes a
human rights-based approach and focuses
on multisectoral collaboration, while more
than 85% of countries indicated that their
policies address principles related to equity,
empowerment and UHC (Figure 12).
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FIGURE 12

Cross-cutting principles included in dementia plan
Human rights
based approach

43

Equity

37

Empowerment

37

Multisectoral

39

Universal health
coverage

37

The Global dementia action plan recognizes
the importance of engaging people
with dementia in policy and legislative
development and implementation processes.
Yet, people with dementia, their carers and
families continue to be largely outside these
processes (33, 34). Formal mechanisms
aimed at consistently, meaningfully and

countries

countries

countries

countries

countries

comprehensively involving people with
dementia and their carers are required in
order to avoid tokenism, improve trust in the
social–political contract between citizens
and government, and ultimately augment the
effectiveness of service delivery, foster rightsbased care and improve health outcomes.

Vulnerable population groups
Although the GDO indicator related to equity
promotes a gender-sensitive perspective
and includes migrants, gender minorities and
sexual minorities as vulnerable groups, it does
not allow for disaggregation by population
subgroups. As revealed in the literature,

the needs of ethno-cultural minorities and
vulnerable populations – e.g. migrants and
refugees, gender minorities and sexual
minorities, people living with disabilities
(including physical or psychosocial disabilities
or sensory impairments), and people with
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a comorbid mental health or substance use
condition, or in extreme poverty) remain largely
unaddressed in national dementia plans (33).
A study of 35 countries in the European Union
and the European Free Trade Association
indicates that more than half of those with a
national dementia plan (n = 23) do not refer to
migration (35). When addressed, references
tend to be cursory, with few countries having
specific health services for people with
migration backgrounds (36). This is important
in view of the sharp increase in global migration
patterns over the past two decades, and the

projected increased prevalence of dementia
among this population subgroup (36, 37).
While vulnerable populations have specific
and complex social, economic and health
needs, they are less likely to utilize health-care
services. Particular attention is required to
understand the specific impact of dementia,
prevent marginalization and reduce inequities
in health outcomes among vulnerable
populations (38). Evidence-based, culturallysensitive resources and services should be
available and should be appropriately tailored
for the needs of subpopulations.

Legislation addressing
dementia
To protect the human rights, wishes and
preferences of people with dementia, the
global dementia action plan recommends
that countries implement accountability
mechanisms and relevant legislation in line
with the CRPD and other international human
rights instruments. Of the 62 GDO countries,
only 21% (n = 13) adopted dementia-specific
legislation. However, 68% (n = 42) have
included legal provisions in other legislation
to protect the rights of people with dementia
(universal laws). It is worth noting that only
one LMIC has dementia-specific legislation
although 12 out of 40 have included legal
provisions in other universal laws.
As part of the GDO, countries are also asked
to identify whether they have legislation that
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safeguard concepts such as legal capacity,
self-determination, supported decisionmaking, power of attorney and protection
against exploitation and abuse of people with
dementia in institutions and the community.
As identified in Table 13, legal provisions
may be adopted specifically within the
context of dementia-specific legislation or
be incorporated into other laws related to,
or that apply to, protection of the rights of
people living with dementia (i.e. universal laws).
Importantly, countries differ in the extent to
which they have such legal provisions, and
the limitations of self-reporting with regard
to these provisions should be noted since
interpretations of these criteria may vary from
what is intended by human rights standards.
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Legal provisions in countries to protect human rights of people with dementia

Total

Dementia-specific
legislation

Universal law

Legal frameworks to promote supported
decision-making

38

5

33

Legal procedures to protect the human rights of
people with dementia

40

1

39

Promote the transition of dementia care to
community-based services

28

5

23

Regular inspections of human rights conditions
and/or care quality by an independent body in
facilities where people with dementia reside

36

2

34

Advance care directives

29

0

29

Legislation to end discrimination against people
with dementia

36

1

35

Legislation to end discrimination against carers
of people with dementia

28

2

26

The GDO also measures whether countries prohibit, regulate
or allow coercive practices – including seclusion and the use
of mechanical/physical/chemical restraints – against people
with dementia. Coercive practices are prohibited (n = 8) or
regulated (n = 29) by the majority of countries. However, this
is predominantly the case in HICs and no such legal provisions
exist in the five LMICs from different WHO regions that
reported on that indicator.

"The limitations
of self-reporting
with regard to legal
provisions should
be noted since
interpretations of
these criteria may
vary form what is
intended by human
rights standards."
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The way forward
As demonstrated by GDO data, a concerted
effort to develop and renew appropriately
funded national dementia plans, with clear
implementation targets is needed globally.
The 2019 G20 Health Ministers’ Declaration
included a commitment to “develop and
implement multi-sectoral national action plans,
and adopt integrated approaches on dementia in
line with the Global Action Plan to improve the
quality of care and the quality of life of people
with dementia, their families and caregivers” (31).
However, in many countries the ongoing lack
of political leadership for dementia represents

an important barrier to moving from discourse
to action. There is a need for concerted efforts
at national and global levels to place dementia
on national health agendas through policy
forums (including the G7 and G20) in order
to achieve the targets outlined in the Global
dementia action plan. In doing so, strategic links
with existing global commitments such as the
2030 Agenda for Sustainable Development
and its SDGs, UHC and the UN Decade of
Healthy Ageing 2021–2030 can be leveraged
to mobilize action on dementia on the basis of
findings from this report.

Moreover, the forthcoming Intersectoral
global action plan on epilepsy and other
neurological disorders (requested in World
Health Assembly resolution WHA 73.10) also
represents a unique opportunity to renew
concerted action for dementia within the
broader context of addressing neurological
disorders, on the basis of an integrated public
health approach. Figure 13 outlines the
actions included in the Global dementia action
plan, key barriers to implementing the actions,
and opportunities to overcome the barriers
through accelerators for action.

Where national dementia plans exist, GDO
data demonstrate that appropriate funding
and implementation targets are often lacking.
In fact, low levels of national health budget
expenditure and technical capacity in the area
of dementia represent significant barriers to
implementation. Technical support provided
through national and regional workshops in
partnership with WHO can help build national
capacity, facilitate intercountry learning and
assist in rationalizing resources to improve
the lives of people with dementia, their carers
and families. WHO resources such as the
GDO Knowledge Exchange Platform also
foster mutual learning and knowledge-sharing,
including in related to policy and legislation.

FIGURE 13

Proposed actions for Member States, identified barriers and accelerators
PROPOSED ACTIONS
Develop, strengthen and implement

BARRIERS
Lack of political leadership for dementia

national or subnational dementia
policy or plans

Lack of earmarked funding to dementia and

OPPORTUNITIES TO ACCELERATE ACTION
Advocate for renewed political

Create strategic linkages with global

commitment to dementia through

commitments such as the 2030 Agenda

relevant international forums

for Sustainable Development and its
SDGs, and UHC

low proportion of national health budgets
Allocate sustainable resources to

allocated to mental health and ageing

exchange through WHO’s Global

Implement national and regional

Insufficient technical expertise and capacity

Dementia Observatory Knowledge

dementia workshops, with technical

to implement national dementia policies

Exchange Platform :

assistance from WHO

dementia plans/policies
Establish a focal point, unit or functional

Foster mutual learning and policy

division responsible for dementia

www.globaldementia.org

Implement legislation and mechanisms

Leverage WHO resources such as

to promote the human rights of people

Towards a dementia plan: a WHO guide

with dementia and their carers

to develop and operationalize national
dementia plans
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BOX 4

WHO national and regional dementia workshops
To catalyze commitment to achieving Global target 1, WHO initiated
regional workshops that focus on strengthening countries’ comprehensive,
multisectoral public health response to dementia. Since 2017, WHO has
conducted a series of national and regional workshops that involved 76
countries from all six WHO regions and brought together stakeholders –
including people with dementia, policy-makers, health-care practitioners,
academic researchers and civil society representatives. Workshops represent
a unique opportunity for countries to exchange lessons learned and good
practices to inform the development of both regional and country-specific
responses to dementia. Workshops also enable participants to learn about
WHO’s Global dementia action plan, including its global targets, key actions
areas and available WHO tools.

Tools such as WHO’s Towards a dementia plan: a WHO guide
provide actionable means of developing and operationalizing
national dementia plans (28). This might involve developing
a new, stand-alone dementia plan, strengthening an existing
dementia plan, or integrating dementia into related policies.
The guide describes the process of creating a dementia plan in
three phases: preparation, development and implementation.
The first phase focuses on the steps involved in gathering
evidence and setting priorities. The second phase guides
countries through the creation of a strategic framework,
assessing resource needs and obtaining political and
stakeholder approval. Finally, the third phase outlines the steps
involved in implementing and evaluating the dementia plan.
The WHO guide identifies the process of developing a
dementia plan as both iterative and dynamic, with stakeholder
engagement and multisectoral collaboration throughout. The
resource is linked closely to the GDO and includes associated
aids such as a checklist for the preparation, development and
implementation of the dementia plan as well as stakeholder
mapping and priority-setting tools. The guide has been
successfully used by several Member States to develop their
own national dementia plans.

Towards a dementia plan:
a WHO guide

Towards a dementia
plan: a WHO guide

Photo: Participants of a bi-regional European/Eastern Mediterranean dementia workshop in
Malta in September 2019, organized and hosted by the Government of Malta

Workshops provide a forum for participants to work collaboratively towards
addressing dementia on global and local scales. They facilitate the crosspollination of ideas and foster new opportunities for collaboration both
across sectors and WHO regions. Post-workshop survey findings highlight
high levels of participant satisfaction, a strong intent to apply lessons
learned and a recognition of value in terms of national capacity-building
and intercountry knowledge exchange to strengthen the development and
implementation of comprehensive public health responses to dementia at
national and regional levels.

"A concerted effort to develop
and renew appropriately
funded national dementia plans,
with clear implementation
targets is needed globally."

A virtual workshop held in December 2020 for the Eastern Mediterranean Region
indicated the feasibility and success of conducting similar capacity-building efforts
through the use of digital technology during the COVID-19 pandemic.
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BOX 5

Towards a dementia plan:
a WHO guide – adaptation in Czechia
In accordance with WHO recommendations in the Global dementia action
plan, the Ministry of Health of Czechia introduced systemic changes to
strengthen dementia policy. The first step was to appoint a national dementia
focal point within the ministry. The role of the focal point was twofold: 1)
to gather information about gaps in the system in Czechia itself, as well as
creating a platform for key stakeholders; and 2) to connect the country to
international structures such as WHO or Alzheimer Europe.
While the first activity mainly indicated what needs to be done, the latter provided
valuable methodological support in how to achieve it. As a result of this effort, three
specific activities stand out in the current dementia policy in Czechia.
First, Czechia joined the Global Dementia Observatory (GDO) initiative and created
a structured situation analysis on the basis of GDO indicators.
Second, The National Action Plan for Alzheimer’s Disease and Related Illnesses
2020–2030 was developed during 2019 in line with the document Towards a
dementia plan: a WHO guide. To ensure multisectoral collaboration, the Plan is
a joint initiative of both the Ministry of Health and the Ministry of Labour and
Social Affairs and is currently being approved by the Cabinet.
Third, thanks to established collaboration and experience with methodological
support from WHO, Czechia decided to do a rapid adaptation of iSupport as a
response to Covid-19 which had created additional burden for family carers
(see Chapter 8).
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Concluding remarks
While some progress is being made to develop, strengthen
and implement national and subnational dementia plans, there
continue to be wide variations between countries. Allocating
earmarked funding and identifying clear targets to ensure
the development and effective implementation of national
dementia plans constitute significant challenges, particularly
in LMICs. A renewed focus on ensuring equity of access to
dementia services from prevention to diagnosis, treatment
and palliative care is also needed in order to reach all groups of
the population, especially the most vulnerable. In this respect,
additional efforts are required to strengthen legislation aimed
at protecting the human rights of people with dementia, their
families and carers in line with the principles of the CRPD.

"A renewed focus of
policies on ensuring
equitable access to
dementia services is
needed to reach all
population groups,
especially the most
vulnerable."

5. Dementia
awareness and
friendliness
Context

62%

of health care
practitioners believe that
dementia is a natural and
inevitable part of ageing

‘Don’t talk about people living
with dementia in a way that rip off
their dignity as a person or make
them feel ‘not good enough’ to be
part of the community.’
Emily Ong
Singapore

International human rights instruments such as the CRPD
were developed to prevent human rights violations and
discrimination, including against people with dementia.
These instruments provide the foundation for identifying
and eliminating barriers to ensure that people with dementia
can live safely in their own communities and enjoy equitable
access to their environment. However, people with dementia,
their carers and families worldwide continue to experience
stigma, discrimination and human rights violations. These
include coercive or forced treatment or institutionalization,
disregard for an individual’s legal capacity to make decisions
and depriving a person of dignity and autonomy. Moreover,
dementia is frequently misconceived as a natural and
inevitable part of ageing rather than as a syndrome, which
raises barriers to diagnosis and care.
While there is growing commitment to reduce stigma and
increase knowledge and understanding of dementia, much
still needs to be done to increase awareness across WHO’s
194 Member States and beyond. In 2019, ADI and the London
School of Economics conducted a global survey of almost
70 000 people from 155 countries and territories to understand
stigma and to assess the knowledge and understanding of
dementia. The survey analysis exposed a startling lack of
knowledge about dementia. The report revealed that two thirds
of the general public still believe that dementia is a natural and
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inevitable part of ageing and, more worryingly, 62% of healthcare practitioners share this view (39).
The first step to dispelling myths and stereotypes is to provide
accurate information to improve public understanding of
dementia. Action area 2 of the Global dementia action plan
focuses on increasing public awareness, acceptance and
understanding of dementia. It also seeks to foster dementiainclusive societies that enable people with dementia to
participate in the community and maximize their autonomy
through improved social participation. Global targets 2.1 and
2.2 to be reached by 2025 are that:

100% of countries will have at least one functioning public awareness-raising
campaign on dementia; and
50% of countries will have at least one dementia-friendly initiative (DFI) to
foster a dementia-inclusive society.

Achieving these targets involves the ongoing
and meaningful involvement of people with
dementia, their families and carers in planning,
implementing and evaluating both dementia
awareness campaigns and DFIs. It also
requires close collaboration among multiple
stakeholders, including governments, civil
society, the media and academia.
This chapter provides an overview of progress
made to date in achieving the global targets
associated with Action area 2. Based on
available GDO data. The chapter outlines
success factors associated with effective
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dementia awareness campaigns and DFIs,
ongoing gaps in and opportunities to improve
the social and built environment, good
practices in including people with dementia and
their carers in decision-making, and the impact
of COVID-19 on efforts related to dementia
awareness and dementia-friendliness. The
chapter further outlines activities carried out
by WHO’s secretariat and regional offices to
support countries in raising public awareness
of dementia and fostering dementia-inclusive
environments. Finally, the chapter features
country case studies and identifies key
accelerators for action.
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Progress to date
Dementia awareness campaigns
An understanding that dementia is a clinical
syndrome associated with the progressive
decline of brain function is imperative for
promoting dementia risk reduction, timely
diagnosis and access to support for people
living with dementia and their families.
Effective public health and awareness
campaigns have the power to change the way
people think about dementia, improve the
accuracy of public knowledge about dementia,
reduce stigmatization, dispel myths, and
promote the recognition of human rights of
people with dementia. The Global dementia
action plan recommends that countries

organize national and local public health and
awareness campaigns that are both culturally
– and community-specific – and to do so in
collaboration with people with dementia, their
carers and other stakeholders.
Available GDO data indicate that two thirds
of countries have implemented at least one
functioning public awareness campaign to
improve the understanding of dementia and
reduce stigma and discrimination. Figure
14 shows these data disaggregated by
WHO region, and by World Bank income
classification.

"2/3 of GDO countries have
implemented at least one
functioning dementia public
awareness campaign to improve
the understanding of dementia
and reduce stigma and
discrimination."
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The GDO also measures whether dementia public awareness
campaigns were implemented at national or subnational
level. Of the 41 GDO countries with at least one national
awareness-raising campaign, 73% indicated that the campaign
was implemented at national level. A majority of awarenessraising campaigns (25/41) are (at least co-) managed and
implemented by nongovernmental organizations (NGOs),
indicating the important role of civil society in this work. When
asked whether dementia awareness campaigns were tailored
to specific audiences, only 5 of 37 countries indicated that
this was the case. Of the countries reporting (non-mutually
exclusive) delivery channels for their public awareness
campaigns, most used social media (n=32), followed by print
media (n=32), television (n=24), and radio (n=23).

FIGURE 14

Numbers of countries with at least one functioning public awareness
campaign for dementia
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Of the 43 GDO countries with dementia plans (i.e. dementiaspecific, integrated or subnational plans), 36 countries stated
that their plans included actions or objectives to address
dementia awareness, stigma reduction and encouragement
of dementia-friendly communities. Of those 36, 87% ran a
dementia awareness campaign and 96% implemented a DFI,
indicating high implementation rates.
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28
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100%

An important first step in establishing a successful campaign
is to ensure meaningful inclusion of people with dementia
and their carers in planning, implementation and evaluation.
Including the voice of those with lived experience will ensure
that the campaign uses the right language and that messaging
is relevant and clear. The use of accurate messaging based on
solid data and evidence is fundamental to any campaign. Data
collection through the GDO enables countries to set targets
and gather key information to monitor progress and impact in
the area of dementia awareness.

"An important first
step in establishing
a successful
awareness campaign
is to ensure
meaningful inclusion
of people with
dementia and their
carers in planning,
implementation and
evaluation."

No

Note: LMICs = Low- and middle-income countries; HICs = High-income countries.
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BOX 6

Indonesia: Case study by the Association of Southeast Asian Nations (ASEAN)
Indonesia has the fourth largest population in the world at 270 million. It is made up of over
17 000 islands, and 600 cultures call these islands home. Indonesia was the first ASEAN Member
State to launch and implement the Dementia National Strategy in 2016, with support from ADI.
In 2013, Alzheimer’s Indonesia (ALZI), an ADI member, spearheaded awareness of Alzheimer’s
in Indonesia by conducting a national campaign titled “Do Not Underestimate Memory Loss”. An
infographic accordion-style brochure about the 10 warning signs of dementia and Alzheimer’s
disease was created to raise awareness.
In March 2018, ADI’s Asia Pacific Regional Director had the opportunity to attend ASEAN’s
Health Cluster 1 Meeting in Lao People’s Democratic Republic (PDR). The meeting was
followed up in September 2020 with a consensus to strengthen collaboration between ADI
Asia Pacific and ASEAN across all 10 ASEAN countries in key areas from 2021 to 2025 in the
promotion of mental health and the promotion of healthy and active ageing.
In 2019, the ASEAN Women’s Circle (AWC) invited ALZI’s risk reduction specialist to lead a
brain gym exercise at an opening session of a meeting attended by all 10 ASEAN Member States
at the ASEAN Secretariat in Jakarta. The session led to an invitation to conduct an educational
session for ASEAN’s staff. It also resulted in the development and translation of an Indonesian
version of the 10 warning signs of the Alzheimer accordion brochure which now also exists
in a further nine languages for Brunei Darussalam, Cambodia, Lao PDR, Malaysia, Myanmar,
Philippines, Thailand, Singapore and Viet Nam. The Alzheimer’s Indonesia ASEAN initiative is
an example of a joint civil society – government initiative replicated by the local provincial and
national government, which will be implemented in other ASEAN Members States.

Impact of dementia awareness campaigns
Public engagement can be measured as visits
to a campaign website to see how often
materials are downloaded, or by monitoring
media (and social media) attention. However,
lasting behaviour change takes time and
is a longer-term indicator of success. One
example of an ongoing dementia awareness
campaign that has been scaled up globally is
ADI’s World Alzheimer’s Month that occurs
every September. Alzheimer and dementia
associations, as well as other groups in more
than 90 countries worldwide, take part in
the campaign that enables collaborative
engagement with governments and people
living with dementia and their families, directly
contributing to the global target outlined in the
Global dementia action plan (34).
Of the 41 GDO countries that reported
having a national dementia awareness
campaign, six are located in the WHO Region
of the Americas. In 2019, the Dominican
Republic, as one of the GDO countries,
participated in the joint WHO-ADI regional
campaign “Let’s Talk about Dementia” with the
Pan American Health Organization (PAHO)
(see page 111).

Measuring the impact of awareness-raising
campaigns on changes in attitudes and beliefs
about dementia is complex. It is encouraging
that two thirds of GDO countries so far are
running awareness campaigns. However, little
evidence exists to date on the impact of these
campaigns in terms of reducing stigma. This
was one of the driving forces behind ADI’s
World Alzheimer Report 2019 on stigma, and
there are plans to follow up with another
global survey in five years to measure the
effectiveness and impact of national, regional
and global dementia awareness campaigns on
stigma reduction.
It is important that dementia awareness
campaigns are accessible for all people,
including people with all forms of disabilities
– including physical, psychosocial and
intellectual disabilities, as well as sensory
impairments (e.g. vision or hearing). For
instance, campaigns and information
materials should contain clear messaging and
should be provided in easy-to-read formats,
including in braille or in audio/video format
where appropriate.

By working on this campaign, the local
Alzheimer association, Asociación Dominican
de Alzheimer, developed a collaborative
relationship with both PAHO and the Ministry
of Health which contributed to the launch of
the country’s first National Dementia Plan in
July 2020.
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Dementia-inclusive societies

2 in 3

GDO countries have
initiatives to improve
the accessibility of
the physical and social
environment

Fostering inclusive and age- and dementia-friendly
environments is an important way to promote respect,
acceptance, participation, safety and inclusion of people with
dementia in a manner that meets their needs and those of
their families and carers. This means ensuring that people
with dementia and their carers can participate fully in society
and are empowered to live independently and enjoy respect,
freedom, dignity, equality, accessibility and quality of life.
Making changes to the social and built environment – such
as home modifications, opportunities for social, cultural and
community participation, and the provision of person-centred
health and social care – is key to this process.
Examples from Kenya and South Africa in ADI’s World Alzheimer
Report 2020 demonstrate that simple design solutions within
the built environment can reduce risk and improve safety.
Families are encouraged to make simple changes such as
installing grab bars in the shower or bathtub to support
independence and safety, constructing ramps to help prevent
falls or enable wheelchair access, or installing night-lights in
hallways, bedrooms or bathrooms to help orient people living
with dementia. Home modifications such as these are costeffective and can be done easily and quickly, enabling people
living with dementia to remain independent longer, to live safely
and with dignity in their own homes (40).

FIGURE 15

Number of countries with initiatives to improve accessibility of the physical
and social environment
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HICs

LMICs

DFIs refer to all activities and actions that
promote lasting change to the social and/
or physical environment in order to make
societies more inclusive of people with
dementia, their families and carers. One
example of placing people living with dementia
at the heart of community development is in
Machida City in the suburbs of Tokyo. Once
a week, people living with dementia hold a
“Living Together with Dementia” meeting
at which they discuss their concerns and
share knowledge to improve their quality
of life. Members of the meeting try to
expand opportunities to make meaningful

12
15
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contributions to the local community, such as
by giving lectures on dementia in high schools.
Importantly, the members have created 16
statements that express a vision for the type
of inclusive community in which people living
with dementia want to live (32).
GDO data indicate that, of 36 countries that
included awareness-raising, stigma reduction
and dementia-friendliness in their dementia
plan, 90% identified having a DFI and 85%
provided training and education on dementia
to population groups outside the health and
social sector.

Of the 62 GDO countries, 41 reported that there were
initiatives to improve the accessibility of the physical and social
environment – including for people with dementia (see Figure
15), of which 29% were in LMICs.
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BOX 7

Susitikime muziejuje dementia-friendly arts programming in
museums in Lithuania
The NGO Socialiniai meno projektai (SMP) is a pioneering “arts for health”
organization in Lithuania. SMP aims to promote the well-being of various
groups of society by making the arts more accessible. Activities based on crosssectoral partnerships include arts projects (plays, exhibitions, performances
and creative experiments), creative arts (participatory) workshop programmes,
training and “arts for health” research and publishing.
Since 2014, SMP and a number of partners (museums, social/health-care
organizations, Alzheimer’s clubs), started implementing a programme called
Susitikime muziejuje (“Let’s meet at the museum”). The programme aims to build
access to culture and arts for people living with dementia, their carers and
family members, to support their well-being, community and care relationship
development. Additionally, by expanding the competencies of educators, the
programme aims to increase the availability of museums and galleries to a
diversity of audiences who face social difference and the stigmatizing attitude
of society in their daily life. Susitikime muziejuje includes training for museum
staff, museum tours, workshops in residential care settings and the evaluation
of the programme’s impact on the well-being of people living with dementia,
their carers and family members.
According to the results of the evaluation, the programme helped to increase
the well-being of the participants. It gave them the opportunity to engage in art
activities in a safe, failure-free and friendly environment; it stimulated learning
and self-expression in equal participation; it increased participants’ self-esteem
and helped them to relax; participants learned new things about themselves
and each other; participants experienced a range of positive emotions which
enhanced their mood; and there was an increased a sense of community and
improved communication.
Susitikime muziejuje contributes to the research in dementia care and extends
the evidence that cultural interests can play an active role in developing crosssectoral partnerships and a person-centred approach to dementia care.
Picture on page 115 “Susitikime muziejuje at The National Art Gallery in Vilnius"
accredited to: “Socialiniai meno projektai”. Photograph by Egle Gudonyte.
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The GDO measures the different dimensions
covered by countries’ DFIs. Figure 16
shows the DFI dimensions reported by
countries globally and by World Bank
income classification. Of the 41 countries
that reported having DFIs, most countries
addressed accessibility of public spaces and

buildings (90%) and creating community
places where older people can meet (90%),
followed by offering social opportunities and
accessible information on leisure and social
activities (85%). GDO responses further
suggest that, in both LMICs and HICs, DFIs
focus the least on assistive technology.

FIGURE 16

Types of DFI dimensions covered by countries (% of countries)
All countries
n=39

n=38

n=39

n=39

n=41

n=41

HICs

90%

n=27

71%

n=27

77%

n=27

64%

n=27

90%

n=28

85%

n=28

LMICs
93%

74%

81%

67%

86%

82%

n=11

82%

n=11

64%

n=11

64%

n=12

58%

n=12

100%

n=12

92%

Accessibility of public spaces and buildings

Assistive technology to compensate for loss of capacity

Accessibility of public transportation vehicles

Availability of community places where older people can meet

Assistance with home modiﬁcation

Availability of social opportunities as well as accessible
information on leisure and social actives

*n reﬂects the number of countries that replied to the respective indicator.
Bars show the percentage of ‘n’ where services are available
*n reflects the number of countries that replied to the respective indicator.
Bars show the percentage of ‘n’ where services are available.
Note: LMICs = Low- and middle-income countries; HICs = High-income countries.

Dementia awareness and friendliness

WHO

101

Success factors of DFIs
The key to success in any DFI is ensuring
that people with dementia and their carers
play a central role at all stages of planning,
implementation and evaluation. In order
to succeed, DFIs need to work across

communities. They need to ensure social
inclusion, encourage organizations to be
responsive to the needs of people living with
dementia, and work in partnership with all
levels of government and civil society.

Building dementia capacity in the population
The Global dementia action plan recommends
the development of programmes to
encourage dementia-friendly attitudes in the
community, the private sector and among the

public, informed by experiences of people with
dementia. Such programmes should include
evidence-based and culturally appropriate
training tailored to specific settings and

population groups. As part of the GDO, countries are asked
to identify whether groups outside the health and social
sector receive training and education on dementia. The
purpose of the training is to increase awareness of dementia
and enable populations to assist people who are living with
dementia. Of the 62 GDO countries, 66% indicated that they
provide training and education on dementia to populations
outside the health and social care sector (Figure 17), of
which 29% are LMICs.

66%

of GDO countries provide
training and education on
dementia to populations
outside the health and
social care sectors

BOX 8

Dementia friendliness and awareness in Poland
Dementia friendliness and awareness are topics that are gradually gaining
ground in Poland. Although there is still much to be done, it is possible to point
to many initiatives that can be treated as potentially valuable in the hope that
the coming years will bring progress in creating favourable environments for
people living with dementia and those supporting them. For this reason, it is
important to recognize every initiative – even grassroots efforts such as local
support groups, Alzheimer’s cafés, workshops, online forums etc.
All these initiatives exist in Poland but they are usually isolated local efforts
that are often run by activists – usually people who are directly or indirectly
affected by the suboptimal way in which dementia care is organized nationally.
Their persistence and determination constitute a potent and vital foundation
which, with top–down institutional support, could develop into nationwide
programmes for coherent care and support. An important factor empowering
and facilitating the dissemination of information about such activities are
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the contributions of researchers. One example is the establishment of
Meeting Centres operating within the European MeetingDem network and
spearheaded by the research team from Wroclaw Medical University. Although
these are not large-scale activities and their availability is limited, even small
and gradual changes in local, community-based dementia care significantly
improve lives. The best hope for integrating these good practices throughout
Poland is the introduction of a national dementia strategy that has already
been developed but has not yet been authorized or implemented. Moreover,
as friendliness stems from understanding, the everyday reality of people and
their families living with dementia should be made public in order to stimulate
reflection and spark empathy. Making dementia care a common cause and
taming stigma may be building blocks to create an environment that is open to
dementia-related issues on many levels – social, organizational, architectural –
as well as to research and policy-making.
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FIGURE 17

Promoting a dementia-inclusive world – examples
from three countries

Number of countries providing training and education on dementia to
populations outside the health and social sector
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Initially launched by Alzheimer’s Society UK, the Dementia
Friends programme aims to transform the way people think,
act and talk about dementia. There are currently 67 Dementia
Friends programmes launched or in development in 56
countries, with nearly 19 million Dementia Friends worldwide.
One study at Bemidji State University in Minnesota, USA,
examined whether Dementia Friends could affect attitudes
toward people with dementia. The study used the Dementia
Attitudes Scale to measure participants’ attitudes before
and after participating in a one-hour Dementia Friends
session. Of the 80 people who participated, overall scores
showed a statistically significant improvement in attitudes
toward dementia after taking part in training. Participants
also reported a statistically significant increase in dementia
knowledge as well as a statistically significant increase in
social comfort around people with dementia (9).
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Note: LMICs = Low- and middle-income countries; HICs = High-income countries.

There are many examples of successful training
initiatives from around the world. They are
primarily run by civil society and contribute
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to raising awareness and understanding of
dementia and promoting dementia inclusiveness
globally (see Box 9 for examples).
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In Bangalore, India, the local branch of the Alzheimer’s &
Related Disorders Society of India (ARDSI) partnered with
Nightingale’s Medical Trust, a local service provider, to drive
forward several DFIs. In September 2019, ARDSI started a pilot
programme called “Creating a Dementia-Friendly Generation”
to increase awareness. On the first day, they signed up nearly
1500 persons with the aim of increasing that to 10 000 new
dementia friends in the first year. Another initiative was the
Bengaluru race, in which 600 participants engaged in an
innovative treasure hunt that was created to reduce stigma and
increase awareness across the city as people participated (10).
Finally, Alzheimer’s New Zealand has developed a “Dementiafriendly recognition programme” to help expand the number
of dementia-friendly businesses. An important component
of the programme is a toolkit that enables private companies
to “self-evaluate” their practices in order to gauge their own
level of dementia awareness. The programme then helps the
company to establish a more dementia-friendly model (11).

Dementia awareness and friendliness

WHO

105

Figure 18 shows population groups that
received training and education on dementia
by countries globally and by World Bank
income classification. Of the countries that
reported on this sub-indicator, most countries
trained volunteers (98%), followed by police

and fire services (63%), and first responders/
paramedics (63%). GDO data further suggest
that HICs and LMICs put the least emphasis on
training of judges, solicitors and notaries (30%)
and bankers and financial service staff (39%).

Volunteers were the most common
population group to receive training, with
92% trained in LMICs and 100% in HICs.
Significant differences can be seen for training
of community and city workers. While 70% of

HICs report training this population group,
only 18% of LIMCs do so. Similarly, while 62%
of HICs provide training to hospitality staff,
only 18% of LMICs reported doing so.

FIGURE 18

Populations outside the health and social sector who receive training and
education on dementia (% of countries)

All countries
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Volunteers

Judges, solicitors, notaries

Bankers, ﬁnancial service staff

Police and ﬁre services

Community/city workers (e.g. public transport staff, librarians)

Retail and hospitality staff (e.g. restaurants, grocery stores)

First responders/paramedics

School children

*n reflects the number of countries that replied to the respective indicator.
Bars show the percentage of ‘n’ where training is provided.
Note: LMICs = Low- and middle-income countries; HICs = High-income countries.
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BOX 10

Awareness raising efforts and innovative responses to the COVID-19 pandemic
by civil society partners
Response type

Country/civil society examples

Information/
guidelines

Alzheimer’s Indonesia (ALZI) developed an infographic on COVID-19 key
messages for people with dementia, older adults and family carers which was
translated into English by HelpAge International Asia Pacific Region and has been
disseminated in Indonesia and in the Asia Pacific Region.
Iran Dementia & Alzheimer’s Association (IDAA) translated information and key
messaging from ADI and WHO into Farsi, producing videos on COVID-19, and
posting on their website, Instagram and the Telegram channel.
Madagascar Alzheimer ran short radio programmes twice weekly providing tips
and advice around COVID-19 for older persons, especially those living with
dementia and their carers.

Awarenessraising

The Alzheimer Society of Ireland engaged in an extensive advocacy programme
highlighting concerns about the impact of COVID-19 on people living with
dementia and their family carer.
The US Alzheimer’s Association developed Tips for Dementia Caregivers at Home to
support carers to help people with dementia remember important hygiene practices.
Practical tips

Regional Alzheimer’s societies in Germany developed materials (e.g. documents,
podcasts and videos) to support people living with dementia and their family carers
during the pandemic.
Alzheimer Indonesia (ALZI) produced a “dementia care tips and tricks” video
and provided music therapy, Poco-Poco traditional dancing, yoga and brain
gym exercise sessions online as well as online webinars to support people with
dementia and their carers. Families were supported with educational sessions,
online counselling and talk shows.
The Alzheimer Society in the United Kingdom provided “Singing for the Brain”
sessions online.

Virtual support
Dementia Alliance International (DAI) provided peer-to-peer support for people
living with dementia.
Fundación Alzheimer de Venezuela provided online carers’ groups and personal
zoom calls to people living with dementia.

The way
forward
There is an ongoing need to raise public awareness and
improve the understanding of dementia by engaging
communities and helping them assume ownership of this
endeavour. This is the first step in combating stigma. Wellresourced public awareness campaigns – implemented in
partnership with civil society, people with dementia, their
carers and other relevant stakeholders – represent an
important actionable step towards achieving the targets
outlined in this chapter.
There may also be strategic opportunities to integrate
dementia into existing awareness-raising campaigns such as
those for NCDs, ageing, neurological disorders or disability.
These actions are aligned with the 2019 G20 Health
Ministers’ Declaration (31), which committed to promoting
“age-friendly and dementia-inclusive environments by raising
awareness to enable better understanding of dementia and
prevent and overcome stigma” and empowering “families and
carers to support persons with dementia”.
Achieving the global targets for dementia awareness and
friendliness also involves creating strategic links to existing
commitments – such as the Decade of Healthy Ageing 2021–
2030 – in order to integrate dementia into existing initiatives
– such as through WHO’s Global Network for Age-friendly
Cities and Communities – and build community-level capacity
on dementia. Additionally, combating ageism may be key to
improving care and support for older persons with dementia.
In March 2021 WHO issued a global report on agism (41).

"Combating ageism
may be key to
improving care
and support for
older persons with
dementia."

Figure 19 outlines the actions included in the Global
dementia action plan, key barriers to implementing these
actions, and strategies to overcome the barriers through
accelerators for action.

Alzheimer’s and Related Disorders Society of India (ARDSI) provided support to
carers via telephone, video-conferencing and social media platforms.
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FIGURE 19

Learning from experience: ADI/PAHO “Let’s Talk
About Dementia” campaign

PROPOSED ACTIONS

Regional awareness-raising campaigns implemented in
partnership with civil society, WHO and other stakeholders
have the potential to increase the understanding of dementia
significantly and to reduce stigma. One example is the regional
PAHO “Let’s Talk About Dementia” campaign which started
in September 2019 and ran alongside the global World
Alzheimer’s Month campaign in partnership with ADI. Although
each campaign had the same theme, the PAHO campaign had a
unique design that was tailored to be regionally and culturally
relevant. The PAHO campaign was implemented as part of
PAHO’s Regional Strategy and Plan of Action on Dementias in
Older Persons (2015–2019), which aimed to promote UHC and
access to quality interventions for people with, or at risk of,
dementia. The campaign sought to de-mystify dementia through
conversation and contribute to better planning and support for
people living with dementia and their carers.

Proposed actions for Member States, identified barriers and opportunity to
accelerate actions

Implement public awareness campaignS
Foster dementia-friendly environments
Provide dementia training to non-health and social care professionals/sections
of the population

BARRIERS
Lack of guidance, awareness and knowledge
Stigma and misconceptions
Reliance on NGOs to run campaigns/initiatives

OPPORTUNITIES TO ACCELERATE ACTION
Partner with civil society, WHO and other relevant stakeholders to implement,
replicate and/or scale up regional awareness-raising campaigns such as the
joint ADI/PAHO Let’s Talk Dementia campaign.
Leverage strategic commitments such as the Decade of Healthy Ageing 2021–
2030 to integrate dementia into existing initiatives such as WHO’s Global
Network for Age-friendly Cities and Communities.
Implement WHO’s Towards a dementia-inclusive society: WHO toolkit for
dementia-friendly initiatives to train and build capacity of non-health and social
care professionals on dementia.
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Campaign materials, including posters and social media cards,
were made available in Dutch, English, French, Portuguese and
Spanish. They not only highlighted the importance of talking
about dementia, but also explained its warning signs and ways
to reduce risk factors for the disease. Social media (particularly
via Facebook, Twitter and Instagram) was the main tool used by
PAHO country offices to implement the campaign. Campaign
data show that the 237 social media posts disseminated
through the campaign reached almost 800 000 people in the
Region. PAHO´s website hosted the campaign pages as well as
a press release announcing it. Overall, the campaign webpages
registered nearly 30 000 visits. Additionally, it received press
coverage across the Region.
The campaign brought increasing awareness about the need
to better understand dementia and how discussions could
improve care for older adults in the Americas. There were
multiple requests to adapt the materials to country contexts
and, as a result, the campaign was extended from the initial
month of September to include October and November too.
Additionally, the campaign enhanced multisectoral
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collaboration between civil society, ministries of
health and PAHO country offices – a model that
can be recreated in other regional contexts.
Given the long period required to monitor
behavioural and attitudinal change, it will
take years to realize the full impact of the

campaign. However, a promising example
mentioned earlier in this report is provided by
the Dominican Republic, where multisectoral
collaboration was particularly successful
and accelerated the launch of the country’s
national dementia plan in July 2020.

Leveraging existing global commitments: the
Decade of Healthy Ageing 2021–2030 & WHO’s
Global Network for Age-friendly Cities and
Communities
In August 2020, the Seventy-third World
Health Assembly endorsed the UN Decade
of Healthy Ageing 2021–2030. The Decade
represents an opportunity over the next ten
years to bring together partners – including
governments, civil society, international
agencies, academic institutions, health and
social care professionals and the private
sector – to improve the lives of older people,
including persons with dementia, their
families and communities. As demographics
rapidly change, a decade of concerted global
action on healthy ageing is needed. To date,
there are more than 1 billion people aged
60 years or older, most of them living in
LMICs (42). Many do not have access to basic
resources and face multiple barriers that fail
to respect their dignity and prevent their full
participation in society.
The Decade of Healthy Ageing refers to
healthy ageing as the process of developing and
maintaining the functional ability that enables
well-being in older age (12). The Decade
of Healthy Ageing shares similar principles
to those of the Global dementia action

112

CHAPTER 5

plan, including a focus on inclusion, equity,
multistakeholder partnerships and sustained
global action. The focus is on changing how
people think, feel and act towards age and
ageing, and ensuring that communities
foster the abilities of older people, which are
particularly relevant to dementia awareness
and friendliness. This includes conducting
campaigns to increase public knowledge and
understanding of healthy ageing, taking action
against ageism, stigma and discrimination, and
developing programmes on age-friendly cities
and communities (12).
Established in 2010, WHO’s Global Network
for Age-friendly Cities and Communities is
particularly relevant. The network supports
cities’ efforts to become more age-friendly
by improving their responses to the needs
of ageing populations and involving older
people in urban planning (43). The network
promotes the exchange of experience
and mutual learning between cities and
communities worldwide that are committed
to promoting healthy and active ageing.
Age-friendly environments share many
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goals that are similar to those envisioned by
dementia-inclusive societies and DFIs. These
include: 1) the creation of environments that
are free from physical and social barriers;
and 2) the promotion of health, physical and
mental capacity, and independent living.
Both also aim to empower older people and

those with dementia to make decisions and
participate in society. The Decade of Health
Ageing 2020–2030 and the Global Network
for Age-friendly Cities and Communities
represent opportunities to leverage important
international commitments to achieve impact
at national and local levels.

Implementing existing tools to build capacity on
dementia. Towards a dementia inclusive-society:
WHO toolkit for dementia-friendly initiatives
Tools such as Towards a dementia-inclusive society: WHO toolkit for
DFIs provide actionable means of fostering dementia-friendly
environments and building an understanding of dementia at
community level, both among the general population and among
non-health and social care professionals.
The toolkit supports individuals, communities and
countries in empowering people with dementia to remain
in their community and be a significant part of it. Through
a person-centered, rights-based approach, it is grounded
in international commitments such as the CRPD, the 2030
Agenda for Sustainable Development and its SDGs and UHC.

Towards
a dementiainclusive
society
WHO toolkit
for dementia-friendly
initiatives (DFIs)

The toolkit supports persons working in communities with
little or no experience in programme planning, implementation,
management and/or evaluation, nor of creating a dementiainclusive society. The toolkit has two parts. The first part
contains introductory information on dementia and a
conceptual framework, while the second part includes
four modules, each featuring a series of practical steps and
exercises. The modules focus on: 1) starting a new DFI; 2)
integrating dementia into an existing initiative; 3) monitoring
and evaluating a DFI; and 4) scaling up a DFI. The modules can
be used together or separately and can be adapted to suit local
needs and settings.
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Concluding remarks

BOX 11

Inclusion begins at home: supporting dementia-inclusive
communities through strategic communication
To support the implementation of the Global dementia action plan, WHO’s
Western Pacific Region launched a strategic communication tool developed
for community leaders and organizers, programme managers, mental health
advocates, and specialists in health promotion, education and communication.
The toolkit contains essential information about dementia, case studies of
similar initiatives, and a full range of multimedia materials that are applicable
across different communication channels. The toolkit also gives guidance on
organizing various activities that are designed to:

Improve the accuracy of the general public’s knowledge
about dementia;
Reduce stigma;
Dispel myths and misconceptions;
Promote early diagnosis; and
Emphasize the need for appropriate services for people
living with dementia.

The centrepiece of the toolkit is a strategic communication framework to
help communities to L.I.V.E. (learn, identify, value, empower) with dementia.
A monitoring and evaluation framework is also provided to facilitate proper
planning and implementation.
The tool was launched online during World Alzheimer’s Month in September
2020, to be followed by its progressive implementation through government
and development partners across the Western Pacific Region over
subsequent months.
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While progress is being made in establishing dementia
awareness campaigns and DFIs, more concerted action is
required, particularly in LMICs where the majority of people
with dementia live. Guidance on how to implement, evaluate
and scale up these activities is also needed. In many countries,
stigma and discrimination against people with dementia, as
well as their families and carers, remain high. However, much
can be done to enhance public understanding and knowledge
of dementia at all levels of the general population. Efforts are
needed to ensure that the key principles included in the CRPD
are implemented at national level by fostering dementiainclusive societies as well as implementing, evaluating and
scaling up DFIs.

6. Dementia risk
reduction
Context

Up to
40%

of dementia cases can
potentially be prevented

"There is more and more information coming
out, telling us what to do to reduce our risk of
dementia. But many people feel that dementia
won't happen to them. Risk reduction should
start in primary school, geared to their level of
understanding as they move up, and this will
also benefit their general health.”
James McKillop,
United Kingdom

While age is the strongest known risk factor for cognitive
decline, dementia is not an inevitable consequence of ageing.
A growing evidence base demonstrates that there are clear
risk and protective factors that affect the cognitive health
of adults. Potentially modifiable risk factors include physical
inactivity, unhealthy diets, tobacco use and the harmful use of
alcohol. Protective factors include access to formal education,
employment and other opportunities for cognitive stimulation,
physical activity and social connection. Moreover, a number of
NCDs are also associated with the risk of cognitive impairment
and dementia – including depression, hypertension, diabetes,
hearing impairments and mid-life hypercholesterolemia
and obesity. Additionally, environmental risk factors such as
exposure to ambient and indoor air pollution and the impact
of traumatic brain injuries are increasingly being recognized.
All these factors together account for up to 40% of dementia
risk, as detailed by the 2020 Lancet commission on dementia
prevention, intervention and care (44).3 Importantly, these risk
factors may cluster together across the life course especially
in marginalized populations, thus increasing the risk at earlier
ages and for whole communities.

3 Alzheimer’s Disease International developed an infographic highlighting the 12
modifiable risk factors for dementia detailed in the 2020 Lancet Commission on
dementia prevention, intervention and care, which included the following: physical
inactivity, smoking, alcohol consumption, air pollution, head injuries, infrequent social
contact, less education, obesity, hypertension, diabetes, depression, and hearing
impairment. See: https://www.alzint.org/resource/dementia-risk-factors-infographic/
(accessed 6 July 2021).
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The COVID-19 pandemic has heightened
risk factors for dementia globally and
continues to do so. In addition to concerns
about the long-term sequelae and impacts
of SARS-CoV-2 infection on the central
nervous system, the broader consequences

of the pandemic – including disruption of
essential health services, access to emergency
services, routine care and supply chains for
medications – have prevented the diagnosis
and management of numerous NCDs known
to be risk factors for dementia.

BOX 12

Disruption of essential health services due to COVID-19 pandemic (WHO
Pulse surveys)
WHO’s Pulse survey on the continuity
of essential health services during the
COVID-19 pandemic, released in August
2020, revealed that 48% of 105 countries
surveyed reported at least partial disruptions
in all services for NCDs and mental health
(7). Further, 69% of countries reported
disruptions in services for diagnosis and
treatment of NCDs, with 5% of countries
reporting severe disruptions.
As a complement to the Pulse survey, WHO
also carried out a rapid assessment specifically
focused on NCD resources and services in
the context of COVID-19 in May 2020. This
survey found that both human and financial
resources were by necessity being reallocated
away from NCDs during this time. In the
majority of countries surveyed (94% of 163),
all or some NCD focal points within ministries
of health were focusing on COVID-19 efforts
either full-time or alongside routine NCD
activities, and 20% of countries reported that
public funds previously allotted to NCDs were
shifted to non-NCD services. Over one third
(37%) of countries reported suspension of

mass communication campaigns related to
NCDs. Over half (53%) of countries reported
disruptions to hypertension management
services, and close to half (49%) reported
disruptions to diabetes and diabetic
complication management services. Close to
one third of countries reported disruptions to
services for cardiovascular emergencies (31%),
with differences across income brackets, with
50% and 17% of LICs and HICs, respectively,
reporting these disruptions.
WHO’s second Pulse survey on the continuity
of essential health services during the
COVID-19 pandemic, released in April 2021,
demonstrated some improvements over
2020 but noted persistent disruptions to
NCD services (45). Roughly half of countries
surveyed reported disruptions to one or more
essential NCD services, with 45% reporting
disruptions to hypertension management,
42% reporting disruptions to diabetes
management and 20% reporting disruptions
to services for cardiovascular emergencies
(see Figure 20).

See Box 12 for more information. Moreover, public health
measures designed to control the pandemic, such as repeated
lockdowns, have led to increased social isolation in countless
older adults which in turn accounts for 4% of dementiaattributable risk (44).

FIGURE 20

Prevalence of countries reporting disruptions in NCD services

Average disruption
in service group

19%

Cancer screening
(n=86)

20%

Hypertension Management
(n=95)

27%

Diabetes and Diabetic
Complications Management
(n=97)
Urgent dental care
(n=85)

21%

Cancer Treatment
(n=90)

18%

Asthma services
(n=87)

15%

Cardiovascular emergencies
(91)

11%
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37%

9%

10%

49%

19%

9%

24%

8%

11%

7%

6%

42%

7%

42%

14%

32%

9%

8%

7%

45%

30%

20%

7%
2%
10%

20%

30%

40%

50%

Percentage of countries
5% to 25% disrupted
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8%

26% to 50% disrupted

More than 50% disrupted
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"Reducing
dementia risk
requires addressing
socioeconomic
inequalities across
the life course
and improving
environments in
which people live."

A public health approach to dementia risk reduction is needed
now more than ever and requires an interdisciplinary, crosssectoral perspective across the life course, as outlined in the
Global dementia action plan. Studies have shown that risk
factors are cumulative in their impact on the risk of dementia.
There is increasing support for addressing more than one
risk factor simultaneously to obtain the best outcomes.
Importantly, reducing dementia risk factors necessitates
addressing socioeconomic inequalities across the life course
and improving the environments in which people live.
Evidence-based, effective interventions and strategies for
dementia risk reduction are required, especially in LMICs, and
should be appropriately designed for vulnerable populations
(see Box 13).

BOX 13

Reducing the risk of dementia globally supports WHO’s Triple
Billion targets, and specifically the target of one billion more
people enjoying better health and well-being, as well as SDG
target 3.4 on reducing mortality from NCDs and promoting
mental health. A global commitment to address the risk factors
of dementia is also reflected in the Okayama Declaration of the
G20 Health Ministers in October 2019 (31). Relevant WHO
and UN initiatives to support this endeavour are summarized
in Annex 2.

This has particular relevance in LMICs because the exposure to lifestyle and
clinical risk factors is becoming more common as LMIC economies grow. This
is the only collaborative network of researchers to focus global attention on
prevention and on LMICs.

To reflect the inherent links between dementia and other NCDs,
the Global dementia action plan links the attainment of Global
target 3 to the targets defined in the Global action plan for
prevention and control of NCDs 2013–2020. After all, addressing
NCDs will ultimately help reduce the risk of dementia.
This chapter provides an overview of global progress made
to date in achieving the global target and recommended risk
reduction actions of the Global dementia action plan. It begins
by assessing country-driven progress based on data collected
through WHO’s Global Coordination Mechanism (GCM) on the
Prevention and Control of NCDs and WHO’s GDO, and identifies
barriers to achieving further progress. The chapter additionally
outlines opportunities to accelerate action and presents country
case studies in the area of dementia risk reduction.

Boosting dementia risk reduction evidence
in low- and middle-income countries (LMIC)
The International Research Network on Dementia Prevention (IRNDP) was
established in 2017 with support from the Australian Dementia Centre for
Research Collaboration. It has a mission to “link researchers globally to foster
new research and accelerate knowledge translation that will delay or prevent
dementia worldwide”.
IRNDP’s vision is for “global delay and prevention of dementia”. The IRNDP
aims to increase dementia risk reduction messaging worldwide, and to develop
targeted research to answer questions about the impact of known and
emerging risk factors in dementia.

The IRNDP has facilitated the open access publication of articles on dementia
risk reduction and has supported international webinars, an early career group
and a conference focusing solely on dementia prevention.
Australian researchers have also developed a risk index for Alzheimer’s
disease that is freely available online4 and can be completed by self-report. It
was designed to be accessible to the general public and has been shown to be
effective in assessing risk in cohorts from LMICs.
For more information, see:
Anstey KJ, Peters R. Dementia, risk, risk reduction, and translation into
practice: An International Research Network for Dementia Prevention
(IRNDP) Special Issue. J Alzheimers Dis. 2019;70(s1): S1–3. doi.
org/10.3233/JAD-190506.
Stephan BCM, Pakpahan E, Siervo M, Licher S, Muniz-Terrera G, Mohan
D et al. Prediction of dementia risk in low-income and middle-income
countries (the 10/66 Study): an independent external validation of
existing models. Lancet Glob Health. 2020;8(4):e524–35.

4 Available here: https://anuadri.anu.edu.au/take-the-assessment.html?view=adri (accessed 21 July 2021)
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Progress to date
The Global dementia action plan recommends countries
to link dementia with other programmes, policies and
campaigns on NCD risk reduction and health promotion
across relevant sectors, as well as developing and delivering
evidence-based risk reduction training to health professionals.
International, regional and national partners can support these
recommendations by promoting population health strategies
to foster a socially active lifestyle that is physically and
mentally healthy for all, taking specific actions to reduce the
risk of dementia (particularly during mid-life) and supporting
national efforts for the prevention and control of NCDs in
general and dementia in particular.

"It is crucial to
link dementia
with programmes,
policies and
campaigns on NCD
risk reduction and
health promotion."
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As WHO data show, these recommendations still stand and
require urgent action. The Global Coordinating Mechanism
on the Prevention and Control of NCDs monitors NCDrelated indicators, including the number of countries which
have set voluntary NCD targets, as well as proxy outcome
indicators which contribute to the eventual reduction of
dementia incidence in the long term. Additionally, the GDO
provides insights into the number of countries that include
dementia risk reduction in their national health or national
dementia plans, countries that have guidelines for dementia
risk reduction, and the number of countries that have carried
out dementia risk campaigns.
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Global progress on NCD indicators
The Global dementia action plan identified indicators from
the Global action plan for the prevention and control of NCDs
2013–2020 that reflect the link between NCDs and dementia
risk reduction. These are:

a 25% relative reduction in overall mortality from cardiovascular diseases,
cancer, diabetes or chronic respiratory diseases;
a 30% relative reduction in prevalence of current tobacco use in persons aged
15 years or older;
at least a 10% relative reduction in the harmful use of alcohol, as appropriate,
within the national context;
a 25% relative reduction in the prevalence of raised blood pressure or contain
the prevalence of raised blood pressure according to national circumstances;
a 10% relative reduction in prevalence of insufficient physical activity;
a halt in the rise in diabetes and obesity.

WHO reports on the progress of NCD risk
reduction at regular intervals. Table 14, which
is derived from a report to the Seventy-second
World Health Assembly in 2019, presents
data from 2010 to 2016 (46). There has been
incremental improvement in overall mortality
from cardiovascular diseases, cancer, diabetes
and chronic respiratory diseases (4% reduction
globally). Additionally, there has been a roughly
2% decrease in both tobacco smoking and heavy
episodic drinking amongst people 15 years of
age or older, and a 1% reduction in the agestandardized prevalence of high blood pressure.
While these changes are encouraging, they fail

to meet global targets. Additionally, the levels of
physical inactivity in adults remain unchanged
and the rates of overweight and obesity in adults
18 years or older has increased by 3%. See Table
14 for more information.
Overall, these figures suggest that urgent
action is required, to both advance
prevention and control of NCDs, as well as
to see concurrent benefits for dementia risk
reduction. As mentioned above, unfortunately
widespread disruption of essential health
services due to the COVID-19 pandemic
has negatively impacted the prevention and
management of NCDs (see Box 12).
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Progress towards the targets of the Global action plan for the prevention and
control of noncommunicable diseases 2013–2020
Target for 2025
A 25% relative reduction in
the overall mortality from
cardiovascular diseases,
cancer, diabetes, or chronic
respiratory diseases

At least 10% relative
reduction in the harmful use
of alcohol

Indicator

A 30% relative reduction
in prevalence of current
tobacco use in persons aged
≥15 years
A 25% relative reduction
in the prevalence of raised
blood pressure or contain
the prevalence of raised
blood pressure

2014

2016
Halt the rise in diabetes and
obesity

Unconditional probability of
dying between ages of 30 and
70 years from cardiovascular
diseases, cancer, diabetes or
chronic respiratory diseases

22%

19%

18%

Total alcohol per capita (aged
≥15 years old) consumption
within a calendar year in litres
of pure alcohol

6.4 litres

No data

6.4 litres

Age-standardized prevalence of
heavy episodic drinking:
• among adolescents (15–19
years old)

15.6%

• among adults (≥15 years old)

20.6%

Age-standardized prevalence
of alcohol use disorders (as a
percentage of population ≥15
years old)

A 10% relative reduction in
prevalence of insufficient
physical activity

2010

13.6%
No data
18.5%

5.1%

No data

5.1%

Prevalence of insufficiently
physically active adolescents

82%

81%

81%

Age-standardized prevalence of
insufficiently physically active
persons aged ≥18 years

28%

28%

28%

Prevalence of cigarette smoking
in 13–15-year-olds

No data

No data

6.8%
(2017)

Age-standardized prevalence of
tobacco smoking among adults
aged ≥15 years

22.1%

20.6%

19.9%

Age-standardized prevalence
of raised blood pressure among
persons aged ≥18 years and
mean systolic blood pressure

Target for 2025

Indicator

2010

2014

2016

Age-standardized prevalence of
raised blood glucose/diabetes
among persons aged ≥18 years

7.9%

8.5%

No data

Prevalence of overweight and
obesity in adolescents

14%

16%

17%

Age-standardized prevalence
of overweight and obesity in
persons aged ≥18 years

36%

38%

39%

Risk reduction in dementia
or other health plans
A critical first step towards prioritizing
dementia risk reduction nationally is to
include it within dementia plans or other
health plans. According to GDO data, out of
62 countries, 35 countries (56%) reported
having dementia risk reduction included in
their dementia plan or other health plans.

Of these 35 countries, over 70% are HICs
(see Figure 21 and Table 15). There are also
regional differences, with a higher percentage
of reporting countries in the WHO European
and Western Pacific regions covering risk
reduction in their policies compared with
countries in other regions (see Table 15).

FIGURE 21

Countries with dementia risk reduction in their dementia or health plans by
World Bank income level

25

23%

22%

22%
(2015)

10
HICs
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GDO countries including risk reduction in dementia or other health plans, by
WHO region and World Bank income classification

BOX 14

Promoting brain health in Finland

GDO countries with
dementia plan

GDO countries with
dementia risk reduction
included in dementia or
health plan

% of GDO countries with
dementia risk reduction included
in dementia or health plan, by
income category or region

The population of Finland is ageing, and the number of people living with
dementia and cognitive impairment is increasing. Approximately 200 000
people in Finland have some form of cognitive impairment and approximately
14 500 new cases of dementia are diagnosed each year.

43

35

81%

African Region

1

1

100%

Region of the
Americas

In order to meet the increasing demand for services and costs, actions
are needed to promote brain health, to prevent dementia and to detect
neurodegenerative diseases as early as possible. Observational studies and
trials show that memory disorders could be prevented by a healthy lifestyle.
One aim of the Finnish social and health-care policy is to promote health and
functional capacity.

7

4

57%

South-East Asia
Region

3

2

66%

European Region

19

16

84%

Eastern
Mediterranean
Region

5

5

100%

Western Pacific
Region

8

7

88%

Low- and middleincome

14

10

71%

High income

29

25

86%

Region
Global

WHO region

The Elderly care act (980/2012) states that local authorities must draw up
a plan for measures to support the well-being, health, functional capacity and
independent living of the older population.
Quality recommendations by the Ministry of Social Affairs and Health and
the Association of Finnish Local and Regional Authorities include nutrition and
physical exercises as one area of recommendations for health promotion.
Current care guidelines contain, for instance, guidelines for physical activity and
exercise training for adults with and without diseases, and guidelines for dementia.

Income level

The FINGER model, the Finnish Geriatric Intervention Study to Prevent
Cognitive Impairment and Disability (2009–2024), includes a multidomain
intervention programme that includes management of metabolic and vascular
risk factors, guidance on healthy diet and exercise and brain training. The
intervention consists of regular meetings over two years with various health
professionals.
The FINGER programme has so far shown that it is effective in preventing
cognitive decline among older people, that it reduces the risk of disability and
multimorbidity, and that it has positive effects on health-related quality of life.
The Finger model will continue to be implemented in social and health-care reform.
Moreover, the model includes guidance and recommendations for physical
activities and nutrition for older people and the population of working age.
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Dementia risk reduction in clinical guidelines
The availability of guidelines on dementia risk reduction is a
vital step to integrating risk reduction into clinical practice.
In 2019, WHO released guidelines on the risk reduction of
cognitive decline and dementia (see Box 15).

Social activity
There is insufficient evidence for social activity and the reduction of risk of cognitive
decline/dementia.
Social participation and social support are strongly connected to good health and wellbeing throughout life and social inclusion should be supported over the life course.
Weight management
Interventions for mid-life overweight and/or obesity may be offered to reduce the risk of
cognitive decline and/or dementia.

BOX 15

WHO guidelines on risk reduction of cognitive decline and dementia (2019)
Physical activity interventions
Physical activity should be recommended to adults with normal cognition to reduce the
risk of cognitive decline.
Physical activity may be recommended to adults with mild cognitive impairment to reduce
the risk of cognitive decline.
Tobacco cessation interventions
Interventions for tobacco cessation should be offered to adults who use tobacco since they
may reduce the risk of cognitive decline and dementia in addition to other health benefits.
Nutritional interventions
The Mediterranean-like diet may be recommended to adults with normal cognition and
mild cognitive impairment to reduce the risk of cognitive decline and/or dementia.
A healthy, balanced diet should be recommended to all adults on the basis of WHO’s
recommendations on healthy diet.
Vitamins B and E, polyunsaturated fatty acids and multi-complex supplementation should
not be recommended to reduce the risk of cognitive decline and/or dementia.
Interventions for alcohol use disorders
Interventions aimed at reducing or ceasing hazardous and harmful drinking should be
offered to adults with normal cognition and mild cognitive impairment to reduce the risk of
cognitive decline and/or dementia in addition to other health benefits.
Cognitive interventions
Cognitive training may be offered to older adults with normal cognition and with mild
cognitive impairment to reduce the risk of cognitive decline and/or dementia.
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Management of hypertension
Management of hypertension should be offered to adults with hypertension according to
existing WHO guidelines.
Management of hypertension may be offered to adults with hypertension to reduce the
risk of cognitive decline and/or dementia.
Management of diabetes mellitus
The management of diabetes in the form of medications and/or lifestyle interventions
should be offered to adults with diabetes according to existing WHO guidelines.
The management of diabetes may be offered to adults with diabetes to reduce the risk of
cognitive decline and/or dementia.
Management of dyslipidaemia
Management of dyslipidaemia at mid-life may be offered to reduce the risk of cognitive
decline and dementia.
Management of depression
There is currently insufficient evidence to recommend the use of antidepressant
medicines for reducing the risk of cognitive decline and/or dementia.
The management of depression in the form of antidepressants and/or psychological
interventions should be provided to adults with depression according to existing WHO
mhGAP guidelines.
Management of hearing loss
There is insufficient evidence to recommend the use of hearing aids to reduce the risk of
cognitive decline and/or dementia.
Screening followed by provision of hearing aids should be offered to older people for
timely identification and management of hearing loss as recommended in the WHO
ICOPE guidelines.
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According to GDO data, of the 36 countries
that report having clinical guidelines for
dementia, 21 report including a specific focus
on dementia risk reduction. Most of these
risk reduction-specific guidelines (16 of the
21 or 76%) come from HICs, with 5 of the 21
(or 24%) reported from LMICs. Around 62%

of the guidelines (13 of the 21) come from
the European region alone (see Table 16).
These data must be interpreted in view of
the limitations of lower rates of reporting on
this question in some regions, and it may not
reflect the overall regional situation.

TA B L E 1 6

GDO countries with risk reduction included in dementia guidelines, by WHO
region and World Bank income classification

Region
Global

GDO countries that
report having a
dementia guideline

GDO countries with dementia
risk reduction included in
dementia guidelines

% within region or
income group

36

21

58%

Existence of dementia risk reduction campaigns
Globally, population awareness of the
possibility of dementia risk reduction is
limited. Given the interrelatedness of NCD
risk factors and those for dementia, it should
be noted that awareness-raising campaigns
focused on health promotion but that
are not dementia-specific may also bring
gains in terms of dementia risk reduction.
Nevertheless, running nationwide campaigns
for dementia risk reduction can help raise
population awareness and educate people

TA B L E 1 7

GDO countries reporting risk reduction campaigns

WHO region
African Region

1

1

100%

Region of the Americas

4

2

50%

South-East Asia Region

2

1

50%

European Region

20

13

65%

about known risk and protective factors.
Twenty-eight GDO countries reported having
run dementia risk reduction campaigns.
Importantly, the majority of these countries
are HICs, with just 8 LMICs reporting risk
reduction campaigns. There are also regional
differences (see Table 17). However, this data
must be interpreted in view of the limitations
of lower rates of reporting for this question in
some regions.

GDO countries reporting risk reduction
campaigns (Yes)

% within region or
income group

28

45%

African Region (n=4)

1

25%

Region of the Americas (n=11)

3

27%

South-East Asia Region (n=5)

3

60%

European Region (n=24)

11

46%

Eastern Mediterranean Region (n=8)

4

50%

Western Pacific Region (n=1)

6

60%

Low- and middle-income (n=27)

8

29%

High-income (n=34)

20

59%

Region
Global (n=62)

WHO region

Eastern Mediterranean
Region

3

1

33%

Western Pacific Region

6

3

50%

Income level
LMICs

8

5

62%

HICs

28

16

57%
Income level
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28 of 62

GDO countries report
running risk reduction
campaigns; most
frequently using print
media, television and
radio to deliver messages

Of the 28 GDO countries reporting risk reduction campaigns,
the majority organized campaigns at the national level (19;
68%), over half reported dedicated funding for the campaign
(16; 57%), and 18 (64%) documented evidence as to whether
certain milestones were reached. Most campaigns were run
by government (20; 71%), while seven countries reported
campaigns that were run by NGOs and four reported campaigns
run by the private sector. In terms of target audience, 18
campaigns (64%) addressed the general population while six
campaigns had a specific target audience. The most commonly
used delivery channels for risk reduction campaigns (not
mutually exclusive) were print media (20 countries), television
(17 countries), radio (16 countries), social media (11 countries)
and billboards (10 countries). See Box 16 for an example of a
dementia risk reduction campaign from the Western Pacific
Region.

Training of health-care
workers in dementia
risk reduction
Overall, the training of health-care workers in dementia is grossly
insufficient. Refer to Chapter 7 for analyses of GDO data on
dementia-specific training reported by countries for different
cadre of health-care workers. No specific data are available on the
training of health-care workers in dementia risk reduction.

BOX 16

Dementia campaigns include risk reduction in the Western
Pacific Region
In 2018, WHO’s Western Pacific Region launched a dementia
awareness campaign with posters that were shared widely over
social media. These posters included several specific areas of focus on
dementia risk reduction, including:

1

the importance of mental stimulation, physical activity and exercise;

2 healthy balanced diets;
3 stopping tobacco and harmful use of alcohol; and
4 addressing cardiovascular risk factors, including weight, blood

pressure, sugar and cholesterol. The following image is from one
such poster which stressed the importance of physical activity and
exercise. All other social media posters from this campaign are
available at the following link:
https://iris.wpro.who.int/handle/10665.1/14005

Healthy ageing:
Physical activity and exercise may
improve cognition and reduce
dementia risk.

www.wpro.who.int/mental_health_substance_abuse/topics/dementia
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The way forward
Numerous barriers serve as bottlenecks that impede progress in
dementia risk reduction. Such barriers include the lack of public
awareness of the importance of risk reduction, lack of financial
resources for dementia risk reduction programmes, inequitable
distribution of services, human resource limitations (including
lack of health workforce and lack of training in this area), and lack
of coordination between sectors both nationally and locally – all
of which are exacerbated by ongoing disruptions in essential
NCD services by the COVID-19 pandemic.

"Accelerating
action will require
population level
health education
on dementia risk
reduction, increased
awareness of the
interrelatedness
of dementia risk
with that of other
neurological,
mental health and
substance use
conditions as well as
other NCDs, and the
need for integration
of care."

134

CHAPTER 6

Additionally, stigma is another impediment to dementia risk
reduction. The 2019 World Alzheimer Report presented results
of a global survey on attitudes towards dementia. A quarter of
respondents felt nothing could be done to prevent dementia
and only a little over half felt that lifestyle factors increased risk
for dementia (47).
Accelerating action will require population-level health
education on dementia risk reduction, increased awareness
of the interrelatedness of dementia risk with that of other
neurological, mental health and substance use conditions
as well as other NCDs, and the need for integration of care.
It will also require increased financial resources in order to
develop, deliver and promote evidence-based risk reduction
interventions in primary care and conduct the necessary
workforce training.
A critical aspect of integrating dementia risk reduction
programmes into primary care will be the creation of national
guidelines on dementia risk reduction and the adaptation of
evidence-based risk reduction interventions tailored for the
local context (see Box 17). Risk reduction interventions should
be integrated into national UHC packages, and health-care
workers should be routinely trained to address modifiable risk
factors such as those associated with NCDs (including weight
management, tobacco cessation and reduction of harmful use
of alcohol) in addition to promoting healthy lifestyles (including
healthy diets and physical activity).

Global status report on the public health response to dementia

BOX 17

Multidomain interventions to promote healthier lives
and reduce dementia risk
The World-Wide FINGERS (WW-FINGERS) network was launched in 2017 as
the first global network of multidomain lifestyle intervention trials for dementia
risk reduction and prevention. The Nordic-UK Brain Network runs the Scientific
Helpdesk of WW-FINGERS, with support from and in collaboration with several
organizations and stakeholders, including WHO, the Alzheimer’s Association
(AA), and Alzheimer’s Disease Data Initiative (ADDI), among others.
The multifactorial and heterogeneous nature of late-onset dementia, including
Alzheimer’s disease, indicates that multidomain interventions and the targeting
of several modifiable risk factors simultaneously can have a potential impact on
optimal risk reduction. The positive results of such an approach are supported
by the landmark multidomain Finnish Geriatric Intervention Study to Prevent
Cognitive Impairment and Disability (FINGER). The overall scope of WWFINGERS is to adapt, test and optimize the FINGER multidomain model for
dementia risk reduction across the spectrum of cognitive decline – from at-risk
asymptomatic states to early symptomatic stages – in different geographical,
cultural and economic settings and contexts.
The WW-FINGERS network currently includes 30-plus countries (including
LMICs) across all continents. The network provides a unique forum to
harmonize and adapt multidomain interventions across various countries and
settings and to facilitate data-sharing and analysis across studies. It promotes
international joint initiatives to identify effective and feasible risk reduction
strategies that can be implemented globally.
For more information, see:
Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen
R et al. A 2 year multidomain intervention of diet, exercise, cognitive
training, and vascular risk monitoring versus control to prevent
cognitive decline in at-risk elderly people (FINGER): a randomised
controlled trial. Lancet. 2015;385(9984):2255–63. doi:10.1016/
S0140-6736(15)60461-5.
Kivipelto M, Mangialasche F, Snyder HM, Allegri R, Andrieu S, Arai
H et al. World-Wide FINGERS Network: a global approach to risk
reduction and prevention of dementia. Alzheimer’s & Dementia.
2020;17(7):1078–94. doi:10.1002/alz.12123.
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FIGURE 22

Dementia risk reduction should be included
in both pre-service training for health care
workers and as a mandatory aspect of
continuing medical education. Unfortunately,
GDO data cannot currently capture riskreduction-specific training of the workforce.
More detailed information will be needed
in the future. There additionally needs to be
increased investment in research on dementia
risk and protective factors to ensure that
interventions are based on the best available
evidence, particularly pertaining to social,
environmental and dietary risk factors.
Figure 22 presents ongoing opportunities
to accelerate action, beginning with the
implementation of WHO’s Global action plan for
the prevention and control of noncommunicable
diseases 2013–2020. Progress of the action
plan is tracked by the Global Coordinating

Mechanism on the Prevention and Control
of NCDs (48). WHO has developed several
guidelines, technical packages and tools relating
to the prevention and control of NCDs which,
if implemented globally, can advance dementia
risk reduction. WHO’s Package of Essential
Noncommunicable (PEN) Disease Interventions
for Primary Care, WHO’s training package on
building capacity for tobacco control and the
WHO HEARTS technical package are three such
examples (49,50). Additionally, WHO’s dementia
risk reduction guidelines provide up-to-date
guidelines on evidence-based interventions for
reducing dementia risk (52). As a complement
to these guidelines, WHO released a module
on dementia prevention in the mDementia
Handbook in order to provide countries with
easy mHealth-based implementation options
(see Box 18) (53).

Proposed actions, identified barriers, and opportunities to accelerate action
in the area of risk reduction
PROPOSED ACTIONS
Link dementia risk reduction
with other programmes, policies
and campaigns on NCDs
Develop, deliver and promote
evidence-based risk reduction
interventions in primary care
Workforce training and education
on dementia risk reduction

BARRIERS
Inequitable distribution of services
(e.g. urban vs. rural, income level)
Human resource limitations (lack of
workforce, lack of training)
Lack of services
Dementia risk reduction not routinely
included in clinical curricula

OPPORTUNITIES TO ACCELERATE ACTION

BOX 18

mDementia
mDementia is an mHealth intervention developed by WHO’s Mental Health
and Substance Use Department and Be He@althy Be Mobile (BHBM), a joint
initiative between WHO and the International Telecommunications Union.
mDementia provides guidance on implementing messaging programmes for
dementia risk reduction (mDementiaPrevention) and support for carers of
people with dementia (mDementiaSupport).
mDementiaPrevention content specifically aims to encourage persons of
middle age or above to manage modifiable risk factors in order to delay or
slow the onset or progression of dementia. According to WHO’s Guidelines
on risk reduction of cognitive decline and dementia, these risk factors include
low physical activity, tobacco use, unhealthy diets and harmful use of alcohol.
Certain medical conditions – including hypertension, diabetes, dyslipidaemia,
obesity and depression – are also associated with an increased risk of
dementia. For this reason, mDementia offers a comprehensive brain and
physical health promotion package.
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Develop national and local dementia risk reduction guidelines, relying on
established guidelines such as WHO’s Guidelines on risk reduction of cognitive
decline and dementia.
Include dementia risk reduction interventions in country-level UHC packages,
modelled after the WHO UHC compendium.
Implement and/or scale up programmes that increase health workforce
knowledge and training in risk reduction of NCDs through WHO’s PEN
package, HEARTS technical package and tobacco training package.
Increase awareness of dementia risk reduction through campaigns such as the
Western Pacific Region’s dementia campaign.
Implement digital health solutions to increase population-level access to dementia
risk reduction strategies through WHO’s mDementia (Prevention) programme.
Leverage synergies with the SDGs, the WHO Global Coordinating Mechanism
on NCDs, and the forthcoming Intersectoral global action plan on epilepsy and
other neurological disorders (World Health Assembly Resolution WHA 73.10).
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Concluding remarks
The risk of developing dementia can be
reduced or its progression delayed by
improving the capacity of health and social
care professionals to provide evidencebased, multisectoral gender- and culturallyappropriate interventions to the general
population, and by educating about and
proactively managing modifiable risk factors
for dementia that are shared with other
NCDs. Dementia risk reduction requires
addressing risk factors for other NCDs. The
Global dementia action plan recognizes the
inherent links between dementia and other
NCDs by outlining a global target linked to
the targets defined in the Global action plan
for prevention and control of NCDs 2013–
2020. While there has been incremental
improvement in overall mortality from
cardiovascular diseases, cancer, diabetes and
chronic respiratory diseases (4% reduction
globally), these changes fall short of global
NCD targets.
Additionally, WHO’s GDO provides important
data on country-driven progress on process
indicators related to reduction of dementia
risk. GDO data provide insights into countries
that include dementia risk reduction in their
dementia plans or other health plans, as
well as within clinical guidelines. Over half
of all GDO countries include dementia risk
reduction in a dementia plan, though most
of these countries are HICs. Similarly, over
a third of GDO countries report including a
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focus on dementia risk reduction in dementia
clinical guidelines, but most of these countries
too are HICs. GDO data also highlights
the existence and types of dementia risk
reduction campaigns globally, the majority of
which were organized in HICs at the national
level, were government-run and addressed
the general population.
Barriers impeding progress in the area of
dementia risk reduction include the lack
of public awareness of the importance of
risk reduction, lack of financial resources
available for dementia risk reduction
programmes, inequitable distribution
of services, human resource limitations
(including lack of health workforce and
lack of training in this area), and lack of
coordination between sectors nationally
and locally, all of which are exacerbated
by ongoing disruptions in essential NCD
services because of the COVID-19 pandemic.
Stigma is another barrier for dementia
risk reduction. Addressing these barriers
requires action in multiple disciplines and
sectors. First, dementia risk reduction should
be linked with other programmes, policies
and campaigns on NCDs. Second, evidencebased risk reduction interventions should
be developed, delivered and promoted
within primary care settings. Both actions
will require the widespread availability of
training and education on dementia risk
reduction for the health workforce.
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7. Dementia
diagnosis,
treatment and care
Context
In line with the principle of UHC, the Global dementia action
plan emphasizes that people with dementia should have access
to person-centred, rights-based health and social services
when and where they need it, without financial hardship.

“When you are diagnosed, you only think,
I'll never do anything again - like drive, cook
dinner, or go on holidays. It would be nice to
be informed of how we can continue to live
and do the things that we did before being
diagnosed, and what you really want is for
your clinician to give you that information.”
Helen Rochford-Brennan,
Ireland

Dementia is associated with complex care needs and high
levels of dependency and morbidity in its later stages. Thus,
dementia requires a range of services from both within
and outside the health sector – such as primary health
care, specialist medical care, community-based services,
rehabilitation, long-term care, and palliative care. Diagnosis
is the entry point to accessing any dementia care and support.
The critical importance of early diagnosis is reflected in target
4 of the Global dementia action plan (i.e., that in at least 50% of
countries, the diagnostic rate for dementia is at least 50%).
With respect to post-diagnostic support, evidence suggests
that multidisciplinary and multi-component care models
for dementia are effective when integrated within primary
care. A recent systematic review of 10 trials examined postdiagnostic dementia care models delivered by primary care in
four countries (Germany, Netherlands, Singapore, the United
States) and found that primary care provider (PCP)–case
management partnerships for people living with dementia
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141

and their carers improved several important
outcomes, including neuropsychiatric
symptoms experienced by people living
with dementia, as well as carer burden and
costs associated with the health system (54).
PCP-led care also yielded better outcomes,
including decreased hospital and memory
clinic costs and improved carer mental health.

WHO hosted a session on dementia care
pathways as part of the 2018 WHO mental
health gap action programme (mhGAP) Forum.
During the session, key stakeholders in the field
of dementia discussed essential components
of dementia care pathways and mapped across
them existing tools and identified gaps that
need future work (see Box 19). As a result,

a working model of integrated dementia
care pathways was developed (see Figure
23). WHO has developed, and continues
to develop, guidance and tools to assist
countries in developing components of
integrated care pathways.

BOX 19

WHO session on dementia care pathways – “Leaving no one behind”
In 2018, WHO hosted the annual mhGAP Forum which had the theme “Accelerating
country action on mental health”. As part of the forum, WHO organized a parallel
session dedicated to dementia care pathways. In line with the vision and goals of the
Global dementia action plan, this small group session discussed stakeholder needs
across the continuum of dementia care, service availability and implementation
mechanisms at country level and mapped these against existing WHO tools and
guidelines on dementia, healthy ageing, human rights and rehabilitation in order to identify
gaps and further needs for WHO guidance.

Statements were followed by an interactive group exercise, during which participants
mapped out the foundation and requirements for an integrated dementia care pathway
along the continuum of a person’s dementia (i.e. from before symptom onset to the end of
life). Participants were encouraged to work creatively on this continuum, add their own
ideas to reflect personal needs or professional experiences and engage in discussions with
each other. The outcome of this exchange of ideas was summarized in a large mind map
(see photo below):

The session was attended by over 30 representatives from Member States, non-State
actors, WHO colleagues at all three levels of the organization and professionals of multiple
disciplines – including experts in public health, psychiatry, geriatrics, neuropsychology,
occupational therapy, neuroimaging and health economics, as well as people with lived
experience of dementia. During this session, partners and stakeholders shared their
views on dementia care pathways, and their statements emphasized the need for
early diagnosis followed by holistic and integrated care and management that can be
adapted to different cultural settings and are based on human rights, equity, evidence
and sustainability. Participants highlighted the importance of empowering people with
dementia to maintain their intrinsic/functional capacity for as long as possible. It was
agreed that a positive approach focusing on abilities rather than disabilities would enable
people with dementia and reduce stigma.
Participants of the dementia care pathways session of 2018 WHO mhGAP Forum
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COVID-19 and dementia care

FIGURE 23

Model for integrated dementia care

Fundamentals

Universal Health Coverage
Pre-diagnosis

Diagnosis

Post-diagnostic
support

Awareness
Reduced stigma
Strengthened
primary care capacity
on risk reduction

Early recognition of
symptoms
Reduced stigma
Strengthened primary
care capacity for
diagnosis

Reduced stigma
Knowledge and information
about available services
Strengthened primary care
capacity to provide
post-diagnostic support

Risk reduction & health
promotion interventions
Prevention and
management of NCDs
Knowledgeable
workforce

Timely and accurate
diagnosis
Knowledgeable
workforce

Psychosocial support, treatment and care
Rehabilitation
Long-term care
Palliative care
Respite care
Knowledgeable workforce

Principles

Access to

For person with dementia and care partner

The ongoing COVID-19 pandemic has
disrupted health care systems globally and
these disruptions threaten to reduce access
to timely dementia diagnosis and entry to care
pathways. WHO’s Pulse survey on the continuity
of essential health services during the COVID-19
pandemic, released in August 2020, revealed
that 48% of 105 countries surveyed reported at
least partial disruptions in all services for NCDs
and mental health (7). Importantly, three out
of four countries reported disruptions in 2020
in services for older adults with mental health
conditions or disabilities, including dementia.

FIGURE 24

Pulse survey Rounds 1 and 2 comparison of disruptions in services for mental,
neurological and substance use disorders

Person-centred, integrated* and evidence-based quality services within the community
(*integrated care includes coordination across providers and sectors including provider continuity)

WHO’s second round of the national Pulse survey
on continuity of essential health services during
the COVID-19 pandemic found that, while there
have been some improvements during the
second year of the pandemic, disruptions to
essential mental, neurological and substance
use services persist (45) (see Figure 24).
When specifically considering services for
older adults with mental health conditions
or disabilities, the percentage of countries
reporting ongoing disruptions in 2021
approached 50% (of 58 countries).

Management of MNS
emergency
manifestations

Round 1 (n=124)

30%

Round 2 (n=94)

35%

6%

35%
39%

4%
Counselling for MNS
disorders

Each step on the dementia care pathway
should be rooted in a human rights-based
approach in line with key principles of
the CRPD, including dignity, choice and
autonomy. The needs and preferences of
people living with dementia must be met and

their autonomy from diagnosis to the end of
life must be respected through integrated,
culturally appropriate, person-centred,
community-based health, psychosocial,
long-term care and support and, where
appropriate, the inputs of families and carers.

Prescriptions for MNS
disorder medicines

Round 1 (n=126)

54%

Round 2 (n=95)

46%

Round 1 (n=125)

25%

Round 2 (n=91)

30%

67%

13%
7%

54%

6% 30%

32%
2%

Services for older adults
with mental health
conditions / disabilities

Round 1 (n=120)

56%

Round 2 (n=85)

39%
10%

70%

14%
9%
20%

30%

40%

48%
50%

60%

70%

80%

Percentage of countries
5-50% disrupted
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This chapter provides an overview of global
progress made to date in improving dementia
care pathways by assessing country-driven
progress based on GDO data. The chapter
discusses the diagnostic gap and ways
to improve diagnostic rates, reviews the
availability of community-based services,
discusses health and social workforce training
and education, and care coordination. The

chapter additionally outlines spotlight
activities, country case studies and key
accelerators for action in this area, showing
links to WHO’s normative work in this area,
including mhGAP, ICOPE, the forthcoming
Package of Interventions for Rehabilitation
(PIR) for dementia and WHO’s guidance
package on good practice community-based
services for mental health and dementia.

Progress to date

to enable countries to be able to track, monitor
and report information. More specifically,
accurate recording of diagnostic rates will
require standardized diagnostic criteria
and processes for recording new diagnoses,
ideally by establishing centralized registries
and/or electronic health records. Additional
information can be surveyed via prescription
records, insurance or other health utilization
data, but reliance on these sources runs the
risk of incompleteness or redundancy.
Furthermore, while the GDO asks countries
to report on diagnostic rates, these data

do not provide insight into the timeliness
of diagnoses or waiting times. Greater
granularity of data – including the severity of
dementia at time of diagnosis and, specifically,
the incidence and prevalence rates of mild
dementia versus moderate/severe dementia
over time – may provide some insight into
waiting times. It may be expected that an
increase in mild dementia diagnoses is
indicative of people being diagnosed earlier,
whereas an increase in moderate-to-severe
dementia may signal the opposite.

TA B L E 1 8

Dementia diagnostic rates by WHO region and World Bank income level
In line with the Global dementia action plan,
the GDO monitors global, regional and
country-level progress concerning diagnostic
rates for dementia; the availability and
accessibility of community-based dementia

services; the existence of care pathways for
dementia; and health and social workforce
training and education for dementia. Progress
in each of these areas is outlined below.

Dementia diagnostic rate
Median

Range

48%

0.08% - 95%

African Region (n = 1)

--

0.4%

Region of the Americas (n = 2)

--

23% - 73%

South-East Asia Region (n = 2)

--

0.08% - 8%

European Region (n = 16)

60%

3% - 95%

Eastern Mediterranean Region (n = 4)

19%

17% - 56%

Western Pacific Region (n = 4)

27%

0.3% - 96%

Low- and middle-income (n = 10)

21%

0.08–96%

High-income (n = 19)

58%

3–95%

Region
Global (n = 29)

WHO region

Dementia diagnostic rate
Receiving an accurate diagnosis of dementia
is a prerequisite for accessing any kind of
services. Globally, we are far from achieving
the target of 50% of countries reporting
at least 50% of dementia being diagnosed.
According to GDO data, fewer than half the
countries (29/62 or 47%) were able to report
on dementia diagnostic rates, by providing
either a nationally calculated rate or the total
number of people diagnosed with dementia,
from which the diagnostic rate could be
calculated. As such, not even for GDO
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countries that are likely biased towards being
more “dementia-ready”, we are meeting the
first condition of the global target.
Moreover, there is considerable variability
in reported diagnostic rates on the basis of
country income, with the median diagnostic
rate for HICs being 58% compared with 21%
for LMICs (see Table 18). The large variation
observed in the range for diagnostic rates
demonstrates the need for quality data on
dementia diagnosis and prevalence estimates.
Increased capacity-building efforts are needed
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Availability of community-based services
Within the context of UHC, broad access
to quality evidence-based person-centred
services for everyone is essential. GDO
data provide insight into the existence of
various types of community-based dementia
services within a country and additionally
the availability of these services in urban as
compared to rural areas within countries.
The majority of GDO countries (89%) report
provision of community-based services for
dementia, but there are significant variations
based on income level – e.g. 97% of HICs
report community-based services, compared
with 78% of LMICs. Of the countries

reporting community-based services, over
90% report providing community-level
diagnostic services, psychosocial services and
rehabilitation, assessment and management
of behavioural and psychological symptoms
of dementia (BPSD), and social and financial
protection (see Figure 25 and Table 19).
HICs reporting on community-based services
report greater availability of all services listed
in Table 19 compared with LMICs. Notably,
all HICs with community-based services
report having social and financial protection,
compared with 75% of LMICs.

Geographical coverage of community-based dementia
services in urban versus rural areas can serve as a proxy
indicator of equitable access. There is a significant gap
between the availability of community-based services in
HICs and LMICs (see Table 20). For all types of communitybased dementia services, there is 37–51% higher coverage
in rural areas in HICs as opposed to LMICs. LMICs report
considerably higher coverage in the capital and main cities
than in rural areas. For diagnostic services, HICs report 41%
more coverage in rural areas than LMICs do. This is a critical
bottleneck since timely and accurate diagnosis is the entry
point to accessing post-diagnostic services. Addressing these
inequities will be essential for increasing the availability of
dementia services globally.

Up to
51%

higher coverage of
community-based
dementia services in rural
areas for HICs compared
to LMICs

FIGURE 25

Number of countries providing community-based dementia services, by
World Bank income classification

53

51
20

18
32

51

Diagnostic
services

32

Global

20
Assessment and
management
of BPSD

LMICs

30

47
16

Psychosocial
services and
rehabilitation

31

50

43
16

14
ADL support

29

Palliative care
33

Social and
financial
protection

HICs

Note: LMICs = Low- and middle-income countries; HICs = High-income countries. ADL = Activities of Daily Living.
BPSD = Behavioural and psychosocial symptoms of dementia.
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TA B L E 1 9

Availability of community-based services by type of service
Types of community-based services

Global (n = 62)

Countries with any
community-based
services

Diagnostic services

Assessment and
management of BPSD

Psychosocial services and
rehabilitation

ADL support

Palliative care

Social and financial
protection

% of GDO countries

% of GDO countries
with any communitybased services

% of GDO countries
with any communitybased services

% of GDO countries
with any communitybased services

% of GDO countries
with any communitybased services

% of GDO countries
with any communitybased services

% of GDO countries
with any communitybased services

55 (89%)

51 (93%)

53 (96%)

51 (93%)

47 (85%)

43 (78%)

50 (91%)

Number of countries reporting community-based services by region
African Region (n = 4)

4

3

3

4

3

3

3

Region of the Americas (n = 11)

8

8

8

7

6

6

8

South-East Asia Region (n = 5)

3

2

3

3

3

3

3

European Region (n = 24)

23

22

22

21

23

21

23

Eastern Mediterranean Region (n = 8)

7

6

7

6

4

3

4

Western Pacific Region (n = 10)

10

10

10

10

8

7

9

Number and % of countries reporting community-based services by income classification
Low- and middle-income (n = 27)

21 (78%)

18 (86%)

20 (95%)

20 (95%)

16 (76%)

14 (67%)

16 (76%)

High-income (n = 34)

33 (97%)

32 (97%)

32 (97%)

30 (91%)

31 (94%)

29 (88%)

33 (100%)

Note that numbers reported by region and/or World Bank income classification do not
necessarily add up to 100%, as some information was missing. ADL = Activities of daily living.
BPSD = Behavioural and psychosocial symptoms of dementia.
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TA B L E 2 0

Urban versus rural availability of community-based dementia services
Availability of community-based dementia
services

HICs

% of GDO HICs
(n=34)

LMICs

% of GDO
LMICs (n=27)

Urban only

7

21%

10

37%

Urban and rural

23

67%

7

26%

Urban only

10

29%

13

48%

Urban and rural

20

59%

6

22%

Urban only

7

21%

16

59%

Urban and rural

21

62%

3

11%

Urban only

5

15%

10

37%

Urban and rural

24

71%

7

26%

Urban only

7

21%

9

33%

Urban and rural

19

56%

4

15%

Urban only

1

3%

1

4%

Urban and rural

29

85%

13

48%

Diagnostic services

Assessment and management of BPSD

Psychosocial services and rehabilitation

Support for ADL

Palliative and end-of-life care services

Social and financial protection

Note: LMICs = Low- and middle-income countries; HICs = High-income countries; GDO = Global Dementia Observatory;
BPSD = Behavioural and psychosocial symptoms of dementia; ADL = Activities of daily living. Note that numbers reported
by region and/or World Bank income classification do not necessarily add up to 100%, as some information was missing.
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Equitable access to essential community-based dementia
services encompasses not only availability, but also
affordability. GDO data can provide insights into geographical
coverage, as discussed above, and affordability when
considering social and financial protection schemes and
majority providers as proxy indicators. Importantly, the
availability of community-based social and financial protection
schemes in rural areas is available in nearly 40% more HICs
than LMCIs in HICs (see Table 20). Social and financial
protection schemes are paramount to accessing services.
Additionally, services in the public sector are generally less
costly than those in the private sector which may require outof-pocket payments. Understanding the majority provider in
a country offers insight into the costs of dementia care to the
end-user. See Box 20 for an illustrative example of an Indian
family's dementia journey, including the struggles of receiving
a diagnosis and accessing services.

"40% higher
availability of
social and financial
protection schemes
in rural areas of HICs
than in LMICs."

BOX 20

Case vignette from STRiDE, India
The STRiDE (Strengthening responses to dementia in countries) Project, supported
by the United Kingdom’s Research and Innovation Global Challenges Research Fund,
has developed case vignettes to represent the many challenges in accessing care for
dementia. The case vignette below is from India.
About five years ago Mrs C started to become forgetful. Now, at 75 years of
age, Mrs C hardly ever leaves her room in her daughter’s house – located in a
metropolitan city – to which she was moved when it became clear that she could
no longer look after herself. The daughter and her granddaughter help her with
dressing, eating, washing and going to the bathroom. The domestic help also
provides additional support with caregiving. The family has to make sure that food
is not too chunky as Mrs C has difficulty swallowing. It is difficult for the daughter’s
family to go away together for the day as someone always needs to be around to
look after her. Mrs C’s other children visit during holidays but they find it difficult
as she cannot always remember who they are. Mrs C has also started displaying
some very strange behaviour.
Mrs C’s granddaughter suggested that her mother (Mrs C’s daughter) take Mrs
C to a psychiatrist. Mrs C’s daughter was initially reluctant to do so, as she was
worried what the neighbours would think if they found out that she was taking her
mother to see a psychiatrist. On the insistence of her daughter, she decides to visit
a psychiatrist at a public hospital. The next day, Mrs C and her daughter visit the
outpatient department of a public hospital 30–40 minutes’ journey from their house.
They find that the psychiatric outpatient department appointments are finished for
the day, so they have to come back another day.
They come back a few days later, but the waiting time is very long and they end up
waiting for almost six hours before they can see the doctor. During this time Mrs C
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gets increasingly agitated and the daughter almost considers going back home. Finally
they manage to see a psychiatrist. The psychiatrist informs Mrs C’s daughter that they
need to do some tests, including an MRI and a neuropsychological assessment, but
the waiting time to get these tests done are 1 month and 3 months respectively. The
consult and the tests are are only partly subsidized and paid for out-of-pocket.
The family provides care as usual as they wait for the test to be conducted. When
they eventually get the tests done and receive the reports, Mrs C’s daughter takes
her mother to see the psychiatrist again for a follow-up.
During the follow-up, the psychiatrist informs the daughter that her mother
has Alzheimer’s disease. He does not go into much detail but prescribes some
medications and refers them to a social worker at the hospital, who can provide
them with further guidance. The social worker explains the diagnosis and advises
the daughter to take Mrs C to a day care centre located 15 kilometres away (about 1
hour by auto-rickhsaw (three-wheeler public transport) from their house.
The daughter has a discussion with her husband, and they agree to take Mrs C to the
day care center as the psychiatrist suggested, as it is run by an NGO and the services
are affordable. However, the daughter is unable to take Mrs C to the center daily due
to her own responsibilities at home. She manages to take Mrs C to the centre only
once or twice a week.
The daughter begins to attend a few carer support meetings at the centre whenever
possible. As Mrs C’s symptoms progress, the burden of caregiving falls heavily
on the daughter, who spends a minimum of 8–10 hours each day providing care.
The granddaughter also helps when possible and spends around 2 hours per day
providing care to Mrs C. The need to provide constant care in addition to her own
family responsibilities has placed a major strain on the daughter’s marriage and her
health, as she also suffers from health problems.
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Availability of health and social care facilities
In addition to the availability of communitybased dementia services, GDO countries
report on the availability of different types
of health and social care facilities. There
is significant variance in the availability
of certain types of health and social care
facilities across country income brackets (see
Table 21). While all or most countries report
the availability of tertiary care facilities (i.e.,
hospitals) and outpatient health centres,
all other facilities are considerably more
available in HICs as opposed to LMICs, with
22% more HICs reporting the availability

of residential and long-term care facilities,
almost 30% more HICs reporting the
availability of hospice centres and adult day
centres, and nearly 50% more HICs reporting
the availability of outpatient community/
social care centres. These inequities must be
addressed in order to ensure access to care
along the full care spectrum from diagnosis
and treatment through rehabilitation and
palliative care when needed. This necessitates
increased financial investment in health
facilities that provide essential services for all
people living with dementia.

TA B L E 2 1

Availability of health and social care facilities, by World Bank income
classification
Availability of health and
social care facilities

HICs

% of GDO HICs
(n= 34)

LMICs

% of GDO LMICs
(n= 27)

Hospitals

34

100%

27

100%

Residential and long-term care
facilities

31

91%

19

70%

Hospice centres

25

74%

12

44%

Adult day centres

32

94%

18

67%

Outpatient health centres

33

97%

24

89%

Outpatient community/social
care centres

31

91%

11

41%

Note: LMICs = Low- and middle-income countries; HICs = High-income countries; GDO = Global Dementia Observatory.
Note that numbers reported by region and/or World Bank income classification do not necessarily add up to 100%, as some
information was missing.

The number of facilities and associated beds or
places, standardized per population, can provide
insights as to availability of dementia services
in a country and, when combined with numbers
of admissions related to dementia, can help us
understand utilization rates. If analysed further
in light of estimated numbers of people with
dementia in the country, service coverage can be
estimated. GDO countries are asked to provide
quantitative information regarding specific
availability of health and social care facilities (i.e.,

hospitals, residential long-term care facilities,
hospice centres, adult day-care centres and
outpatient centres) including number of beds/
places (non-specific, dementia-specific and
geriatric-specific). However, the majority of
countries participating in the GDO are not able
to report such numbers. Possessing such data
is vital in order to identify gaps in the health
and social care services provided to people
with dementia, as well as evaluate the progress
overtime in the efforts to fill these gaps.

Availability of dementia-related medication
and care products
In addition to the availability of communitybased services, as well as health and social
care facilities and their utilization rates,
access to dementia care also necessitates
affordable access to medicines and other care
products. GDO countries provide data on

the availability and affordability of dementiarelated medicines, adult hygiene products,
equipment or assistive technology and housing
adjustments. Table 22 provides GDO data on
the availability of anti-dementia medicines.

TA B L E 2 2

Availability of anti-dementia medicines
Any anti-dementia
medicine n (%) approved

Generic version
available

Reimbursement of anti-dementia
medicine for on-label use

number of countries
(%)

number of countries
(%)

Full

Partial

No

Global (n = 62)

54 (87%)

45 (71%)

33 (53%)

9 (15%)

11 (18%)

LMICs (n = 27)

21 (78%)

16 (59%)

7 (26%)

5 (19%)

8 (30%)

HICs (n = 34)

33 (97%)

29 (85%)

26 (76%)

4 (12%)

3 (9%)

LMICs = Low- and middle-income countries; HICs = High-income countries. Note that numbers reported by World Bank
income classification do not necessarily add up to 100%, as some information was missing.
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While anti-dementia medicines developed to
date have limited efficacy and are primarily
labelled for Alzheimer’s disease, these
medicines are inequitably available around
the world. More studies are needed in
order to establish robust evidence on
the cost-effectiveness of anti-dementia
medicines, though it is clear that increasing
access to early diagnosis and thereby to
treatment, will improve the likelihood of such
treatments being cost-effective(55). That
is, the cost effectiveness of anti-dementia
medicines is highly dependent on the delay to
access treatment and the overall population
coverage(55-57). Social inequalities,
combined with high costs of medication and
lack of financial support and reimbursement
programmes, not only limit the accurate
representation of cost-effectiveness studies,
but also impose barriers into improving the
quality of life of people living with dementia.
In each country the access to medicines
begins with national regulatory approval.
Upon approval, access to a medicine is
expedited by the availability of generic
versions and the presence of reimbursement
schemes to reduce out-of-pocket expenses.
Unfortunately, according to GDO data, antidementia medicines for on-label use remain
far more available and affordable in HICs
than in LMICs. Anti-dementia medicines for
on-label use (again, primarily for Alzheimer’s
disease) are almost universally approved
in HICs (97%) compared with LMICs (78%
approved) (see Table 22). Generic versions of
anti-dementia medicines are available in the
majority of HICs (85%) compared with less
than 60% of LMICs. Furthermore, at least one
anti-dementia medicine is fully reimbursable
in more than 3 out of 4 HICs, compared
with just over 1 in 3 LMICs. Closing the
global equity gap in access to anti-dementia
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medicines necessitates increased regulatory
approvals in-country, widespread availability
of generic versions, and increased provision of
reimbursement schemes to lower the financial
burden on people living with dementia and
their families.
Medications intended to control or treat
common conditions that may be comorbid
with dementia – including diabetes,
hypertension or elevated cholesterol – are
also essential (7, 58). These medications were
already out of reach for many people in lowresource settings prior to the COVID-19
pandemic, and with ongoing disruptions to
supply chains and essential services, have
been even more inaccessible. In the Region
of the Americas, PAHO disseminated a flyer
with key considerations for improving access
to medications for NCDs in 2020 – including
implementing policies that facilitate access
to a 90-day supply of medication, facilitating
physical access to medication supplies
(including home deliveries), and establishing
strong monitoring with planning for potential
stock-outs (59).
It should be noted that psychiatric
medications are sometimes used to alleviate
BPSD, and in doing so the benefits of these
medications should be weighed against any
risks to the individual. Persons living with
dementia, and their carers if appropriate,
should be fully informed of the risks and
benefits, and treatment choices should be
made in accordance with the person’s wishes
and preferences. The off-label use of atypical
antipsychotic medications can be particularly
problematic as multiple studies have linked
these medicines to increased risk of death
in people with dementia. As a result, the
United States Food and Drug Administration
(FDA) issued a black box warning in 2005
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regarding atypical antipsychotic medications
and dementia (60). Similarly, guidance from
the United Kingdom’s National Institute
for Health and Care Excellence (NICE) also
calls for caution and the assessment of the
risks versus limited benefits when using
these medications in people with dementia
(61). Chapter 9 discusses country-reported
monitoring of antipsychotic prescriptions for
people with dementia.
Additionally, when examining GDO data on
adult hygiene products, assistive technologies

and housing adjustments, a similar pattern
emerges between HICs and LMICs. First,
these products and services are more
available in HICs compared with LMICs.
Moreover, these products are more likely to
be reimbursable in HICs than in LMICs (27–
51% more countries reporting affirmatively),
making these products much more likely to
incur out-of-pocket expenses for people living
with dementia and their families residing in
LMICs (see Table 23).

Health and social workforce training
and education
In order to provide timely and adequate
person-centred care rooted in a human-rights
based approach, the training and education
of health and social care workers in basic
dementia competencies (including diagnosis,
care and ethics, among other components)
is essential. Globally, the number of healthcare providers for dementia in countries
remains limited with large variability between
HICs and LMICs. Additionally, GDO data
demonstrate that the extent to which they
are trained in dementia is also limited. With
the exception of few LMICs, mainly HICs
provide routine dementia training to all
professionals (e.g. doctors, specialists and
nurses) but not necessarily to all relevant
cadres (e.g. pharmaceutical personnel). The
majority of countries only train some health
professionals (see Figure 22). That leaves
a significant proportion of the workforce
potentially ill-prepared to provide quality
dementia care. It is crucial that basic

dementia competencies are included in the
pre-service training of all cadres of the health
and social workforce in order to ensure that
those who are meant to serve people living
with dementia and their carers are equipped
with the knowledge they need.
It is also important to note that, in many
countries, formally trained and paid carers
working in nursing or long-term care
facilities are stigmatized and their work is
not adequately recognized by society. This
inadequate consideration may present
barriers to policy development. While these
carers perform physically and emotionally
demanding work, they are typically low-paid,
are not offered ongoing quality training,
supervision or psychological support, and
their career development is not promoted.
As a result, high turnover is common, which
has a significant impact on the availability and
quality of care.
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TA B L E 2 3

Availability of adult hygiene products, assistive technology and
housing adjustments (% GDO countries), by WHO region and World
Bank income classification
Adult hygiene products

Assistive technology

Housing adjustments

Unavailable

Reimbursable

Out-of-pocket

Unavailable

Reimbursable

Out-of-pocket

Unavailable

Reimbursable

Out-of-pocket

Global (n = 62)

4 (6%)

34 (55%)

22 (35%)

4 (6%)

36 (58%)

12 (31%)

13 (21%)

24 (39%)

22 (35%)

LMICs (n = 27)

3 (11%)

9 (33%)

15 (56%)

3 (11%)

12 (44%)

12 (44%)

11 (41%)

3 (11%)

12 (44%)

HICs (n = 34)

1 (3%)

25 (74%)

6 (18%)

1 (3%)

24 (71%)

7 (21%)

2 (6%)

21 (62%)

9 (26%)

LMICs = Low- and middle-income countries; HICs = High-income countries. Note that numbers reported by region or
World Bank income classification do not necessarily add up to 100%, as some information was missing.

FIGURE 26

Number of countries providing routine dementia training to (all, some, or
none) health professionals of relevant cadres
46
40

45
39

38

38

19

17

14

13
3
Physicians/medical doctors
All

3

2

Specialists*
Some

Nurses

5
Pharmaceutical personnel

5

13
9

Social workers

4
Personal support workers

None

* Geriatricians, psychogeriatricians, old-age psychiatrists as well as psychiatrists and neurologists who can diagnose
dementia and provide treatment for individuals with dementia.
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BOX 21

Strengthening dementia capacity in Slovenia
In 2016, Slovenia adopted the Dementia Management Strategy until 2020.
The strategy summarizes the essential elements and commitments contained
in the documents adopted by the EU, UN and WHO. The purpose of the
strategy is to ensure preventive measures, early detection of the disease and
an appropriate standard of health and social protection and health care for
people with dementia.
In order to successfully implement the national strategy, suitably qualified
staff and an informed professional and lay public are of key importance. The
Ministry of Health, in accordance with the guidelines of the national strategy
in 2017, conducted a Call for tender to co-finance education and awareness
programs with the following key objectives:

strengthening the capacities and competencies of
professionals in the care chain for people with dementia in
different settings;
raising awareness of individual occupational and other target
groups in the local environment to create a dementia-friendly
environment;

Dementia-specific clinical guidelines,
standards and protocols
Nationally recognized guidelines, standards and protocols are
critically important prerequisites for implementing dementia
care pathways. Topics covered should include prevention
and risk reduction, diagnosis, management, carer support,
advance care directives, palliative and end-of-life care, care
in nursing and residential facilities, and care in hospitals. In
the absence of such nationally recognized guidelines and
standards, components of the dementia care pathway may
be missing, under-recognized or under-resourced. Only 36
GDO countries report having dementia-specific guidelines,
standards and protocols, and most of these countries are
HIC (82% of HIC report affirmatively versus 33% of LMIC).
Globally, dementia diagnosis and management are prioritized
within guidelines, standards and protocols over other areas
(see Table 24). It is essential to close these gaps in order to
better ensure person-centred, human rights-oriented service
coverage, particularly in caring for advanced dementia through
to end-of-life care.

58%

of GDO countries report
having dementia-specific
clinical guidelines,
standards and protocols

reducing differences between individual Slovenian regions.

In order to apply for programs an intention had been established to form a
consortium of at least three partners from the psychiatric, neurological and
social care professions.
Over 350 lectures were conducted, attended by more than 10 000
participants in all regions.
UKC Ljubljana, the Neurological Clinic, the University Psychiatric Clinic
Ljubljana, the Social Chamber of Slovenia and Spomincica-Alzheimer Slovenije
have the most credit for exceeding the objectives of the tender.
ˆ
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TA B L E 2 4

Standards, guidelines and protocols for dementia and topics covered
Topics covered within standards, guidelines and protocols

Are there standards, guidelines or
protocols for dementia?

Diagnosis

Management

(Yes, % of GDO
countries)

(Yes, % of GDO
countries with
standards, guidelines
or protocols)

(Yes, % of GDO
countries with
standards, guidelines
or protocols)

(Yes, % of GDO
countries with
standards, guidelines
or protocols)

Global (n = 62)

36 (62%)

21 (58%)

35 (56%)

33 (92%)

22 (62%)

19 (53%)

20 (56%)

22 (62%)

23 (64%)

LMICs (n = 27)

9 (33%)

6 (67%)

9 (100%)

9 (100%)

4 (44%)

2 (22%)

3 (33%)

3 (33%)

4 (44%)

HICs (n = 34)

28 (82%)

16 (57%)

27 (96%)

25 (89%)

19 (68%)

17 (61%)

17 (61%)

19 (68%)

19 (68%)

Support for carers

Advance care
directives

Palliative and
end-of-life care

Care in nursing/
residential care
facilities

Prevention/risk
reduction

Care in hospitals

(Yes, % of GDO
(Yes, % of GDO
(Yes, % of GDO
(Yes, % of GDO
(Yes, % of GDO
countries with
countries with
countries with
countries with
countries with
standards, guidelines standards, guidelines standards, guidelines standards, guidelines standards, guidelines
or protocols)
or protocols)
or protocols)
or protocols)
or protocols)

LMICs = Low- and middle-income countries; HICs = High-income countries. Note that numbers reported by
World Bank income classification do not necessarily add up to 100%, as some information was missing.

Care coordination at national
and subnational levels
Coordination across sectors is paramount
in order to achieve integrated and
multidisciplinary care for people living
with dementia. Just over half of GDO
countries (32 countries, 52%) report
having a mechanism to coordinate care
for people with dementia across sectors
in government, while fewer than one
third of GDO countries report having a
formal agreement for such a mechanism
(19 countries, 31%). HICs are more likely
to have a coordination mechanism and a
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formal agreement than LMICs. Globally,
national implementation of dementia care
coordination is far more commonly reported
than subnational implementation. The
sectors that are most commonly included
in care coordination are the health and
social sectors (100% and 97%, respectively),
followed by the private, justice, civil society
and housing sectors. Less than one third
of countries that have a coordination
mechanism include the education or
employment sectors (see Table 25).
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In the delivery of dementia services, components of care
coordination reported by countries also vary (see Table 26).
Components of care coordination reported through the GDO
include the use of multidisciplinary or interdisciplinary teams,
task-shifting, responsive referral pathways, continuity of
care (including both continuity of information and provider
continuity), and a community-based approach.

Dementia diagnosis, treatment and care

WHO

165

TA B L E 2 5

Care coordination mechanisms, level of implementation and sectors involved
Is there a
mechanism to
coordinate care
across sectors?

National

Subnational

Health

Social

Education

Employment

Justice

Housing

Civil society

Private sector

(Yes, % of GDO
countries)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

(Yes, % of GDO
countries
reporting
coordination
mechanisms)

Global (n = 62)

32 (52%)

23 (72%)

9 (28%)

32 (100%)

31 (97%)

10 (31%)

9 (28%)

16 (50%)

13 (41%)

14 (44%)

17 (53%)

LMICs (n = 27)

10 (37%)

8 (80%)

2 (20%)

10 (100%)

10 (100%)

3 (30%)

1 (10%)

3 (30%)

2 (20%)

4 (40%)

6 (60%)

HICs (n = 34)

22 (65%)

15 (68%)

7 (32%)

22 (100%)

21 (95%)

7 (32%)

8 (36%)

13 (59%)

11 (50%)

10 (45%)

11 (50%)

Level of implementation

Sectors involved in care coordination

LMICs = Low- and middle-income countries; HICs = High-income countries. Note that numbers reported by World

Bank income classification do not necessarily add up to 100%, as some information was missing.

TA B L E 2 6

Components of care coordination

Components of care coordination reported

Task-shifting

Responsive referral
pathways

Continuity of information

Provider continuity

Community-based
approach

(Yes, % of GDO countries reporting
coordination mechanisms)

(Yes, % of GDO countries reporting
coordination mechanisms)

(Yes, % of GDO countries
reporting coordination
mechanisms)

(Yes, % of GDO countries
reporting coordination
mechanisms)

(Yes, % of GDO countries
reporting coordination
mechanisms)

(Yes, % of GDO countries
reporting coordination
mechanisms)

Global (n = 62)

33 (53%)

24 (39%)

23 (38%)

23 (38%)

22 (36%)

27 (44%)

LMICs (n = 27)

9 (33%)

9 (33%)

7 (26%)

5 (19%)

7 (26%)

8 (30%)

HICs (n = 34)

24 (71%)

15 (44%)

16 (47%)

18 (53%)

15 (44%)

19 (56%)

Multidisciplinary or interdisciplinary teams

Note that numbers reported by region or World Bank income classification do not necessarily add up to 100%, as
some information was missing.
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Dementia-specific nongovernmental
organizations

TA B L E 2 7

Availability of dementia-specific NGOs and areas of focus

Areas of focus of dementia-specific NGOs

In many countries, NGOs provide essential dementia
services to the public and to people living with dementia and
their carers. Table 27 shows GDO data on the availability
of dementia-specific NGOs and areas of focus for these
organizations. There is some variability between income
brackets as to availability: 94% HICs report the presence of
dementia-specific NGOs in their country, compared with 77%
of LMICs. However, there are similar areas of focus of NGOs
within HICs and LMICs, with almost all reporting involvement
in awareness-raising, 51% involved in home health and social
care services, and over 80% involved in carer training. While
NGOs can and do provide various services along dementia
care pathways, increased resources are needed to ensure
uniform availability of public-sector services across regions
(and urban versus rural areas) as well as assurance of adequate
oversight, quality, standards, monitoring and reporting.

"In many countries, NGOs
provide essential dementia
services to the public and to
people living with dementia and
their carers."

Are dementiaspecific NGOs
available?

Awareness-raising

Home health and
social care services

Carer training

(Yes, % of GDO
countries)

(Yes, % of countries
with NGOs)

(Yes, % of countries
with NGOs)

(Yes, % of countries
with NGOs)

53 (85%)

53 (100%)

27 (51%)

46 (87%)

African Region (n = 4)

3 (75%)

3 (100%)

1 (33%)

2 (67%)

Region of the Americas
(n = 11)

9 (82%)

9 (100%)

3 (33%)

8 (89%)

South-East Asia Region
(n = 5)

4 (80%)

4 (100%)

3 (75%)

4 (100%)

European Region
(n = 24)

23 (96%)

23 (100%)

12 (52%)

20 (87%

Eastern Mediterranean
Region (n = 8)

6 (75%)

6 (100%)

3 (50%)

5 (83%)

Western Pacific Region
(n = 10)

8 (80%)

8 (100%)

5 (63%)

7 (88%)

LMICs (n = 27)

21 (78%)

21 (100%)

11 (52%)

18 (86%)

HICs (n = 34)

32 (94%)

32 (94%)

16 (47%)

28 (82%)

Global (n = 62)

WHO region

Income level

Note: LMICs = Low- and middle-income countries; HICs = High-income countries. Note that numbers reported by region
or World Bank income classification do not necessarily add up to 100%, as some information was missing.

168

CHAPTER 7

Global status report on the public health response to dementia

Dementia diagnosis, treatment and care

WHO

169

Involvement of carers in the care planning
The Global dementia action plan recommends
that countries involve carers in care planning,
with attention being given to the wishes and
preferences of people living with dementia.
However, despite global efforts in the last
few years, informal carers continue to be
excluded from treatment decisions and
care planning affecting people living with
dementia. At present, the GDO is not able to
measure to what extent informal carers are
involved in the care planning at country level.
In addition, research on carer participation
in care planning is also scarce (17). There is
currently no common understanding as to
what participation entails, and no common
agreement on how to assess whether and
how carers can participate in care and policy
decision-making, as well as what the outcomes
of this participation should be (62).
Carer involvement is key at any stage of
the care pathway and can help extend the
participation of persons living with dementia
when otherwise they are no longer able
to participate. However, there are many
barriers to carers’ participation in care
planning, including health and social care
staff perceptions of legal and ethical care

responsibilities, stigma, a perception that
health-care professionals are the only care
experts, and the high health and social care
staff workload (63).
Carer participation in care planning has
important ethical and practical implications,
particularly with respect to end-of-life
care. For this reason, some countries have
started recognizing carers’ rights within
health and social care systems, as well
as their role as care partners through
legislation and guidance. For instance,
the Swedish law Sveriges Kommuner och
Landsting Patientmedverkan (64) (2014–
2015, updated 2018) ensures that people
living with dementia and their carers can
participate in care-related decisions. In
England, the National Health Service has
issued guidance to support the involvement
of carers in care planning (65). Many
countries, especially HICs, also have legal
provisions that enable advance care planning
through legal guardianship and advance
care directives. However, little information
is available regarding how legal frameworks
and guidelines for carer involvement are
implemented in different contexts.

The way forward
Numerous barriers, including financial limitations, serve as
bottlenecks that impede progress in the area of dementia
care pathways, as evidenced by variations in the availability
of community-based services and training by country income
level and urban versus rural inequities. Such barriers relate to:
the affordability of services for the end-user; a lack of national
standards, guidelines and protocols on dementia; human resource
limitations with a limited workforce and limited dementia-specific
training; a lack of coordination between sectors at the national and
subnational levels; a lack of public awareness about dementia; and
pervasive stigma. During the COVID-19 pandemic, the disruption
of access to essential services for all NCDs, as well as disruption
to services for older persons with mental health conditions and/or
disabilities, have further exacerbated these barriers.
Accelerating action in the area of dementia diagnosis, treatment
and care will require: increased investment across regions and
countries; development of dementia-specific national standards,
guidelines and protocols (which will ultimately support
dementia-specific training for all health workers); and the
provision of evidence-based interventions. Dementia-specific
training should be included as a mandatory element in preservice training and continuing medical education. Additionally,
community-based health and social services should be
prioritized over hospital-based services; legislation supporting
community-based care and earmarked funding can facilitate
these efforts. Ongoing coordination mechanisms and regular
meetings within sectors both nationally and locally can ensure
there are efficient coordinated care pathways. The inclusion of
dementia services in national UHC packages for financial risk
protection will also help to increase the scaling-up of necessary
services and will reduce out-of-pocket costs to people with
dementia and their carers. Importantly, stigma reduction
campaigns can normalize help-seeking, increase utilization of
services, and improve the well-being of people with dementia
and their carers.

"Community-based
health and social
services should
be prioritized over
hospital-based
services; legislation
supporting
communitybased care and
earmarked funding
can facilitate these
efforts."

See Figure 27 for a summary of proposed actions, barriers,
and opportunities to accelerate action in the area of dementia
diagnosis, treatment and care.
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FIGURE 27

Proposed actions, barriers, and opportunities to accelerate action in the area
of dementia diagnosis, treatment and care

PROPOSED ACTIONS
Increase diagnostic rate for dementia

OPPORTUNITIES TO ACCELERATE ACTION
Develop national and local clinical guidelines for dementia, relying on
established guidelines such as WHO’s mhGAP guidelines.

Ensure availability of community-based services
Improve access to services and supports
Efficient coordinated care pathways
Workforce training and education

Include dementia services in country-level UHC packages, modelled after
WHO's UHC Compendium.
Enhancing the promotion of human rights in all dementia services by
implementing WHO’s guidance package on good practice community-based
dementia services.
Scale up integration of dementia services within primary care by implementing
WHO’s mhGAP, including through the mhGAP guidelines, Intervention guide,
Community toolkit and mhGAP e-learning.

BARRIERS IDENTIFIED
Lack of availability of services, lack of affordability of services
Inequitable distribution of services (e.g. urban vs. rural and income level)
Human resource limitations (lack of workforce, lack of training)
Dementia-related training not routinely included in clinical curricula
Lack of coordination between sectors nationally and locally

Scale up integration of dementia services within the long-term care sector by
referring to ICOPE and ICARE, and include a focus on rehabilitation utilizing
the forthcoming Package of interventions for rehabilitation.
Implement digital health solutions to increase population-level access to
dementia care and support through WHO’s mDementia programme.
Leverage synergies with the SDGs, WHO’s Global coordinating mechanism on
NCDs, and the forthcoming Intersectoral global action plan on epilepsy and
other neurological disorders (World Health Assembly Resolution WHA 73.10).5

Stigma

5 Requested by the Seventy-third World Health Assembly in November 2020.
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WHO guidelines, tools and packages to
accelerate action
WHO has developed several guidelines, tools and packages
which can be used to accelerate action, beginning with WHO’s
mental health Gap Action Programme (mhGAP) guidelines, the
mhGAP Intervention guide and mhGAP Training manual, which
contain guidelines, training modules and implementation
considerations specific to dementia diagnosis and care for use
by non-specialist health-care workers globally (66). Moreover,
based on WHO’s existing dementia guidelines, WHO’s UHC
Compendium of interventions released in December 2020
contains 22 actions related to dementia risk reduction,
diagnosis and management (67). Other WHO products and
tools include:

WHO’s guidance package on good practice
community-based dementia care services (68, 69)
WHO has recently developed a guidance package on good practice communitybased mental health services that promote human rights and person-centred
recovery approaches. The WHO guidance describes different services around
the world that promote legal capacity (informed consent and the right to decide),
that implement a policy of non-coercive practices, promote participation in the
design and delivery of the service, facilitate community inclusion, and adopt
person-centred approaches. During the course of developing this document
WHO received many requests to develop similar guidance in the area of
dementia services (see Box 22).

BOX 22

WHO’s good practices on community-based dementia
care services
WHO’s good practices on community-based dementia care services will
provide international guidance on community-based good practice services
in the health and social care sectors that promote a person-centered human
rights-based approach to dementia across the care continuum. A similar
methodology will be followed to that used to develop WHO’s guidance package
on good practice community-based mental health services.
Specifically, WHO’s good practices community-based dementia care services
guidance package will include:
a clear articulation of human rights in relation to dementia care with
reference to the CRPD and related international policy and legal
standards, and WHO standards and criteria for good practice services
in dementia care;
a description and evaluation of good practice services across WHO’s
six regions illustrating a wide range of examples from high-, middleand low-income countries in both urban and rural settings, with an
emphasis on their ability to provide person-centred care and support
human rights; description of the services will include costs, outcomes,
and sustainability and transferability to different socioeconomic and
country contexts;
a description and evaluation of good practice multisectoral service
networks, including multisectoral housing, education, employment,
social benefits, transport, advocacy, research highlighting how they
support human rights; and
guidance on how to develop good practice services for dementia as part
of an integrated care pathway and on how to integrate and scale up
good practice services in health and social care systems through policy,
law, community service models, financing, information systems, and
advocacy among other areas.
The guidance package will inform policy-makers and decision-makers, as well as
programme and service managers, in developing, supporting and scaling up rightsbased, person-centred services for dementia as part of integrated care pathways
for dementia within the context of broader efforts to strengthen health systems.
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WHO’s integrated care for older people (ICOPE)
WHO’s Guidelines on integrated care for older people (ICOPE) were released in
2017 and provide guidance on community-level interventions to prevent, slow
or reverse declines in the physical and mental capacities of older people (70).
ICOPE reflects a continuum of care that will help to reorient health and social
services towards a more person-centred and coordinated model of care that
supports optimizing intrinsic capacity (physical and mental capacity) and
functional ability for older people. Several WHO ICOPE guidelines and tools
are available to support ICOPE implementation, namely:
ICOPE Guidelines (70) provide evidence-based recommendations on
what works to prevent, slow or reverse declines in the physical and
mental capacities of older people.
ICOPE implementation framework (71) assists policy-makers and
programme managers concretely to assess and monitor the capacity of
services and systems to deliver integrated care and develop action plans.
ICOPE handbook and application, which are intended for health and
care workers in the community and primary care, describe practical
care pathways to detect declines in intrinsic capacity and to develop a
personalized care plan.
These tools facilitate the implementation of the Decade of Healthy Ageing
(2021–2030) in order to deliver integrated care and primary health services
that are responsive to older people.

WHO package of interventions for rehabilitation
WHO is also currently developing a Package of interventions for rehabilitation
(PIR), which will provide a set of evidence-based interventions for rehabilitation
including for people with dementia (see Box 23).

176

CHAPTER 7

Global status report on the public health response to dementia

BOX 23

Package of interventions for rehabilitation
This package consists of a set of interventions designed to optimize functioning
and reduce disability in interaction with the environment for people with
health conditions. With rising prevalence of NCDs and chronic diseases,
ageing populations and more people surviving injuries thanks to improved
access to health care, global rehabilitation needs are high and are expected to
rise. Rehabilitation is essential in people with dementia as it can help them to
achieve and maintain optimal levels of functioning by: 1) providing preventive,
promotive, restorative and compensatory approaches that are tailored to an
individual’s needs and capacities; and 2) optimizing the individual’s physical
and social environment. Despite the benefit of rehabilitation in people with
dementia, the gap between the existing rehabilitation needs and access to
rehabilitation is evident, particularly in contexts with limited resources.
To address the lack of access to rehabilitation for people with dementia and
other health conditions, WHO is currently developing the Package of interventions
for rehabilitation (PIR). The PIR will provide a set of evidence-based interventions
for rehabilitation that are essential to people with a health condition since they
target aspects of functioning that are frequently impaired or limited but are
amenable to rehabilitation. The interventions are effective, and the cost–benefit
ratio favours the benefit. Specific consideration for the selection of interventions
to be included in the PIR is given to the low- and medium-resource context. For
all the interventions included in the PIR, information on the requirements for
materials (assistive products, equipment, consumables) and human resources
(workforce, time) will be available, and recommendations on the availability at
service delivery platforms will complete the PIR.
The information available with the PIR will support ministries of health in
planning, budgeting and integrating rehabilitation interventions both into
all service delivery platforms and along the continuum of care, according to
national needs and available resources. The PIR will also be useful for service
planners, researchers, academics and service providers.
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Concluding remarks
Action area 4 of the Global dementia action
plan calls for countries to develop efficient,
coordinated dementia care pathways that
are person-centered and fully integrated into
the health and social care system. Integrated
dementia care pathways span the full care
spectrum from dementia diagnosis and
post-diagnostic support, through care and
treatments, to rehabilitation and palliative
care. The GDO monitors global, regional and
country-level progress on diagnostic rates
for dementia, the availability of communitybased dementia services, access to dementia
services, levels of coordinated care, and
training and education of the health and social
workforce for dementia.
Diagnosis is the first step to accessing
dementia care pathways, and currently
fewer than one-third of GDO countries are
able to report dementia diagnostic rates,
which falls far short of the global target of
50% of GDO countries reporting diagnostic
rates. Additionally, there is a large variation
observed between the diagnostic rates
reported by countries of different income
levels, with HICs on average reporting 50%
diagnostic rates versus 29% for LMICs. With
regard to the availability of community-based
services, the majority of GDO countries
report providing community-based services
for dementia, although overall 20% more
HICs than LMICs report providing these
services. There is also a wide gap between
country income categories with respect
to urban versus rural inequities in terms
of service availability. Community-based
dementia services, including social and
financial protection schemes, are more likely
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to be available in rural areas in HICs than
in LMICs. A similar pattern is observed for
health and social care facilities; while all or
most countries report the availability of
tertiary care facilities and outpatient health
centres, all other facilities are more available
in HICs than in LMICs.
Dementia-related health products are more
available and more likely to be reimbursable
in HICs than in LMICs, which has implications
for the out-of-pocket costs to people living
with dementia. Moreover, health and social
workforce training remains inadequate in
the area of dementia. While the majority of
health service cadres receive some training
globally, there are still significant proportions
of the workforce that are not routinely trained
in basic dementia competencies. Dementiaspecific clinical guidelines, standards and
protocols are essential for making health and
social workforce training a reality but less than
two thirds of GDO countries (58%) report
having them. Additionally, just over half of
GDO countries report having a mechanism to
coordinate care across sectors for dementia.
Accelerating action in the area of dementia
diagnosis, treatment and care necessitates
increased global investments. Urgent
action is needed to scale up evidence-based
community interventions for dementia with
adequate health and social workforce training
and education, to close urban–rural inequities,
and with adequate social and financial
protections to reduce out-of-pocket costs to
people with dementia and their carers.
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8. Support for
carers of people
living with
dementia
Context

“The quality of life of persons with
dementia lies also in their carer’s hands.
That’s why we need to support carers
and enable them to provide good care to
persons with dementia.”
Peach Wattanavitukul,
Thailand

"Support services
for carers of
people living with
dementia should
be considered an
investment and not
a cost."

Most people with dementia are cared for by family members or
other unpaid carers without any additional support, especially
in LMICs where the majority of people with dementia live.
Carers often face numerous financial, social and psychological
stressors, all of which may have been heightened due to the
COVID-19 pandemic and can have a significant impact on
their physical and mental health. This, in turn, can lead to a
breakdown of informal home-based care for persons with
dementia and affect their ability to live in the community
for longer and age in place. An anticipated consequence of
this can be the use of residential facilities. As such, support
services for carers of people living with dementia should be
considered as an investment and not as a cost (74). The return
on these investments translates into improved health and
well-being of people with dementia and carers themselves
and are associated with cost savings resulting from decreased
health-care utilization over time. These services also generate
important benefits to society through increased participation,
consumption and social cohesion.
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Carer policies, programmes and services
currently remain underfunded and
underdeveloped due to an overreliance on
informal caregiving, which may in turn affect the
likelihood that carers seek support. As identified
in Table 28, caregiving also disproportionately
affects women, who contribute roughly 70%

of the global hours of informal care, with
the highest proportion in LMICs. Although
perceived social and gender norms vary across
societies and countries, in many settings the
general expectation that families have the
obligation to provide care can represent a
structural barrier to improving care policies.

TA B L E 2 8

Female proportion of hours of informal care, by WHO region and World Bank
income classification, 2019
Female million
hours (all ADLs)

Female %
(all ADLs)

Female million
hours (ADLs +
supervision)

African Region

4 618

79.6

6 861

79.5

Region of the Americas

9 291

76.4

17 121

76.8

South-East Asia Region

9 616

77.2

13 657

77.6

European Region

14 339

68.2

20 043

67.6

Eastern Mediterranean Region

3 875

74.2

6 144

74.1

Western Pacific Region

19 745

60.4

28 678

61.3

Total hours

61 484

68.8

92 505

69.4

Low-income countries

2 977

76.9

4 379

77.1

Lower-middle-income
countries

14 202

76.0

19 696

76.0

Upper-middle income
countries

26 122

63.9

37 702

65.3

43 301

68.3

61 778

69.1

High-income countries

18 183

70.1

30 727

70.0

Total hours

61 484

68.8

92 505

69.4

Female % (ADLs +
supervision)

WHO region

Income level

Low- and middle-income
countries
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Globally, there is a need for increased care and services
integrated into, and funded by, national/subnational health
and social systems – as well as social and financial support
for carers of people living with dementia. Action area 5
of the Global dementia action plan focuses on delivering
multisectoral care, support and services for carers. Carer
supports and services are to focus on preventing decline in
mental and physical health and improving social well-being
in line with carers’ needs. The global target associated with
this action area is that 75% of countries will provide support
and training programmes for carers and families of people with
dementia by 2025.
Achieving the global target requires providing accessible and
evidence-based information, training programmes and respite
services tailored to the needs of carers, as well as social and
financial benefits. Concerted efforts by government in close
partnership with civil society are also required to protect
carers from stigma and discrimination, including through the
implementation of policies, legislation and awareness-raising
efforts. It also necessitates capacity-building of the health
and social care workforce in order to identify and reduce
carer stress and burn-out, and to promote the meaningful
involvement of carers in care planning, policy and research.
This chapter addresses each of these issues in turn by
providing an overview of global progress made to date on the
basis of available GDO data and complementary evidencebased examples and information. The chapter also addresses
the impact of COVID-19 on carers’ mental health, outlining
spotlight activities carried out by WHO’s secretariat to assist
countries in supporting carers of people with dementia and
also featuring country case studies. It should be noted that the
chapter does not represent a comprehensive literature review.
Rather, the goal is to provide a global overview of the current
status in the area of support for dementia carers on the basis
of GDO data, complemented by illustrative examples and
information from peer-reviewed and grey literature.

"Concerted efforts
by government in
close partnership
with civil society
are also required
to protect carers
from stigma and
discrimination,
including through
the implementation
of policies,
legislation and
awareness-raising
efforts."
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Progress to date
Information, services and
supports for carers

38%

higher provision of carer
support services in HICs

It is important that carers have access to supports and services
tailored to their needs so that they may effectively respond
to, and manage, the physical, mental and social demands
of their caregiving role. The Global dementia action plan
recommends that countries provide accessible and evidencebased information, training programmes, respite services and
other resources tailored to the needs of carers. This support
is important for improving knowledge and caregiving skills,
such as coping with behaviour changes related to dementia to
enable people living with dementia to live in the community for
longer and to prevent stress and health problems for carers.
Of the 62 GDO countries, 47 offer services, supports or
programmes for carers of people living with dementia (see
Figure 28a). Of these 47 countries, more HICs provide
carer services and supports compared to LMICs (see Figure
28b). Within the same subset of 47 countries, 70% have
implemented carer services and supports at national level and
30% at subnational level (see Figure 28c). Moreover, Figure
28d shows that 63% (or 30 countries) of these countries
have dedicated financial and human resources and 52% (or
25 countries) have a defined implementation plan for these
services.

FIGURE 28

Existence, types, allocated funding and implementation status of carer
services, supports and programmes

A Existence of services, supports
or programmes for carers of
people with dementia

B Number of countries providing

services, support or programmes for
carers of people living with dementia

LMICs

12

15

47
32

HICs

15
Yes

No

C Percentage of countries with carer
services implemented at national
vs. subnational level

30%

National

No

D Number of countries with a defined
implementation plan vs. dedicated
financial and human resources

Implementation
plan
Dedicated
resources

70%

Subnational

Yes

2

25

22

30

Yes

17

No

It should be noted that GDO country data, although
encouraging, captures information from Member States with
a relatively high level of dementia readiness. As such, this
information should be interpreted with caution as data from
additional countries (not currently part of the GDO) are likely
to influence these findings significantly.
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Types of carer services and supports
Carer services and supports cover a broad
range of programmes. Figure 29 shows that,
out of 47 countries that identified specific
types of carer services and supports through
the GDO, over 87% include carer training and
education on dementia management, 85%

include psychosocial support for carers, 77%
include respite services, as well as information
or advice on legal rights. However, only 68%
report providing financial benefits/social
(security) protection.

FIGURE 29

Types of carer services and support across countries

Financial benefits / social
(security) protection

68

Information or advice
on legal rights

77

Respite services

77

Psychosocial
support for carers

Additionally, a recent systematic review and meta-analysis
found that multi-component interventions for carers of people
living with dementia can have broad-ranging impacts on quality
of life for people living with dementia, depressive symptoms
and on BPSD, and also impacts on carers (77).

85

Carer training
and education

87
20%

40%

60%

80%

There are multiple recent noteworthy examples of carer
programmes implemented by countries (also see Box 24). For
example, Australia created the “Carer Gateway” in 2019 to
connect carers to support services; the Danish Committee
for Health initiated a national education programme for
informal carers in 2018; Finland started to provide coaching
on caregiving in 2018; and Malta implemented a national
“Respite at Home” service in 2017 (75). Some countries –
including Germany, Japan and the United Kingdom – have
promoted an overarching vision of dementia care. For example,
legislation such as the United Kingdom’s Care Act (2014) (76)
recognizes carers as both partners in care planning/delivery
and clients of health and social support services. As part of this
legislation, carers receive assessment and support throughout
the caregiving trajectory and following the death of the person
living with dementia. Recently, some countries have also
initiated or reinforced mechanisms for the financial support
of carers. For instance, with the approval of the carer statute
(Law no. 100/2019) in Portugal, an allowance for primary
carers became available at subnational level. In 2017, the Irish
Government extended carers’ financial allowance for 12 weeks
after the death of the person in care or his/her entry into longterm institutional care.

100%

"Ongoing gaps in
carer services and
supports remain,
particularly in
LMICs. A number
of countries still
lack training
and information
services for carers.
When carer services
and supports
are available,
many remain
underutilized due to
a lack of knowledge
about them."

However, ongoing gaps in carer services and supports remain,
particularly in LMICs. A number of countries still lack training
and information services for carers. When carer services and
supports are available, many remain underutilized due to a lack
of knowledge about them (78). Carer support is also frequently
fragmented across sectors and is not person-centred (79).

Percentage of countries
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BOX 24

Dementia Intervention Team – responding to
community carer needs in Malta
In response to the growing challenge that dementia is posing on the Maltese
society at large, in 2015 Malta launched its first national dementia plan
entitled Empowering Change: A National Strategy for Dementia in the Maltese
Islands (2015–2023) with the objective of enhancing the quality of life of
persons with dementia, their carers and family members. Among the various
intervention streams highlighted in the strategy document, community-based
dementia management, care and support were considered priorities in need
of urgent attention. In view of this, a specialized team of multidisciplinary
health and social care professionals (the Dementia Intervention Team) was
developed with the aim of providing support to individuals with dementia and
their informal carers in their home environment. Even though this service was
initially launched as a pilot project manned by two health-care professionals, it
soon gathered momentum.
Currently, the service boasts six highly skilled professionals who visit more than
600 community-dwelling individuals with dementia and their carers per year.
Through a dedicated landline, the team is in constant contact with carers who
require advice on various issues related to dementia care. In collaboration with
the National Dementia Helpline and working closely with community-based
clinicians and geriatric specialists, the team identifies and intervenes in cases that
need urgent intervention. It also acts as a main body of advice for carers on other
support services that are available and, as a member of the National Dementia
Working Group, is involved in shaping dementia policy. The importance of such
a service was highlighted during the COVID-19 pandemic in which the team
played a central role in ensuring that persons with dementia obtain the right
information pertaining to the effects of the pandemic on their well-being.
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Availability of carer services and supports
The GDO measures the geographical
distribution of carer services and supports
– i.e. whether these are available across: 1)
the capital, main cities and rural areas; 2)
the capital and main cities; or 3) the capital.
Figure 30 shows that, of the countries that
responded to this indicator, most provide
all types of carer services, supports or
programmes across urban and rural settings.
More specifically, while the majority of HICs
provide all carer services and supports across
urban and rural settings, these programmes

tend to be concentrated in urban settings
only for LMICs. Making it difficult if not
impossible for carers in rural areas to access
services. Moreover, financial and social
protection is more frequently provided in
HICs as compared to LMICs (Figure 30).
Importantly, while availability of services is a
prerequisite of access, it says very little about
service coverage and utilization. Although the
GDO attempts to measure service utilization,
countries at large are not able to provide that
information due to a lack of available data.

FIGURE 30

Accessibility of carer services and supports

Global

29

24

22

11

2

1 Access to legal
information

Access to
1 financial benefits

12

8
5 Access to
respite services

4

23

23
10
Access to
psychosocial
support

6 Access to
carer training

By income level
1

1

1
2
3

3
2

3

4

3

3

3

3

8
27

22

21

5

9

21

7

2
23

2
HICs (n=28)
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HICs (n=26)

Access to legal
information

Capital and main cities only
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1
LMICs (n=9)

Access to
respite services

Capital only

HICs (n=28)

LMICs (n=12)

Access to
psychosocial
support

HICs (n=27)

LMICs (n=12)

Access to
carer training

"Importantly, while
service availability
is a prerequisite
of access, it says
very little about
service coverage and
utilization. The GDO
attempts to measure
service utilization,
but countries at
large are not able
to provide that
information due to
lacking data."
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The GDO also measures who the majority
service provider of carer supports is –
i.e. whether the supports are offered
by the public sector, private sector or a
nongovernmental provider. Figure 31 shows
that, across countries, NGOs are the majority
providers of legal advice or information,
psychosocial support and carer training. In
contrast, the private sector is the majority
provider of respite services and financial
benefits/social (security) protection. The
data disaggregated by income level show
that NGOs are the majority providers for all
carer services and supports in LMICs – except
financial benefits/social (security) protection

which is provided mainly by the public sector.
In HICs, the public sector represents the
majority provider for respite services and
financial benefits/social (security) protection,
while NGOs are the main providers of carer
training and education as well as psychosocial
support. Legal information or advice is
provided equally by NGOs and the public
sector in HICs, according to GDO data.
The reliance on NGOs and civil society
organizations for providing carer support
services, however, comes at the risk of being
short-lived and lacking coordination (80).

Monitoring service availability and use is key to understanding
which services benefit carers, at what time and in which
context. Understanding the effectiveness of carer services
and supports in both clinical and community settings and
how such findings are incorporated into health and social
systems is also important. Another important issue relates to
determining whether under-represented carer groups receive
appropriate support, such as older carers with specific physical
and mental health needs (81), or carers who are illiterate,
have low levels of health literacy, live in rural areas, or who
are migrants (82), refugees or from other vulnerable groups.
Strengthening health and social information systems to collect
and report on equity measures is particularly important in
this regard, especially in low-resource settings. In this regard,
gaps in health information systems and infrastructure limit
comprehensive reporting by countries on all GDO indicators
related to dementia carer support.

FIGURE 31

Majority provider of carer services, programmes and support
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BOX 25

Carer schools in Norway: information and training for
relatives and carers of people living with dementia
The Norwegian Dementia Plan aims to promote the development of
good, flexible and tailored municipal health and care services that focus
on prevention, timely diagnosis, post-diagnostic follow-up, daily activity,
housing and education. People with dementia and their families need
information about dementia, support and access to arenas where they can
meet others in the same situation. Therefore, grants were established that
all municipalities can apply for to participate in an educational programme of
“Carer schools” and support groups. A manual for establishing the measure
in the municipalities was developed and implemented nationally through
the grants. The municipalities receive material for information and guidance.
Some 66% of the municipalities participated in the programme and arranged
the courses in 2018–2019.
Regional measures have also been established. “Meeting for coping” provides
courses for people with early onset dementia together with their partners,
and “Time to be young” provides information and an arena for the children of
people with dementia. A national summer camp is arranged for the youngest
children together with the parent who does not have dementia.
Courses tailored to carers from ethnical minority groups and the Sami
people, and for people with intellectual disabilities, have been developed and
implemented, including through e-learning. Carers can also attend courses
to receive guidance on how to tell their stories to support other carers.
The experiences of family members who have followed the educational
programmes and the different courses are systematically evaluated
and responses have in general been very positive. Examples of common
statements from participants are: “I feel better prepared to meet the future”
(person with dementia); “We travel back feeling richer both individually and as a
couple” (carer); and “I am more motivated to be open both towards my family and
friends, and to seek help when necessary” (young carer).
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Carer protection
Globally, people living with dementia and
their carers continue to suffer from stigma,
discrimination and human rights violations,
in part due to limited public awareness of
the caregiving role and carer needs (83-85).
Stigma and discrimination result in delayed
diagnosis, increased carer burden, depression
and social isolation, as well as reduced helpseeking behaviours and capacity to provide
care to the person living with dementia
over the long term (86). Public awareness
and education campaigns, co-designed
with carers, are promising approaches
for addressing stigma and enhancing the
recognition of the carer’s role by employer
and society (39, 87). Recent examples of such
initiatives include the celebration of national
“carer days/weeks/months” (e.g. in Canada
and the United States of America), media
campaigns (e.g. in Sweden (87)) and caregiving
conferences and events (e.g. in Slovenia (75)).
Global movements, such as the “Embracing
Carers” campaign, have also begun to emerge
in an effort to promote greater visibility and
awareness of carer challenges, to support
increased policy attention and action, and
to create innovative opportunities for
integration into the health-care system.

Stigma and discrimination are multilevel social
phenomena involving structural, intrapersonal
and interpersonal issues (88). Structural
stigma can be tackled at policy and service
level by, for instance, proposing anti-stigma
actions that are feasible and measurable,
using nondiscriminatory language (e.g. avoid
calling dementia “a burden to society”), and
reporting on equity indicators related to
service access and use, stratified by different
population groups. To address stigma against
carers of people living with dementia, the
Global dementia action plan recommends
that countries develop or strengthen the
protection of carers, including through
policies and legislation against discrimination,
and support them beyond their caregiving
roles in all settings.
Of the 43 GDO countries with stand-alone,
integrated or subnational dementia plans,
37 included carer support as an action area.
National dementia plans represent important
first steps in protecting carers and responding
to their multiple needs. Fewer than half the
countries (26 or 44%) indicated having legal
provisions that aim to end discrimination
against family carers included in universal
laws, while only 2 indicated including these in
dementia-specific legislation (see Figure 32).
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FIGURE 32

Countries with legal provisions to end discrimination against carers of people
with dementia
Yes

(dementia-speciﬁc)

2

countries

26

Yes

countries

(universal law)

32

No

In some countries, carers’ responsibilities
are protected under equal opportunity
and anti-discrimination legislation (i.e.
universal laws), especially concerning
the workplace (89). A recent example
in this area is the introduction of new
federal legislation – the Protecting Family
Carers from Discrimination Act (2020)
– in the United States of America. A
few countries also protect family carers
from “discrimination by association” – i.e.
discrimination against someone associated
with a person living with dementia – as in
the Equality Act in the United Kingdom
(2010). Other countries have developed
specific legislation to recognize and support
carers’ roles. For example, in 2019 France
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countries

adopted a legislation to promote the
recognition of carers, secure their social
rights and provide them with information
and support (75). Other similar initiatives
are seen, for instance, in Belgium (2019),
Italy (2019) and Portugal (2019) (75). Some
countries have also dedicated new budget
allocations to operationalize legislative
measures on caregiving. While promising,
complicated bureaucratic processes that
do not take into account the accessibility
needs of carers (e.g. literacy) may prevent
the formal recognition of carers and hinder
their access to financial and social support,
particularly among carers with lower
education or socioeconomic status (80).

Global status report on the public health response to dementia

Health and social care worker training
The Global dementia action plan recommends that health and
social workers are trained to identify and reduce carer stress
and burn-out. GDO data reveal that efforts to train the health
and social care workforce in dementia core competencies,
including assessment and treatment of carer distress, remain
insufficient. As noted in Chapter 7, out of 59 countries
reporting on this GDO indicator, no more than 5% across all
WHO regions have trained all health and social care workers
in core dementia competencies. Additionally, while 37 GDO
countries report including carer support in a dementia plan,
only 37% all countries (23 of 62) report having standards,
guidelines or protocols for carer treatment and support.
Indeed, critical gaps in education and training for the health
and social care workforce, including a lack of knowledge
related to the assessment and treatment of carer distress,
continue to be identified by stakeholders in the dementia field
(90). One promising example is England’s national Dementia
Training Standards Framework which includes educational
content and learning outcomes for health and social care staff
focused on carers’ support needs (2015, updated in 2018)
(91). Health and social care workers need to understand
carers’ roles and be able to effectively communicate with them,
foster their mental and physical resilience, empower them,
and guide them through accessing services and resources (92).
This is particularly important for carers who have low levels
of literacy or education, and who are from vulnerable or lower
socioeconomic groups (e.g. migrants, refugees, cultural or
religious minorities) (62).

37%

of GDO countries
have guidelines on
carer support
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Impact of COVID-19 on dementia carers
The COVID-19 outbreak brought new
challenges to informal carers. Lockdowns
limited the range of services offered to people
living with dementia, resulting in delayed
access to diagnostic and post-diagnostic care
and a significant impact on cognitive health (9395). Carer support programmes such as respite
services offered through day centres were also
frequently discontinued (96). The disruption of
formal services has resulted in increased social
isolation and a more intensive care burden,
having an impact on carers’ physical and mental
health – potentially over the long term (96,
97). According to WHO’s rapid assessment of
the impact of COVID-19 on mental, neurological
and substance use services more than 20% of
surveyed WHO Member States reported
that services for carers of people with mental,
neurological and substance use disorders were
completely disrupted due to the pandemic
(4). Additionally, as outlined in WHO’s updated
infection prevention and control guidance for longterm care facilities in the context of COVID-19
(98), it is important to consider the impact
of visitation restrictions on the health and
well-being of people with dementia who live
in institutional or hospital settings and their
family members, and the need to recognize
carers as core partners of the care team. While
limiting face-to-face interactions represents
an important step in controlling the spread
of infection in nursing and long-term care
facilities, these procedures have resulted in the
increased isolation of people with dementia
and significant worry among health-care staff
concerning residents’ well-being (39).
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While many countries included paid leave
policies and special allowances for childcare in
their national COVID-19 response, social and
financial benefits for carers of older relatives
were rarely included (99). This policy gap may
expose carers of people living with dementia
to a double burden of caregiving while
working from home full-time (100). Together
these factors are likely to contribute to a
decreased capacity to provide care over the
long term, which is associated with premature
institutionalization of the person living with
dementia (101).
To address some of these issues, digital
interventions have gained momentum in
facilitating carer access to training and
support. Evidence shows that Internet-based
interventions can be beneficial in reducing
symptoms of anxiety and depression,
diminishing subjective burden and improving
the quality of life among carers of people living
with dementia, including during COVID-19
lockdowns (102-104). However, increased
demands and stress resulting from COVID-19
measures may result in carers having less
time to use online interventions. In addition,
older, less educated and socioeconomically
disadvantaged carers may not have access to
new technologies (105). As a result, further
efforts are needed to develop online solutions
that respond to carers’ cultural, accessibility
and socioeconomic needs, and to help
overcome the technology gap. More generally,
additional evidence is required to better
understand the design, benefits and outcomes
of digital interventions for carers.
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The way forward
While wide variations exist between countries, access to
and availability of carer services remain particularly limited
in LMICs, where the majority of people with dementia are
cared for at home in the community. Achieving the global
target requires establishing appropriate services, support and
training that are accessible to carers in their communities,
in partnership with civil society and international partners.
Effective training programmes represent an important
element in building carers’ capacity to protect their mental and
physical health and well-being and enabling them to continue
providing care over the long term. Ensuring that health and
social workers are appropriately trained to identify and
manage carer stress and burn-out is also key to supporting
carers in the community. Digital health programmes – such
as WHO’s iSupport, mDementia and e-mental health Gap
Action Programme (e-mhGAP) – represent opportunities to
overcome barriers related to access and cost as well as service
discontinuation due to COVID-19.
Due attention should be given to addressing stigma,
discrimination and competing responsibilities (e.g. childcare,
work obligations), which constitute important barriers to
carers in seeking available support. Carer protection – in
the form of social, financial and disability benefits, policies
and legislation against discrimination – is an important
prerequisite to supporting carers beyond their caregiving role
and enhancing service demand. The forthcoming Intersectoral
global action plan on epilepsy and other neurological disorders
represents a significant opportunity to strengthen legislation
and embed carers in the care continuum within the broader
context of neurological disorders. Figure 33 outlines the
actions included in the Global dementia action plan, key
barriers to implementing these and strategies to overcome
them through accelerators for action. Key accelerators are
subsequently reviewed.

"Effective training
programmes
represent an
important element
in building carers’
capacity to protect
their mental and
physical health
and well-being and
enabling them to
continue providing
care over the
long term."
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FIGURE 33

Proposed actions, identified barriers and opportunities to accelerate action to
support dementia carers

Digital health solutions to support carers of
people with dementia

PROPOSED ACTIONS
Implement carer training and education programmes

iSupport

Train health and social care workers to identify and reduce carer stress and burn-out
Develop/strengthen protection for carers
Empower carers, including participation in care planning

BARRIERS
Lack of appropriate and accessible training and education
Service disruption due to COVID-19
Lack of training on dementia core competencies
Lack of legislation to end discrimination and ensure carers’ financial protection
Carers not perceived as core members of the care team

OPPORTUNITIES TO ACCELERATE ACTION
Implement digital health solutions to increase carer access to training
and address service discontinuation, including through WHO’s iSupport,
iSupport Lite and mDementia (Support) programmes
Implement and/or scale up WHO’s mental health mhGAP, including through
the mhGAP Intervention Guide, guidelines, community toolkit and mhGAP
e-learning
Leverage synergies with the forthcoming Intersectoral global action plan
on epilepsy and other neurological disorders (World Health Assembly
resolution WHA 73.10)

In 2017, WHO launched iSupport6, an online
knowledge and skills training programme for
carers of people with dementia, to support
Member States in achieving the global target
that 75% of countries will provide support and
training programmes for carers and families of
people with dementia by 2025. iSupport is
a self-help tool and aims to prevent and/or
decrease mental and physical health problems
associated with caregiving, and to improve
the quality of life of those caring for people
with dementia. iSupport includes five modules
and accompanying exercises, namely: 1)
Introduction to dementia; 2) Being a carer; 3)
Caring for me; 4) Providing everyday care; and
5) Dealing with behaviour changes. iSupport is
available both as an online programme and as
a manual that can be printed and used offline,
allowing for a broad reach of the programme,
particularly in regions of the world with low
Internet bandwidth and/or connectivity.
iSupport can be adapted to national or local
contexts and needs. Once adapted, carers
can choose to work through all modules and
lessons consecutively or select the lessons
that are most relevant to their everyday
lives. All lessons consist of brief readings,
descriptive examples, and several exercises.
Carers receive feedback as they work through
each exercise.

iSupport is currently being adapted in over
20 countries, including Australia, Brazil,
China, Czechia, France, Greece, Indonesia,
Ireland, Japan, Malta, Mexico, Netherlands,
New Zealand, Nigeria, Portugal, Qatar, Spain,
Switzerland, Tunisia, the United Kingdom and
Viet Nam and Wales. Lessons learned thus
far from country implementation include the
importance of conducting multistakeholder
user-testing and focus groups in order
to appropriately tailor the programme to
local needs, the need to align iSupport with
emerging technological developments and
trends, and the usefulness of building on other
countries’ experiences.
Multiple studies of the feasibility and
effectiveness of iSupport in improving carer
health outcomes are underway. Preliminary
findings to date indicate that: 1) carers
identified iSupport as an online platform
that can meet their educational and care
management needs; and 2) health and social
care providers can play an important role
in promoting the programme (106). For
instance, among Portuguese carers, most of
the themes reported as training needs are
covered by iSupport (63). The programme
has also shown potential in fostering among
carers positive and person-centered attitudes
towards people living with dementia. In Brazil,
preliminary research data show that iSupport

6 See: https://www.who.int/publications/i/item/isupport-for-dementia (accessed 11 July 2021).
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is easy to understand and is culturally relevant (107). iSupport
can also be integrated into the continuum of services and
programmes offered to carers at national level (64).

iSupport Lite
In 2020, the COVID-19 pandemic and
resulting breakdown of community-based
services for people with dementia and
their carers emphasized the importance of
providing carers with accessible public health
messages to reduce carer stress and improve
their mental health and well-being. Therefore,

WHO launched iSupport Lite,7 consisting of
a set of short, practical support messages for
carers of people with dementia extracted from
iSupport. iSupport Lite offers tips for carers of
people with dementia in the form of a video,
posters, and questions and answers.

mDementiaSupport
mDementiaSupport is part of WHO’s mHealth dementia
programme (53). Its content is based on WHO’s iSupport
programme which aims to improve the quality of life of
carers of people living with dementia and prevent and/or
decrease mental and physical health problems associated
with caregiving. It extracts key messages from each
of the five modules included in iSupport, which can be
disseminated through one- and two-way SMS messaging.
mDementiaSupport is particularly relevant in reducing
carers’ social isolation and overcoming the caregiving burden
associated with disruption of home and community service due
to COVID-19.

Concluding remarks
While progress is being made to support carers of people
living with dementia, there continue to be wide variations
both between and within countries with respect to the types
of services, supports and programmes accessible to carers.
Where these services and supports are available, significant
disruptions to due to COVID-19 restrictions have been
reported within the context of home and community care,
resulting in increased carer burden and stress.
From a legislative and policy standpoint, much can be done
to better protect carers from stigma and discrimination in
communities, care settings and workplaces, and to ensure that
they are supported through financial and social security benefits.
Finally, increased investments in the scale-up of dementia care
services and building the capacity of the health and social care
workforce are necessary in order to identify and manage carer
stress and burn-out more effectively, to involve carers as core
members of care teams, to promote their health and well-being
and provide training and education.
7 See: www.isupportfordementia.org (accessed 11 July 2021).
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9. Dementia
health information
systems and
monitoring
Context
“The development and implementation of
“The
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for the
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actions actions
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and standards
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and measures
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for
implementation.”
thethe
implementation.”
Alister Robertson,
New Zealand

Action area 6 of the Global dementia action plan focuses on
health information systems for dementia. The collection and
analysis of data are used to inform the trends of several indicators
– including the burden of dementia, prevalence of risk factors,
disease mortality and service provision. Effective and routine
monitoring of dementia-related indicators is essential to support
the formulation and implementation of evidence-based policy,
service planning and delivery, and to track progress at national
and subnational levels. Establishing health information systems
for dementia is also aligned with objective 4 of the Mental health
action plan (to strengthen information systems, evidence and
research for mental health). Moreover, it contributes to tracking
progress towards achieving SDG 3 (good health) and targets 3.8
(UHC), 3b (Support research, development and universal access
to affordable vaccines and medicines) and 3c (Increase health
financing and support health workforce in developing countries).
Based on available GDO data, this chapter focuses on
demonstrating the existence of health information systems and
identifying gaps and opportunities associated with monitoring
dementia data across countries.
WHO

205

The Global dementia action plan sets a global target of having
50% of countries routinely collecting a core set of dementia
indicators through their national health and social information
systems every two years by 2025.

Progress to date
Global monitoring of core dementia indicators
To date, 62 Member States have submitted
GDO data (32% of all WHO Member States),
with significant regional/geographical variation
(Figure 34). Of the countries that have
submitted data to the GDO, 56% are HICs,
while 44% are LMICs. Together, countries
participating in the GDO account for 65.5%
of the global population and 76% of the
population aged 60 years or older. Countries’

response rates can be used as a proxy measure
to assess their ability to report on dementia
data. Moreover, the shortage of responses
originating from low-income countries
demonstrates that it is imperative to support
countries in strengthening their health systems
and health infrastructure, and in building
capacity to enable effective health information
systems, especially where resources are limited.

FIGURE 34

Member States’ submissions to the Global Dementia Observatory (GDO)
32%

Although data completion for GDO indicators was overall
satisfactory – especially for those indicators relating to
dementia law and policy, service availability and training – the
response rate was particularly low for other indicators that
required the quantification of users receiving a service and
physical installations that provided the services. Notably,
on average 93% of countries were not able to report on the
quantification of services provided to carers (e.g. proportion of
carers receiving a particular service), and approximately 80%
of countries could not provide complete data related to the
availability of health and social care facilities. Overall, countries
encountered major challenges in reporting indicators that
reflected the quantitative availability of services/personnel/
health infrastructure as well as the number of people
providing/receiving such services.
Indeed, according to the countries participating in the GDO,
only 31% routinely monitor people with dementia and, among
those, 79% report having electronic records of these data.
The lower response rate in these indicators is a reflection of
the scarcity and difficulty that countries often encounter in
obtaining and providing data at national level.

45%

45%
38%

37%

31%

9%
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The low number of specific reports, or even the lack of general
reports including dementia, show that it is still necessary
to raise awareness of the importance of having monitoring
systems for dementia.

National reports on dementia
Systematic, routine population-level
monitoring of dementia indicators is essential
to guide evidence-based actions to improve
services and to measure progress towards
implementing national dementia policies.
Moreover, the evaluation of health and
social care data can help to identify gaps in
service delivery, improve accessibility to, and
coordination of, care for people with dementia,
and allow a better understanding and detection
of population-level changes and trends. By
building and/or strengthening information
systems for dementia, the functional
trajectories of people with dementia, their
carers and families can be improved.

It is noteworthy that specific reports on
dementia can raise the profile of dementia and
effectively support the policy-making process.
Globally, fewer than 1 in 5 countries collected
public- and/or private-sector dementia
information and compiled it in a dementiaspecific report. Some 45% of GDO countries,
at least, compiled dementia data (in either
the public system, or the private system, or
both) for general health statistics but not in
a specific report, while 37% of the countries
affirmed that no dementia data have been
compiled in a report for policy, planning or
management purposes (Figure 35).

FIGURE 35

Extent of dementia monitoring and reporting in GDO countries by WHO region
Global
(n=62)

100%

Region of the Americas
(n=11)

30%

South-East
Asia Region
(n=5)

80%

Eastern Mediterranean
Region
(n=8)
Western Paciﬁc
Region
(n=10)
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only 14 report routinely monitoring people
with dementia, showing that further action is
needed to translate the goals outlined in the
dementia plans into reality.

National surveillance and monitoring systems
are important assets for improving the
availability of high-quality and multisectoral
data on dementia. Thus, implementing
dementia registers that are fully integrated
with existing national health information
systems can be a powerful tool to ensure
access to health and social care data, and to
monitor resource implementation at national
and regional levels. At the policy level, out
of 43 GDO countries that indicated having
any kind of dementia plan, 34 include the
promotion of monitoring and information
systems for dementia. However, of these 34,

In total, 19 GDO countries report routinely
monitoring people with dementia. Among
these, a range of different sources are being
used to collect the data, with 68% collecting
data from clinical records (77% HICs, 23%
LMICs) or administrative data (85% HICs, 15%
LMICs), 37% from facility surveys (71% HICs
and 29% LMICs) and 11% from household
surveys (100% HICs) (Figure 36).

8% 8%

45%

FIGURE 36

African Region
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European Region
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In line with the Global dementia action plan’s
cross-cutting principle of equity, an important
issue remains the collection of appropriately
disaggregated data in relevant dimensions
addressing, for instance, common health
inequities and, in turn, the use of those data
to design valuable interventions and increase
the rate of successful implementation. In
this context, 84% of the 19 GDO countries
that routinely monitor people with dementia
indicate being able to disaggregate the

numbers of people with dementia (e.g. by
sex, age, type of dementia). However, since
only 31% of GDO countries are routinely
monitoring people with dementia, the share
of countries that possess these types of data
represents just 26% of the total. Moreover,
although 84% of GDO countries that
routinely monitor people with dementia are
able to disaggregate data, almost all (14 out of
16) are HICs.

Monitoring of health services
The establishment of monitoring systems
is paramount to identifying gaps in service
provision, ensuring appropriate funding
allocation and developing evidence-based
policies. Moreover, such surveillance
systems are indispensable tools for the
evaluation of services that are already in
place or that were recently implemented.
Together with the monitoring of healthcare services, the monitoring of social care

services can provide quality surveillance and
support a comprehensive reporting of care
services. Moreover, better links between
hospital and long-term settings can improve
communication and the flow of data across
the care network and help to: 1) break silos
of some settings; 2) provide the means for
better quality controls; and 3) facilitate the
continuation of care.

BOX 26

Germany’s national dementia strategy as an example to monitor
country-level action
Germany’s national strategy on dementia was developed between 2019 and 2020.
It builds on previous initiatives of the federal government such as the so-called “Alliance
for people with dementia”, on existing measures of the long-term care insurance and
health insurance systems, as well as on activities of the federal states (Länder) and
non-governmental organisations. In addition, dementia plans and guidelines of other
countries and international organisations were taken into consideration.
Governmental actors of different policy areas and administrative levels, as well as over
50 relevant organisations and interest groups were involved in the drafting process.
The strategy identifies four priority fields of action:

1 building dementia-inclusive communities,
2 improving support for persons living with dementia and their family
caregivers,

3 improving medical care, nursing care and long-term care for people

All involved actors agreed on 27 goals and 162 measures to substantially improve
the situation and living conditions of persons with dementia and their families. Many
measures thus focus on enhancing the quality of everyday life of people living with
dementia and the quality of care in various care settings. Examples of such measures
are increasing the number of local dementia networks, conducting coordinated
campaigns on dementia-awareness, more training on dementia for different target
groups, promoting dementia-friendliness in hospitals and long-term care facilities, and
fostering research and better transfer of research results into practice.
The implementation of the strategy will be regularly monitored to ensure
sustainable improvements and to allow necessary adaptations to new challenges
such as the current COVID-19 pandemic. The strategy’s goals are interlinked with
other governmental strategies such as the so-called "Concerted Action on Care"
("Konzertierte Aktion Pflege") which was signed in 2019 to improve training and
working conditions for professional care workers in Germany.
The strategy in its entirety and further information can be found at:
https://www.nationale-demenzstrategie.de/

with dementia, and

4 promoting research on dementia.
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Several indicators can be used to inform the provision of
health services for people living with dementia. Of the 62
GDO countries, 47% monitor medications/pharmaceutical
treatment and the prescriptions of antipsychotics, while 44%
monitor the number of hospital admissions, 37% monitor the
number of outpatient visits, and 24% monitor the types of
outpatient interventions and treatments received (Figure 37).

Monitoring the prescriptions of antipsychotic
medication in people with dementia is a
powerful indicator of dementia care quality.
As noted in Chapter 7, the FDA and NICE in
the United Kingdom have issued warnings
and cautions about the use of antipsychotic
medications in people with dementia due to
increased risks of death in this population.

Studies suggest that drug advisory warnings
such as that issued by the FDA can be
effective in changing prescribing patterns.
Thus, systematic monitoring of prescription
utilization serves to evaluate prescriber
practice and is an essential element of
ensuring that people with dementia receive
evidence-based medicine and care.

FIGURE 37

Monitoring of services for people with dementia

Monitoring of patient-level data

Prescriptions of
antipsychotics

47%

Medications /
pharmaceutical treatment

47%

Number of
hospital admissions

Systematic monitoring of indicators that
can inform the quality of care for people
living with dementia is important to ensure
that 'to ensure that their human rights are
respected. The indicators can also serve as
parameters for designing new strategies
for improvement in accessibility and care
coordination. Moreover, this monitoring also

provides information on whether people
have access to quality and timely care in an
equitable manner across the country (Figure
38). Over 50% of countries that provided
data to the GDO, including both HICs and
LMICs, do not monitor clinical indicators
such as quality of life, adverse events and
disability or functional status.

44%
FIGURE 38

Number of
outpatient visits

37%

Routine monitoring of patient-level data (number of countries by World Bank
income level)
Quality of life

Types of outpatient
interventions and
treatments recieved

24%

Percentage of countries (out of 62)

11

23

HICs

Adverse events
15

7
19

LMICs

19

HICs

Yes
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Disability or
functional status
14

7
19

LMICs

20

HICs

10
16

LMICs

No
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The way forward
Several barriers have been identified to
strengthening health monitoring systems
for dementia. First, a scarcity of resources
and infrastructure limits countries' ability
to collect dementia-related data across
different sectors. Additionally, lacking
digital infrastructure can impede the
integration of data and implementation of
national surveillance systems, especially
in low-income settings. Moreover, current
health information systems are unable
to disaggregate data by common equity
measures such as age, gender, income,
educational level and geographical area (rural
versus urban).
Accelerating action in the area of health
monitoring systems for dementia will
necessitate the integration of national
surveillance and monitoring systems into
existing health information systems in
order to improve access to high-quality,
multisectoral data on dementia. There should
be access to health and social care data
at national and regional levels in order to
improve service delivery and coverage across
the care continuum. Additionally, policies or
legislation pertaining to the measurement,
collection and sharing of data on health and
social care for dementia should be created
and updated, where relevant. Importantly, the

collection of data on epidemiology, care and
resources relating to dementia should be used
to evaluate the implementation of dementia
policies and plans. Importantly, collecting and
analyzing country-level data is not only crucial
to identify the magnitude of gaps throughout
the entire dementia care pathway, but also to
unravel the reasons why such gaps persist and
how they can be better addressed.
WHO has developed several guidelines
and tools that can be used to accelerate
action in the area of monitoring systems
for dementia, beginning with the GDO to
support countries in measuring progress in
implementing the Global dementia action plan
(Box 27). Secondly, the implementation of
WHO’s SCORE technical package can assist
countries in strengthening health data and
information systems. Additionally, countries
can implement health inequity monitoring
by utilizing tools and resources from WHO’s
Health Equity Monitor, which will allow
countries to disaggregate and analyse data
across different population subgroups in
order to identify and close gaps in care and
realize health equity. Figure 39 summarizes
proposed actions, identified barriers and
accelerators to support monitoring systems
for dementia.

FIGURE 39

Proposed actions, identified barriers and opportunities to accelerate actions
to support monitoring systems for dementia
PROPOSED ACTIONS
Integrate national surveillance and
monitoring systems (e.g. registers)
into existing health information
systems to improve access to
high-quality, multisectoral data on
dementia

Update or create supportive policy
or legislation pertaining to the
measurement, collection and sharing
of data on health and social care for
dementia
Collect and use necessary data on
epidemiology, care and resources
relating to dementia to implement
relevant policies and plans

Enable access to health and social
care data at national and regional
levels to improve service delivery and
coverage across the care continuum

BARRIERS
Scarcity of resources and
infrastructure to conduct data
collection across different sectors

Lack of adequate digital
infrastructure to facilitate
the integration of data and
implementation of national
surveillance systems, especially in
low-income settings

Lack of equity monitoring to
understand the health needs of
subgroups within populations

OPPORTUNITIES TO ACCELERATE ACTION
Monitoring of dementia-related
indicators through WHO's Global
Dementia Observatory

Implement health inequity
monitoring with resources from
WHO’s Health Equity Monitor9

Implementation of WHO’s SCORE
technical package8 to strengthen
health data and information systems
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8

See: https://www.who.int/data/data-collection-tools/score (accessed 11 July 2021).

9

See: https://www.who.int/data/gho/health-equity (accessed 11 July 2021).
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BOX27

Concluding remarks

The Global Dementia Observatory
The Global Dementia Observatory (GDO) is a data and knowledge exchange
platform that offers easy access to key dementia data from WHO Member
States across the following three domains: policies, service delivery, and
information and research. The GDO supports countries in measuring progress
on dementia actions outlined in the Global dementia action plan and assists
them in strengthening policies, service planning and health and social care
systems for dementia.
Through data collection and monitoring of progress, the GDO supports
countries in identifying gaps and challenges where actions are needed to
address dementia.

To support countries’ responses, WHO recently launched the GDO Knowledge
Exchange (KE) Platform (www.globaldementia.org) which contains key
resources to support the implementation of the Global action plan and its
seven action areas. The GDO KE Platform provides a space to share resources
(e.g., policies, guidelines, case studies and examples of good practice) and to
facilitate mutual learning and knowledge exchange. Resources included are
available at no cost and are reviewed by the WHO secretariat, a panel of peer
reviewers who are experts in the field of dementia, as well as a Focus Group of
people with lived experience of dementia.

It is evident that action must be taken to develop and strengthen
monitoring systems for dementia worldwide. As of August
2021, 62 WHO Member States participated in the GDO. That
is 32% and falls short of Global target 6 of the Global dementia
action plan.
The dearth of resources that are currently available for the
development of appropriate monitoring systems hinders the
implementation of evidence-based strategies to improve the
lives of people with dementia, their carers and families and
ease the burden on national health and social systems. Building
a comprehensive national surveillance system is a means to
strengthening the response to dementia worldwide, enhancing
countries’ capacities to address gaps in care provision and
ultimately improving the lives of people with dementia.

32%

of WHO Member States
participate in the GDO

The COVID-19 pandemic and its disproportionate effect
on the lives of people with dementia has demonstrated the
importance of establishing robust mechanisms to gather
appropriate data and provide timely and effective responses to
health emergencies.

"The dearth of resources that
are currently available for the
development of appropriate
monitoring systems hinders the
implementation of evidencebased strategies to improve the
lives of people with dementia,
their carers and families and
ease the burden on national
health and social care systems."
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10. Dementia
research and
innovation
Context

“It is important for people living with
dementia to be involved in research
from the beginning to the end, to
ensure that research is appropriate
for their needs and that the research
topics undertaken are relevant.”

As the number of people with dementia rises, investing in
research and innovation is ever more important in order to
minimize the impact of the disease and improve the lives of
people with dementia and their carers (110) in line with the
vision of the Global dementia action plan. Developing new
prioritization strategies and implementing innovative health
technologies is paramount in advancing capabilities for
prevention, risk reduction, early diagnosis, disease-modifying
therapies and care for people with dementia. Action area 7
of the Global dementia action plan sets a target of doubling
dementia-related research output between 2017 and 2025.
Strengthening dementia research and innovation is also
aligned with objective 4 of the Mental health action plan (to
strengthen information systems, evidence and research for
mental health). Importantly, in order to guarantee that any
increase in dementia research is successfully implemented
with translatable impact, social and medical priorities must
be identified to guide Member States, which will ultimately
increase the likelihood of effectiveness and progress.

Howard Gordon,
United Kingdom

WHO
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In 2018, a report by the World Dementia
Council emphasized the need for all G7
countries to live up to the collective commitment
of significantly increasing the amount of funding
for dementia research (111). In 2019, G20
health ministers pledged to promote research
and development for healthy ageing, including
for risk reduction, early detection, diagnosis and
treatment of dementia.
Based on data submitted to the GDO, WHO’s
Global Observatory of Health Research and
Development and data centrally collected by
the WHO secretariat, this chapter provides

an overview of country-driven progress in
the implementation and funding of dementia
research programmes, as well as the current
status of research towards the achievement
of the global target for Action area 7. It also
analyses the participation of people with
dementia and their carers in the research
process and identifies gaps and opportunities
for improvement. Finally, this chapter features
country case studies, accelerators for action
and a spotlight on current activities being
developed by WHO.

Existence of national or subnational research plans

30%
63%

goal (112). Available data show that between
2011 and 2016 the overall research funding
in six out of the eight countries formerly part
of the G8 has in fact increased, albeit with
considerable variation between them (113).

37%
70%

No research plan

Progress to date
In 2013, during the G8 dementia summit,
countries committed to finding a cure or
disease-modifying therapy for dementia
by 2025, and to increasing significantly the
amount of funding as a means to achieve that

FIGURE 40

Research plan

Whether a country has a research plan in
place appears to be intimately tied to the
country’s income level, as no low-income or
lower-middle-income countries reported
having a dementia research plan. This is in
contrast to countries of higher wealth, where
31% of upper-middle-income countries and
50% of HICs reported having national or
subnational research plans.

64%

58%

on data submitted by 62 GDO countries,
37% of countries have dementia research
plans, of which 70% are national and 30% are
subnational research plans (Figure 40).

36%

Mental Health
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Dementia research plans can also exist as
part of a larger national research agenda on a
range of different disease topics. Of 62 GDO
countries, 33 have a dementia research plan
included into another research plan, of which
52% are integrated into mental health, 64%
into ageing, 58% into neurodegenerative
diseases and 36% into NCDs (Figure 41).

Dementia research plan integrated into other research agendas

52%
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Subnational

FIGURE 41

Existence of a dementia research agenda
The extent of prioritization of dementia
research can be measured by the existence
of research agendas or plans specifically
designed for dementia. Worldwide, based

National

Ageing

Neurodegenerative
diseases

NCDs

Dementia research and innovation

WHO

221

The implementation of research plans needs to be
accompanied by the allocation of appropriate funding
and infrastructure to enable scientific breakthroughs and
innovative interventions, and to have their impact effectively
translated into benefits to society. Currently, 37% of GDO
countries have allocated funding specifically for dementia
research. Notably, the existence of any kind of dementia plan,
dedicated or integrated, is associated with an increase in
funding allocation for dementia research. Specifically, 47% of
countries that have a dementia plan possess dedicated funds
for dementia research, whereas only 16% of countries that do
not have a dementia plan have a dementia-specific research
funding allocation.

37%

of GDO countries have
allocated funding
specifically for
dementia research
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The staggering socioeconomic impact of dementia and other
brain disorders on society has not translated into financial
support that pushes forward care and therapeutic research
(114). The COVID-19 pandemic has exacerbated an already
existing disproportionate lack of funding for neurological
disorders worldwide. With recent reports of funding cuts to
brain research, the dire consequences of the pandemic are
likely to slow down progress in research and innovation for
dementia (115).
Investments in research are also needed in the areas of
social science, public health and implementation science.
Epidemiological studies are crucial to provide adequate
data that will ultimately help to evaluate the readiness of a
country and its national health system in caring for people with
dementia. These studies are also needed to track prevalence
and incidence of dementia, understand risk and protective
factors, and to observe the impacts of public health measures.
GDO data show that countries that allocate funds to dementia
research have, on average, 2% higher dementia prevalence
(Figure 42). Another trend that can be observed is the lower
proportion of LMICs allocating funds for dementia research
as compared to HICs. Although LMICs show an overall lower
dementia prevalence, it is worth noting that the prevalence
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FIGURE 42

Dementia research investment relative to dementia prevalence
5.97%
Governamental funds allocated
to dementia research

Enabling the research
environment and funding

of dementia is expected to increase at much higher rates in
LMICs as compared to HICs, warranting an increased focus on
and investment in dementia research, innovation and related
areas, especially in LMICs.

No

2%

Yes

7.98%
2%

4%

6%

8%

10%

12%

Dementia prevalence (+65 population)

HICs

An increase in investment in dementia
research is imperative to drive progress in
several research areas. In particular, the
Global dementia action plan recommends
a focus on budget allocations that will
promote national and international research
collaboration, encourage data-sharing and
open access research to reduce redundancies,

LMICs

and support the retention of a dementia
research workforce. Further, interdisciplinary
research collaboration is essential to ensure
that the knowledge of basic research is
transferred into preclinical and clinical
research, and ultimately that it will promote
effective changes in the lives of people with
dementia, their families and their carers.
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Only
2.6%
of research
collaborations
with LMICs

WHO’s Global Observatory on Health Research and
Development10 is a data platform that reports on a number of
indicators for health research, including funding distribution
and research collaboration resulting from grants for health
research by major funders. Data available from 2019 show that,
although funding allocation for Alzheimer’s disease and other
dementias has increased, it is primarily restricted to HICs such as
Canada, theUnited Kingdom and the United States of America.
Accordingly, out of the 50 organizations/institutions that received
the largest number of grants for Alzheimer’s and other dementias
for that year, 41 were from the United States of America, six from
the United Kingdom and three from Canada. This discrepancy
also influences with whom the institutions establish research
collaboration – out 178 direct research grants, 100% were
offered to high-income country institutions. These 178 grants
have led to the establishment of 540 instances of research
collaboration, of which 527 were with institutions in other highincome countries, 11 in upper-middle-income countries and only
three in lower-middle-income countries. No collaboration with
low-income countries was reported in this data set.

BOX 28

Data – the key to unlocking answers for Alzheimer’s disease
The Alzheimer’s Disease Data Initiative (ADDI) is a new global effort that aims
to advance innovation for Alzheimer’s disease (AD) and related dementias. Led
by Bill Gates and a coalition of partners, the initiative connects researchers
with the data needed to generate insights and inform the development of
improved treatments and diagnostic tools.
In November 2020, Gates announced ADDI on Gates Notes and unveiled
its AD Workbench which is a data-sharing and analytics platform that
empowers researchers around the world to share data, resources and tools
to achieve the ADDI vision of accelerating research into Alzheimer’s disease.
With AD Workbench, researchers will have the ability to work with multiple
interoperable data sets from different sources, allowing them to securely
add, access and transfer data from other platforms. This ability to access and
share data and collaborate with other scientists and researchers will increase
the speed of discoveries and innovations for Alzheimer’s Disease and related
dementias. Additionally, the AD Workbench provides a space for open access
models, applications and algorithms that will expand the Workbench’s existing
analytics for the benefits of advancing dementia research.

Collaboration and data sharing
To address the above challenges and to cultivate an equitable
and collaborative environment, several initiatives worldwide
have the goal of increasing data-sharing activities by creating
platforms that will make data more accessible and will connect
dementia researchers. In these efforts, WHO strongly
supports the establishment of cross-regional collaboration
with emphasis on the inclusion of LMICs, acknowledging
country-specific needs and moving towards the equitable codesign and co-production of science. An encouraging example
is the Alzheimer’s Disease Data Initiative (ADDI), that aims to
empower and increase the capacity of dementia researchers
by facilitating access to resources and enabling data-sharing
(see Box 28). Such collaboration has the untapped potential
of filling scientific gaps, promoting inclusion and equity, and
building research capacity in LMICs.

10 See: https://www.who.int/observatories/global-observatory-on-health-research-and-development (accessed 11 July 2021).
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Investments from the private sector and
the establishment of research coalitions are
needed to keep dementia research progressing.
Several national and international efforts exist
to address key challenges in the field; these
efforts aim to foster research collaboration,
support health-care system preparedness,
and accelerate the development of innovative
interventions while decreasing the cost
of research. The European Union’s Joint
Programme for Neurodegenerative Disease
Research (JPND) is one such initiatives that
brings together leading researchers, scientific
evidence and national funding bodies to
establish a collaborative research environment,

accelerate the discovery of treatments
and enable early diagnosis. Similarly, the
Davos Alzheimer’s Collaborative brings
together key actors from the private sector,
government leaders, NGOs and academics
to link current research efforts, scale up
successful models and create new initiatives
to tackle unaddressed challenges in several
areas. Finally, the Strengthening responses to
dementia in developing countries (STRiDE)
project aims to build capacity to conduct
research in LMICs and to turn that research,
using evidence, advocacy, and stakeholder
engagement, into actual policy change that will
have a positive impact on the lives of people
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affected by dementia. The project works with
local teams made up of senior and early-career
researchers and Alzheimer associations
in seven countries: Brazil, India, Indonesia,
Jamaica, Kenya, Mexico, and South Africa.
Despite these recent successful efforts,
there is still a need for higher government
investment and coordination of dementia
research. This is especially evident in lowerincome regions. GDO data show that no
low-income or lower-middle-income countries

specifically allocates money for dementia
research, whereas 25% of upper-middleincome countries and 56% of HICs report
the direct allocation of funds for dementia
research. Recent efforts have been made
in the United States of America towards
the allocation of funding for dementia
research, leading to the strengthening of
existing initiatives and the establishment of
new programmes and partnerships and the
sponsorship of clinical trials (Box 29).

BOX 29

The United States’ response to deliver on Action area 7 – Research and
Innovation
Fighting Alzheimer’s disease and related dementias (AD/ADRD) is
a national priority in the United States. Heightened interest in AD/ADRD resulted
in passage of the National Alzheimer’s Project Act in 2011 and unprecedented
increases in research funding targeting AD/ADRD in recent years.
Overall, the National Institutes of Health (NIH) annual investment in AD/ADRD
research has increased from US$ 631 million in the 2015 financial year to
an estimated US$ 2.8 billion in the 2020 financial year, or an increase of US$ 2.2
billion over the last five years. This tremendous public investment in research
has enabled enormous advances in our understanding of the complexities of AD/
ADRD. The funding has been applied to a broad, multidisciplinary programme in
which research moves through a pipeline from studies of basic mechanisms to
application in clinical trials and studies, as well as research on care and caregiving.
Recent boosts in funding have enabled:
Basic studies of the biology of AD/ADRD, including genetics, in
order to better understand what causes the pathology and which
interventions may protect against it.
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Translational studies that are yielding an increasing number
of new therapeutic targets that address treatment and
prevention. For example, investigators with the Accelerated
Medicines Partnership have identified over 500 potential new drug
targets for AD/ADRD.
Discovery and development of biomarkers, such as imaging and
blood tests, to track the course of disease and test the effectiveness
of new therapies.
Support of programmes and infrastructure to make data, knowledge
and research tools widely available to all researchers to address key
challenges in therapy development.
Clinical trials to test a range of potential therapies. NIH currently
sponsors some 230 active trials of interventions (both
pharmacological and non-pharmacological) to enhance cognitive
health in older adults and to prevent, treat or manage AD/ADRD.
Research to support improved quality of life for people living with
dementia and their carers/care partners.
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FIGURE 44

If the target of doubling dementia research
output by 2025, as set by the Global
dementia action plan, is to be achieved,
urgent action is needed to support dementia
research and create an environment where
this research is prioritized. Yet, due to the
lack of dementia awareness in all spheres
of society, accompanied by a challenging
research environment and consequent
decreased interest, dementia research
output accounts for less than 1.5% of the
total health research output across all WHO
regions (Figures 44 and 45).

African Region

0.1%

Region of the Americas

0.6%

Volume of dementia research
by income level as % of total
research

1.1%
Eastern Mediterranean
Region

0.2%

0.3%
1.3%

European Region

HICs

South-East
Asia Region

0.2%

Western Paciﬁc
Region

0.7%

LMICs

141 000

Over the past decades, the repeatedly
unsuccessful clinical trials in the field,
combined with high costs for research and
development, resulted in dementia research
being deprioritized by various stakeholders,
including within the private sector. Indexed
peer-reviewed publications on life sciences
and the biomedical databases (e.g. PubMed)
can be used to track the research output
pertaining to different disease areas and serve
as a proxy for the amount of research being
conducted. These data show that the research
output on other NCDs such as cancer, heart
conditions, kidney disease, diabetes and
depression is substantially higher than the
output on dementia (Figure 43).

Volume of dementia research as
% of total research by WHO region

FIGURE 43
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Depression
2017

Kidney disease

92 700

97 000

22 200

21 700

13 500

19 000

18 700

13 000

13 700

13 200

7 500

Stroke
2007
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10 200

10 200

5 300

10 100

9 900

5 600

69 500

96 100

Global research output on selected NCDs (2007, 2017 and 2018)

145 600

Dementia research output

FIGURE 45

Diabetes

Cardiovascular disease

Neoplasm

2018
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Innovation and novel
technologies for dementia

43%

of GDO countries do
not involve people with
dementia in research
development process

Multiple fields within the health and social care sector are
beginning to utilize and implement innovative technologies
such as robotics, artificial intelligence and telemedicine
to provide support and manage long-distance treatment,
diagnosis, and many other services, especially in the context
of the COVID-19 pandemic. There is growing interest in,
and demand for, the use of innovative health technologies at
all stages of the dementia care pathway. Innovations aim to
enhance knowledge, skills and coping mechanisms in order to
improve and support the daily lives of people with dementia
and their carers. In particular, innovations should meet
identified needs in an evidence-based and age-, gender- and
culturally sensitive manner.

Dementia research
participation, engagement
and involvement
In March 2015, during the first WHO Ministerial Conference
on Global Action against Dementia(11), participants
reinforced the need to empower people with dementia and
support their full and active engagement in society. Similarly,
Action area 7 calls for more inclusiveness of people with
dementia, their carers and families, in all areas of research.
GDO data show that only 14% of countries frequently involve
people with dementia in the research process; in 21% of
countries there is occasional involvement, in 23% of countries
there is rare involvement, and 43% of countries report that
people with dementia are not at all involved in the research
development process (Figure 47).
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FIGURE 47

Extent of involvement in the research process by people living with dementia
as reported by countries

14%
43%

21%

Frequently
Sometimes

23%

Although some progress has been made in
including people with dementia, carers and
families in the research process and monitoring
their participation, greater efforts should be
made to ensure the involvement of people with
lived experience in the research process. If
progress is to be realized and the lives of people
with dementia are to be improved, they must

Rarely
Not at all

be seen as key stakeholders from research
conceptualization to its implementation.
Moreover, in order to ensure that the results
of research are generalizable and strategies
implementable across different regions,
the diversity of backgrounds – including
socioeconomic and ethnic – within countries
and across income levels must be reflected.

The way forward
In 2013, the former G8 countries collectively
committed to increase their coordination for
greater innovation and to increase structured
funding for dementia research by setting an
ambitious goal of identifying a cure or diseasemodifying therapy by 2025. Similarly, in 2017,
all 194 WHO Member States adopted the
Global dementia action plan and committed
to strengthen their response to dementia,

support people with dementia and their
families and achieve the targets set by the
action plan. This commitment was further
reinforced by the G20 countries in 2019 when
they recognized the impact of dementia and
urged countries to develop ambitious national
responses and adopt integrated approaches in
line with the Global dementia action plan.
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However, while progress has been made in some areas,
research and innovation in the dementia field has yet to
receive more attention and support. The actions proposed in
the Global dementia action plan are key to creating an enabling
research environment in which dementia research is seen as
a priority and a constant stream of investments will allow for
scientific breakthroughs and sustainable research. Figure 48
outlines proposed actions, identified actions and opportunities
to accelerate dementia research.

The lack of dementia awareness, insufficient
funding and a fragmented research landscape
together present major barriers to effective
research development and implementation.
Moreover, the under-representation of LMICs
due to scarce funding and insufficient research
capacity, together with the exclusion of people
with dementia and carers from the research
development, hinders inclusiveness which
is a vitally necessary approach in dementia

research. In order to support worldwide
innovation in dementia, and to address the gaps
and barriers that stand in the way of effective
actions, several initiatives aim to increase
research collaboration and data-sharing in
order to fast-track innovation in the field.
WHO is developing the Dementia Research
Blueprint (Box 30) as a global coordination
mechanism to enable and facilitate policy in the
area of dementia research.

FIGURE 48

Proposed actions, identified barriers and opportunities to accelerate
dementia research
PROPOSED ACTIONS
Develop, implement and monitor the
establishment of a national research
agenda on prevention, diagnosis,
treatment and care of people with
dementia
Increase investment in dementia
research and innovative research
governance
Foster the development of
technological innovations
Promote equitable opportunities and
access for people with dementia and
their carers to be part of clinical and
social research that concerns them
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BARRIERS
Lack of dementia awareness at all levels
of society, leading to decreased interest
and support for research

OPPORTUNITIES TO ACCELERATE ACTION
WHO Dementia Research Blueprint to guide:
research prioritization exercises

Insufficient funding for dementia
research and its implementation aggravated by the COVID-19 pandemic

establishment of collaboration and data-sharing initiatives

Fragmented research landscape with
scarce data-sharing initiatives and open
access resources

equitable access to research funding

Insufficent research capacity in the field,
with under-representation of LMICs at
the forefront of dementia research

promotion of the availability of open access data

institution of co-research environments with the inclusion of
patients and carers in the research development process
Targeted actions based on evidence collected through WHO’s Global
Dementia Observatory and GDO Knowledge Exchange Platform

Exclusion of people with
dementia and carers from
research development
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BOX 30

Dementia Research Blueprint
Global research prioritization is necessary to ensure that ongoing research
efforts cover critical areas within the full care pathway (including prevention,
treatment, cure and implementation science), in ways that harmonize
investigative approaches and reduce redundancies. Moreover, research efforts
must be rooted in equity, diversity, and inclusiveness, be person-centred and
family inclusive. This necessitates building greater research capacity in all
income settings, as well as developing mechanisms to ensure inclusion of
people with dementia and their carers in all research activities.
To this end – and building on the successful WHO R&D blueprints for infectious
diseases (116) – WHO is developing the WHO’s Dementia Research Blueprint.
Being the first in the context of NCDs, the Blueprint aims to accelerate global
dementia research and innovation and make research more productive and
efficient, as well as promote research capacity-building in low-resource settings
and ensure inclusiveness at all stages from generation to implementation.
Being developed with active contributions from a diverse group of stakeholders,
the Blueprint will catalyze processes for increased investment in dementia
research and innovation, increase capacity-building in all income settings, and
foster uptake and equitable dissemination of effective interventions in both
policy and programme planning. By leading such a coordination mechanism for
dementia research, WHO’s Dementia Research Blueprint can provide direction to
funders for research investment, increase the profile of dementia research and
innovation in the global agenda and ultimately enable and facilitate policy-making
for dementia research.

Concluding remarks
While different initiatives have been put in place to push
dementia research forward and address long-standing gaps, the
COVID-19 pandemic has created additional barriers that must
be overcome. With reports of funding disruption and dementia
research being deprioritized, it has never been so important to
find synergies and avoid duplication in research efforts.
Given the complexity of the disease, dementia cannot be
solved by working in silos. If we are comprehensively and
meaningfully to improve the lives of people living with
dementia, their carers and families, we must reach beyond
our traditional ways of doing research and find better
strategies to coordinate between sectors and stakeholders,
including governments, multilateral organizations, academic
institutions, civil society, people living with dementia and
the private sector. Finally, promoting equitable inclusion
and research capacity-building in lower-income settings, as
well as ensuring the meaningful participation of people with
dementia, their families and carers in research, will foster an
environment where scientific discoveries are translatable
and deliver higher impact.

"If we are comprehensively and
meaningfully to improve the lives
of people living with dementia,
their carers and families, we must
reach beyond our traditional ways
of doing research and find better
strategies to coordinate between
sectors and stakeholders."
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Annexes
Annex 1 Making dementia a public health
priority – the Global dementia action plan
The World Health Organization (WHO) published its
first report on dementia Dementia: a public health priority,
prepared in collaboration with Alzheimer’s Disease
International (ADI), in 2012. That report summarized
the challenges that countries and societies – but first and
foremost people with dementia and their carers across the
world – were facing and continue to face.
To address these global challenges, a number of international
efforts have been undertaken in recent years (see Box 31),
leading to the adoption of the Global action plan on the public
health response to dementia 2017–2025 (2).

BOX 31

International efforts to address dementia
2012

WHO launched the report Dementia: a public health priority in
collaboration with Alzheimer’s Disease International (ADI)

2013

The United Kingdom hosts G811 summit on dementia followed
by G712 legacy events

2014/15

G7 legacy events on dementia in Canada, Japan, the United
Kingdom and the United States of America

2015

First Ministerial Conference on Global Action Against
Dementia

2017

Global action plan on the public health response to dementia
2017–2025
Launch of WHO’s Global Dementia Observatory (GDO)

2019

G2013 Osaka Leaders’ declaration committing to a
“comprehensive set of policies to address dementia, including
promoting risk reduction and sustainable provision of longterm care as well as inclusive societies aiming to improve
quality of lives of people with dementia and carers”.

11 The G8 dementia summit was held in London on 11 December 2013, together with government ministers, researchers,
pharmaceutical companies and charities. In 2013, the following countries took part in the meeting: Canada, France, Germany,
Italy, Japan, Russia, United Kingdom and United States of America.
12 The G7 (Group of seven) is an intergovernmental political forum involving Canada, France, Germany, Italy, Japan, United
Kingdom and United States of America.
13 The G20 is the international forum that brings together the world’s major economies. Its members are Argentina, Australia,
Brazil, Canada, China, France, Germany, India, Indonesia, Italy, Japan, Republic of Korea, Mexico, Russia, Saudi Arabia, South
Africa, Turkey, United Kingdom, United States of America and the European Union.
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The vision of the Global dementia action plan is “a world in
which dementia is prevented, and people with dementia and
their carers live well and receive the care and support they
need to fulfil their potential with dignity, respect, autonomy
and equality”. Concretely, the plan aims to improve the lives
of people with dementia, their families and the people who
care for them, while decreasing the impact of dementia on
communities and countries. Areas for action include:

making dementia a public health priority through policy and legislation;

global action plans and strategies, decisions
and resolutions adopted as international
commitments, including the forthcoming
Intersectoral global action plan on epilepsy
and other neurological disorders.14
Reaching the targets included in the Global
dementia action plan is intimately connected
to the achievement of other high-level
commitments such as the 2030 Agenda for
Sustainable Development and the Sustainable
Development Goals (SDGs), the United

Nations (UN) Convention on the Rights of
Persons with Disability (CRPD), the Political
Declaration of the High-level Meeting of the
General Assembly on the Prevention and
Control of Non-communicable Diseases
(2018), the UN Decade of Healthy Ageing
2021–2030, commitments to UHC and
the Declaration of Astana on strengthening
primary health care (2018), and the 2019
Okayama Declaration of the G20 Health
Ministers(31).

raising dementia awareness and inclusion;
reducing the risk of dementia;
improving dementia diagnosis, treatment and care;

Annex 2 WHO & UN initiatives relevant for
dementia risk reduction

developing support and services for dementia carers;
strengthening health information systems for dementia; and
fostering research and innovative technologies.

The Global dementia action plan is deeply
grounded in principles such as human rights,
empowerment and the engagement of people
with dementia and their carers, evidencebased practice for dementia risk reduction and
care, multisectoral collaboration, universal and
social health coverage for dementia, equity, and
appropriate attention to dementia prevention,
disease modification, cure and care.
Specifically, preventing dementia for those
at risk represents an important component
of achieving population health for all and is
required to ensure that more people enjoy
better health and well-being. Similarly, timely
and affordable access to quality diagnosis,
treatment, care, rehabilitation and palliative
care for people with dementia, their carers
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and families is central to ensuring universal
health coverage (UHC) for all. Finally,
ensuring that the needs of people with
dementia are met within the context of the
ongoing COVID-19 pandemic, and also in
humanitarian crises and the aftermaths of
natural disasters, represents an integral
part of addressing health emergencies.
Additionally, socioeconomic inequities
increase risk factors and reduce protective
factors for whole communities; thus need
to be addressed using a whole-of-society
approach at both international and national
levels, with specific focus on vulnerable
or marginalized populations who may be
at increased risk. The Global dementia
action plan also supports numerous other

Global status report on the public health response to dementia

2005: FCTC Framework Convention on Tobacco Control: https://www.who.
int/fctc/en/
2010: Global Strategy to reduce the harmful use of alcohol: https://apps.who.
int/iris/handle/10665/44395
2010: WHO Package of essential noncommunicable (PEN) disease
interventions for primary health care in low-resource settings. Geneva: WHO;
2010. https://apps.who.int/iris/handle/10665/334186
Global recommendations on physical activity for health. Geneva: WHO; 2010.
http://www.who.int/dietphysicalactivity/publications/9789241599979/en/
2011, 2014, 2018: UN High-level meetings on noncommunicable diseases:
https://www.un.org/en/ga/ncdmeeting2011/
https://undocs.org/en/A/66/L.1
14 These include: the Strategy for Healthier Populations 2020–2030; the Decade of Healthy Ageing 2020–2030; the WHO
Global Disability Action Plan 2014–2021; WHO’s Global Action Plan for the Prevention and Control of Noncommunicable
Diseases 2013–2020; the Comprehensive Mental Health Action Plan 2013–2020; World Health Assembly Resolution
WHA67.22 (2014) on Access to Essential Medicines; and the WHO Guideline: Recommendations on Digital Interventions for
Health System Strengthening.
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Political declaration of the High-level Meeting of the General Assembly on the
Prevention and Control of Non-communicable Diseases, 2011
https://www.who.int/nmh/events/2014/a-res-68-300.pdf?ua=1
(Resolution adopted by the General Assembly on 10 July 2014)
2013: Global action plan for prevention and control of noncommunicable
diseases (2013-2020): https://www.who.int/nmh/events/ncd_action_plan/en/

Web annex Methodology for estimating
dementia cost
The methodology for estimating dementia cost can be
accessed via the following link: https://apps.who.int/iris/
bitstream/handle/10665/344479/9789240033269-eng.pdf

Strengthening health systems for treating tobacco dependence in primary
care. Geneva: WHO, 2013. https://apps.who.int/iris/handle/10665/84388
Prevention and control of noncommunicable diseases: guidelines for primary
health care in low-resource settings. Geneva: WHO; 2012.
http://apps.who.int/iris/bitstream/10665/76173/1/9789241548397_eng.pdf
2013: WHO Comprehensive mental health action plan https://www.who.int/
publications/i/item/9789241506021
2015: WHO First Ministerial Conference on Global Action against Dementia
https://apps.who.int/iris/handle/10665/179537
2016: Integrated care for older people (ICOPE): Recommendations on
interventions to improve physical and mental capacities of older people at
community level. https://apps.who.int/iris/handle/10665/258981
2017: WHO Global action plan on the public health response to dementia
2017–2025 https://apps.who.int/iris/handle/10665/259615
2018: HEARTS Technical package for cardiovascular disease management in
primary health care: evidence-based treatment protocols. https://apps.who.
int/iris/handle/10665/260421
2019: WHO Guidelines on risk reduction of cognitive decline and dementia:
https://apps.who.int/iris/bitstream/handle/10665/312180/9789241550543eng.pdf?ua=1
2019: Recommendations on healthy diet. http://www.who.int/en/news-room/
fact-sheets/detail/healthy-diet
2020: WHO guidelines on physical activity and sedentary behavior https://
apps.who.int/iris/handle/10665/336656
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For more information, please contact:
Department of Mental Health and Substance Use
World Health Organization
Avenue Appia 20
CH-1211 Geneva 27
Switzerland

Email: whodementia@who.int
Website: https://www.who.int/health-topics/dementia

